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Abstract
Mammalian cell cultures are used for production of biopharmaceuticals, e.g.
monoclonal antibodies. Only mammalian hybridoma cells contain the pathways
for antibody production, but due to their multicellular origin the cells have complex
nutrient requirements. Cell growth and antibody production are limited by supply
of essential nutrients such as glutamine and accumulation of toxic waste products
such as lactate. Many attempts have been made at tackling these challenges, e.g.
by optimising growth media to keep metabolite concentrations at optimal levels.
These approaches have been hampered by our ability to monitor relevant cell culture
parameters such as metabolite concentration dynamics in real time.
The aim of this study is to develop a solution to this problem using a synthetic
biology approach. Whole-cell bacterial biosensors for important culture parameters,
glutamine, leucine, alanine and lactate, were designed, built and characterised. The
biosensors were designed from natural metabolite-sensing systems, specifically the
Escherichia coli Ntr regulon, Lrp regulon and lldPRD operon and the Bacillus
subtilis GlnK-GlnL system. Characterisation of the biosensors in defined medium
using known lactate concentrations was followed by validation in mammalian cell
culture media and using cell culture samples.
A lactate sensor based on the lldPRD operon showed a reliable lactate-response
during initial characterisation and was chosen to determine lactate concentrations
in cell culture samples in parallel with lactate analysis using a bioprofiler. Generally,
the lactate concentrations from the two methods showed a good match. Data points
where the results differed showed that there are some sources of error in the usage
of the biosensor that could be addressed in future.
The results of this study also highlight the many challenges of applying synthetic
biology constructs to complex industrial contexts. The biosensors presented in this
study are more generally applicable in any experimental context that requires sensing
of metabolites.
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1 Introduction
1.1 Synthetic Biology
Synthetic biology is a new applications-driven field with the aim to apply engineering
principles to biology. The idea is that biological molecules are parts, which come
together to form devices and these in turn can form complex de novo systems with
predictable behaviour (Weber and Fussenegger, 2011). Using engineering principles,
such as modularity, characterisation and standardisation at every level of a biological
abstraction hierarchy, far more complex and predictable systems than ever before
can be engineered according to specifications. By synthetically reconstructing a
pathway, we can gain greater understanding of the underlying processes (Kampf and
Weber, 2010). To help the rapid assembly and testing of so-called biological “parts”,
high throughput DNA assembly and part characterisation platforms and standards
are being developed (Canton et al., 2008; Shetty et al., 2008). This fast-developing
field has been reviewed numerous times (Canton et al., 2008; Freemont and Kitney,
2012; Kitney and Freemont, 2012; Church et al., 2014). Successful outcomes of this
field so far include biological logic gates (Miyamoto et al., 2012), pattern-generators
(Basu et al., 2005) and biosensors (Gu et al., 2010; Wang, Barahona and Buck,
2013).
1.1.1 Principles of synthetic biology - Parts, assembly and
characterisation
Synthetic biology is based on a number of foundational principles of systematic
design (Figure 1.1). Projects that aim to design and build complex biological systems
should follow the design cycle, which outlines the steps in the process (Figure 1.1a).
Biological parts are biological objects that perform a biological function and may
be engineered to meet specified design or performance requirements (Canton et al.,
2008) (Figure 1.1b). They are usually engineered DNA sequences based on natural
ones (Canton et al., 2008). For instance, the biological object may be a promoter,
performing the biological function of gene expression control. This promoter may
be designed and engineered to switch on gene expression in response to the presence
of red light, which represents the performance requirement. Biological parts are
14
Figure 1.1: Principles of synthetic biology - Systematic design. a) The design
cycle. b) Biological parts. c) Biological abstraction hierarchy. d) Assembly
standards. e) Modularity. f) Characterisation standards. g) Chassis choice.
Further detail in the main text.
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collected in libraries or registries such as the Registry of Standard Biological Parts
[http://partsregistry.org], which today already holds thousands of parts.
Engineering biology is a less daunting task when we use a biological abstraction
hierarchy (Figure 1.1c). The idea here is that bioengineers can concentrate on
working at a particular level of the hierarchy, e.g. devices, and treat the lower
levels as “black boxes”, where the exact mechanisms of action do not need to be
known. Building devices and systems from parts is supported by assembly standards
and varied assembly methods (Figure 1.1d). After a genetic design for the desired
circuit has been drawn up, the circuit needs to be assembled physically. There are
numerous DNA assembly methods, but assembly remains one of the limiting steps
in synthetic biology. Common assembly methods include restriction enzyme-based
methods (for example BioBricks, Figure 1.2), PCR-based methods (for example
the Gibson DNA Assembly method) or gene synthesis by commercial companies
(Ellis et al., 2011; Goers et al., 2013). Another helpful concept in systems design is
modularity (Figure 1.1e). This means that modules could be exchanged for different
part of the same type, without having to significantly change the others. Assembly
standards can help enforce this.
Once the construct is assembled, the next step in the design cycle is characterisation
(Figure 1.1f). This involves experimental testing to understand the behaviour of the
part. The exact method of characterisation depends on the parts to be characterised.
One of the developments in synthetic biology is the establishment of standardised
characterisation procedures (Canton et al., 2008; Kelly et al., 2009). Results of
characterisation can be recorded in standardised data sheets (Canton et al., 2008).
Ratiometric analysis allows comparison of data across institutions (Kelly et al.,
2009). Biological systems need a chassis, meaning an organism in which they can
be implemented (Canton et al., 2008). Chassis choice opens up many questions
for implementation and needs to be carefully considered (Figure 1.1g). Model
organisms such as Escherichia coli, Bacillus subtilis or Saccharomyces cerevisiae
have been commonly used in science and industry and are therefore well established
with molecular biology tools available. There are also cell-free systems available,
which have the advantage of reduced biological complexity (Chappell et al., 2013).
Synthetic biology is still a young field and there are many challenges still to be
overcome. Systems often suffer from cross-talk and context dependency. We
have limited knowledge and understanding of many biological parts and systems.
Biological systems will not work in all contexts and over arbitrarily long times.
During characterisation it needs to be determined whether the system fulfils the
performance requirements. It is useful to define conditions under which a system
fails during characterisation (Canton et al., 2008).
16
Figure 1.2: BioBrick standard assembly. Figure taken from [http://parts.
igem.org/Assembly:Standard_assembly].
1.2 Biosensors
Biosensors represent an increasingly important field (Belkin, 2003; French and
Gwenin, 2012; Goers et al., 2013; Park et al., 2013). The term biosensor has been
given a number of definitions. Generally, it refers to any, at least partially biological,
entity that be used to monitor a parameter of interest or target molecule (Goers
et al., 2013). Biosensors come in many forms, e.g. purified proteins attached to
electrodes or incorporated into membranes. Some biosensors are fully biological
systems, such as whole cells, others have a biological detection unit and information
is passed on to and processed by a chemical or electrical component. Biosensors
predate synthetic biology but many have been created using synthetic biology
principles (Checa et al., 2012). Numerous examples of biosensors have been created
e.g. (Aleksic et al., 2007; Voigt, 2012; Siedler et al., 2013). Biosensors form the
basis of most larger synthetic biology circuits (Bacchus and Fussenegger, 2013).
Logic gates, such as AND or NOT, and pathways start with a point of input, which
is detected by a biosensor. Biosensors are therefore needed to build such systems.
Being based on biological elements can bring advantages and disadvantages (Belkin,
2003; French and Gwenin, 2012; Goers et al., 2013). The advantages include high
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sensitivity and specificity, due to the underlying enzymatic or other biomolecular
mechanisms, and cost-effectiveness. The disadvantages are that biological elements
may not be as resistant to extremes of temperature and pH as other kinds of sensors,
and current limitations in our ability to engineer biological elements.
1.2.1 Whole-cell biosensors
Cells naturally monitor their external environment and respond to what they detect.
The underlying mechanisms tend to involve three processes: detection, transduction
and response (Checa et al., 2012; Miyamoto et al., 2012). Whole-cell biosensors are
genetically engineered cells that express a detection mechanism for the compound
of interest, which is linked to an output, often in the form of a detectable reporter
protein (Muranaka, 2009). Whole-cell biosensors tend to make use of natural sensing
and signalling pathways of cells, specifically the pathways of protein synthesis (Goers
et al., 2013). Sensor mechanisms can be transcriptional, translational or post-
translational (Marchisio and Rudolf, 2011) (Figure 1.3; Table 1.1). Depending on
the underlying detection mechanism, the target compound could be extracellular or
intracellular. Some “traditional” biosensors do not detect any specific metabolite
and instead monitor general cell growth and well-being. These are used as
environmental biosensors to detect general toxicity or “nutrient bioavailability”
(Belkin, 2003; Darwent et al., 2003; Goers et al., 2013). Over 100 different genetically
encoded biosensors have been developed for diverse targets, including ions, molecules
and enzymes (Palmer et al., 2011). Whole-cell biosensors have been previously
reviewed (Daunert et al., 2000; van der Meer and Belkin, 2010; Marchisio and Rudolf,
2011; Goers et al., 2013).
The mechanism of the biosensor defines the possible downstream effects (Goers
et al., 2013). Transcriptional or translational biosensors can translate the target
molecule input into transcription or translation, both of which ultimately lead to
protein expression. FRET (Fo¨rster resonance energy transfer) sensors provide an
output that can be measured, but which does not easily translate into a biological
output such as protein expression.
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Figure 1.3: Mechanisms of different types of whole-cell biosensors,
including transcription-based, translation-based and post-translational. In all
biosensors, detection of a target molecule leads to an observable signal of some
kind, but different biological mechanisms connect the two. More detail on the
different kinds of biosensors can be found in the main text and in Table 1.1.
Figure and legend adapted with permission from Goers et al. (2013).
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Whole-cell biosensors have advantages and disadvantages in their use over other
biosensors such as purified proteins (van der Meer and Belkin, 2010). Many of
the advantages relate to synthetic biology in general. There is potential for large
size of biosensor cell populations, rapid growth rate, low cost, improved stability
and easy maintenance (Belkin, 2003; Park et al., 2013). These factors mean that
whole-cell biosensors lend themselved for being used in remote areas where complex
chemical equipment and storage may be scarce. Once made, the biosensors can
be made easily by culturing, and do not require ongoing purification of proteins
(Muranaka, 2009). A whole-cell biosensor allows for the sensing input to be complex,
e.g. through logic gates and by combining several sensors. This allows for complex
information processing (Muranaka, 2009). Limitations of working with whole-cell
biosensors are as follows. The availability of appropriate natural sensors is limited,
and creating new ones might require elaborate protein engineering or directed
evolution (Muranaka, 2009). Limited information (e.g. structural, regulatory)
may be available about natural systems, thus making a synthetic biology approach
difficult. Cellular metabolism can interfere with sensing mechanisms (cross-talk).
Only a few bacterial biosensors have been commercialised so far, due to problems
with legislation concerning GM organisms and technical hurdles, such as shelf
life and scalability (van der Meer and Belkin, 2010). Whole-cell biosensors have
generally been used toxicity and bioavailability of contaminants in water and soils
(?). A well known example of an environmental whole-cell biosensor that is moving
towards commercial application is the arsenic biosensor basd on the 2006 Edinburgh
iGEM project [http://www.arsenicbiosensor.org/].
1.2.1.1 Reporters for biosensors
Any biosensor needs to link detection of a target to an observable output
signal (Figure 1.3; Table 1.1). Common types of signal include fluorescence,
bioluminescence and colour change. But there are also many other kinds of outputs.
For instance, general cell well-being or electrical potential. The most suitable choice
will depend on the context in which the biosensor is to be used. Reporter genes and
their uses for synthetic biology biosensors have been previosuly reviewed (French
et al., 2011). Some common biosensor outputs will be described below. This
summary of reporters for biosensors is based on that given in (Goers et al., 2013).
Fluorescence is a commonly used biosensor output. GFP and other fluorescent
proteins are widely used in molecular biology. These proteins emit fluorescence
at a certain wavelength when exposed to another wavelength of light. They offer
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Table 1.1: Characteristics of different classes of biosensors. Table adapted
with permission from Goers et al. (2013).
Transcription-
based
Translation-
based
Posttranslational
Response time Slow (minutes to
hours), though
there are exceptions
(Purnick and Weiss,
2009)
Intermediate
(minutes)
Fast (seconds)
Target location Intra- or extracellular
(receptor)
Intracellular Intra- or extracellular
(depends on protein
localisation)
Form Inducible promoters,
cell-surface receptors,
signalling proteins
RNA switches Immobilised enzymes,
multidomain fusion
proteins, surface-
displayed proteins
Metabolic bur-
den on the cell
Reporter protein
only expressed in the
presence of inducer.
Transcription
factor could be
constitutively
expressed
Need to make consti-
tutive mRNA
Need to express con-
stitutive protein
Ease of
construction
Can be easy to con-
struct using existing
plasmids
Engineering of DNA
is straightforward
these days
Can be difficult
to construct, as
may require protein
engineering
Specificity As the recognition of
the target is protein-
based, it can be very
specific. The final
output may not be a
direct measure of the
target molecule due
to downstream steps
in protein synthesis
Target recognition
can be very specific
with well-designed
aptamer. The final
output is a more
direct measure
of the target
molecule than for
transcriptionbased
sensors
As the recognition of
the target is protein-
based, it can be very
specific. The final out-
put is a more direct
measure of the tar-
get molecule than for
translationbased sen-
sors
Output Can be linked to gene
expression.
Can be linked to pro-
tein synthesis. Other
outputs also possible.
Cannot be linked to
gene expression. In
case of FRET, fluores-
cence output only
Examples Arsenic sensor (Alek-
sic et al., 2007);
Amino acid sensor
(Mustafi et al., 2011)
Theophylline sensor
(Desai and Gallivan,
2004);
Doxorubicin and
kanamycin sensors
(Ferguson et al.,
2013)
Glutamine and
glucose FRET sensors
(Behjousiar et al.,
2012);
Laconic lactate FRET
sensor (San Mart´ın
et al., 2013)
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an output that can be detected with great specificity and sensitivity. Several
fluorescent proteins can be used in the same experiment to allow monitoring of
several parameters in parallel and they allow very intuitive visualisation. The use of
more than one fluorescent protein is fundamental to FRET-based biosensors. Being
derived from natural proteins, they can be produced by cells and their genes can
be incorporated into gene circuits as reporter genes. This makes them very suitable
outputs for transcription- and translation-based biosensors. Many molecular biology
techniques exist for measuring fluorescence with cells being grown in various formats.
An alternative biosensor output to fluorescence is bioluminescence. Proteins such
as firefly luciferase are similar to fluorescent proteins in their use and advantages
for the engineering of biosensors, although the mechanism by which a detectable
output is produced differs. Here, the protein itself does not emit light, but it acts
as an enzyme that catalyses a reaction that leads to light emission. This means
that the reaction substrate needs to be provided during the experiment, although
in some cases, the genetic construct can be modified as well to allow the cells to
biosynthesise the substrate (French et al., 2011).
Some biosensors use colour change as their output. For any sensor that is intended to
be used in the field (e.g. in a field test kit or in a hospital at point of care), an output
that can be detected without the use of expensive equipment is desirable, making a
colour change more suitable for such contexts than fluorescence or bioluminescence.
This is a more varied category than the earlier mentioned and includes a number of
very different systems. Most of such systems require the addition of a substrate that
is chemically transformed into a related colour-producing compound. A commonly
used reporter that causes a colour change is the lacZ (b-galactosidase) gene and the
chromogenic compound 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (Xgal).
The 2010 Imperial College London iGEM team used the compound catechol and the
enzyme catechol 2,3-dioxygenase (C23O) to produce a yellow colour [http://2010.
igem.org/Team:Imperial_College_London]. The 2009 Cambridge iGEM team made
a set of colour generators using pigments [http://2009.igem.org/Team:Cambridge].
The 2006 Edinburgh iGEM team made an arsenic sensor with an output that
resulted in a pH change, which could be visualised using a coloured pH indicator
[http://2006.igem.org/wiki/index.php/University_of_Edinburgh_2006].
1.2.1.2 Engineering whole-cell transcriptional biosensors
The process of engineering whole-cell biosensors was extensively outlined by Goers
et al. (2013). When using synthetic biology principles, then the methods here
will be similar to the process outlined in Figure 1.1. When planning the design
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and assembly of a biosensor construct, there are certain general principles, even
though each construct will have specific context-dependent elements (Figure 1.4).
Appropriate control constructs need to be designed to be characterised alongside
the biosensor constructs. The methods of characterisation will depend on the sensor
design. Output characteristics of biosensors can be varied and, depending on system
requirements, there may be several useful kinds of dynamics (Figure 1.5).
Figure 1.4: Typical elements of a transcriptional biosensor and control cell
gene circuits and possible arrangements of biosensor and control circuits in
the cells. Biosensor constructs can contain different basic elements. The
relevant transcription factor could be overexpressed (green). An additional
reporter protein can be constitutively expressed for ratiometric analysis (blue).
Control circuits lack the responsive element that acts as the biosensor, but
could contain all other parts that are in the biosensor construct. Biosensor
and control constructs could be placed in the same cell or in different cells.
In the case of ratiometric analysis they can be located on the same plasmid.
Figure and legend adapted with permission from Goers et al. (2013).
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Figure 1.5: Idealised possible biosensor response characteristics. a) Dynamic
performance. This shows possible behaviours of biosensors over time after
addition of inducer. b) Static performance. This shows possible behaviours of
biosensors over concentrations of inducer. Various parameters can be gained
from such curves that can be used to describe the bevaiour of biosensors in
comparison with other sensors. Figure and legend adapted with permission
from Goers et al. (2013).
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1.3 Mammalian cell bioprocessing
1.3.1 Biopharmaceuticals
Biopharmaceuticals have become increasingly important in recent years (Reichert
et al., 2005; van Berkel et al., 2009; Kyriakopoulos and Kontoravdi, 2013).
Biopharmaceuticals include protein compounds such as hormones, growth factors,
therapeutic enzymes, vaccines and therapeutic monoclonal antibodies (mAbs) and
related products, of which the latter are currently the predominant and fastest-
growing group (Coco-Martin and Harmsen, 2008; Beck et al., 2010; Kyriakopoulos
and Kontoravdi, 2013). Clinical successes and approvals of therapeutics are
numerous (Coco-Martin and Harmsen, 2008; Beck et al., 2010; Weiner et al.,
2010). MAbs are currently used largely for treating cancer, inflammatory and
orphan diseases (Beck et al., 2010). Examples of currently used mAb cancer
therapeutics include Trastuzumab (Herceptin) for breast cancer, and Rituximab
(Mabthera) for non-Hodgkin lymphoma. Biopharmaceuticals such as mAbs are
very complex molecules and can be used to very specifically treat human conditions
(Kyriakopoulos, 2014). Past and recent successes promise continued developments
in this field with many new mAbs expected to be developed in coming years (Coco-
Martin and Harmsen, 2008). To expand the applicability and affordability of these
therapeutics, improvements in efficiency, effectiveness and specificity are sought at
all stages of the development, production and use of mAbs (Beck et al., 2010). MAb-
based cancer therapeutics are very costly. Process developments accounts for a large
fraction of the cost of bringing a drug to the market (Harms et al., 2002). Limiting
factors in mAb production include the timescale of the required cell cultures and
the yield of drug protein from these cell cultures (Kyriakopoulos, 2014). Reducing
production and processing costs by improving the methods used is therefore an
important aspect of improving affordability of mAbs and other drugs (Beck et al.,
2010; Zhou et al., 2011).
1.3.2 Bioprocessing
The aforementioned biopharmaceutical compounds are produced by large cultures
of mammalian cells in the field known as bioprocessing (Hu and Aunins, 1997).
Commonly used cell types in bioprocessing include CHO (Chinese hamster ovary),
mouse or human hybridoma and myeloma cells, of which mostly hybridoma cells,
and increasingly CHO cells, are used for the production of mAbs. Due to their
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multicellular origin mammalian cells are difficult to culture and have complex
nutrient requirements. For a lot of other industrial bioprocesses, the organisms
of choice are unicellular microbial cells, e.g. bacteria and fungi, which are
more easily cultured. Bacteria have many advantages over mammalian cells in
bioprocessing, including ease of manipulation, rapid growth rates and simpler
nutrient requirements. Before mammalian cell culture techniques matured, non-
mammalian cells were also more commonly used for biopharmaceuticals. However,
only mammalian cells contain the post-translational modification pathways of
glycosylation that are essential for the proper structure and function of mAbs (del
Val et al., 2010) and over the last few years, there have been many more approved
therapeutic proteins produced by mammalian cells than by microbial or yeast
expression systems (Coco-Martin and Harmsen, 2008). While expression systems
in Pichia pastoris are being considered (Vogl et al., 2013), today, mammalian cells
are the only kind of cells that can produce mAbs and be efficiently grown in lab or
industrial settings.
1.3.3 Metabolites are limiting factors in bioprocessing
All aspects of hybridoma (and generally mammalian) cell culturing have been subject
to study and attempted improvements (Hu and Aunins, 1997). As in any cell culture,
hybridoma cell cultures are limited by nutrient availability and metabolic waste
accumulation (Figure 1.6a). In many different kinds of cells these waste products
limit cell growth and mAb production (Glacken et al., 1986; Ozturk et al., 1992;
Kurano et al., 1990). Limiting factors in hybridoma cell cultures have been reviewed
by Newland et al. (1990).
The major limiting nutrients for hybridoma cultures are glutamine and glucose, but
there are also vitamins, salts and serum components. The major metabolic waste
products are ammonia and lactate (Hu and Aunins, 1997). Ideally, for maximum
product yield, waste products need to be kept to a minimal level, whereas nutrients
need to be kept at optimal levels, which does not automatically imply maximal levels
(see Fig. 1.6b). However, all these factors are very cell line-dependent.
For pharmaceutical purposes a very large amount of mAbs needs to be produced
using bioreactors, where the mammalian cells grow at high proliferation rates
(Newland et al., 1990). Initial process development is usually done in small
volumes using flasks. These processes are then upscaled to the volumes of industrial
bioreactors. This is a complex process requiring much optimisation as cells behave
differently in large bioreactors compared to flasks.
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Figure 1.6: Limiting factors in bioprocessing. a) Changes in bioreactor
cultures in bioprocessing. Parameters change over the course of a batch
culture. paramers of interest include cellular waste products (red) and
nutrients (blue). b) Hypothetical ideal bioreactor dynamics. Parameters
remain at their ideal level while cells are growing and product is being
produed. c) Mammalian cell metabolism. Glutamine and glucose shown in
blue, ammonia and lactate shown in red. Figure adapted from Newland et al.
(1990).
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In the bioreactor cells are initially subjected to very high glutamine and glucose
concentrations; much higher than those needed for growth and mAb production.
This results in high uptake rates of nutrients and subsequent high rates of
waste accumulation leading to inhibitory levels of waste products and metabolic
byproducts such as ammonia and lactate (Figure 1.6c) (Newland et al., 1990; Paredes
et al., 1999). These byproducts reduce cell viability and product yields as well
as introducing unwanted variability into cell culture bioprocesses (Young, 2013).
Cell lines based on tumour cells (such as myeloma and hybridoma cells) especially
produce a large amount of lactate (Newland et al., 1990). Mammalian cells and
tumour cell lines in particular are “wasteful” with metabolites, as they do not have
a regulated “metabolic policy” like healthy cells would do in a natural context
(Bonarius et al., 1996; Young, 2013). There is therefore a need for controlling cellular
nutrient intake and metabolism to optimise cell growth and production for industrial
purposes. Some ways in which this has been done will be outlined in the following
section.
1.3.3.1 Glutamine and ammonia
Glutamine and ammonia are metabolically linked in mammalian bioprocessing
(Figure 1.6c). This complex problem will be discussed here in detail to illustrate
limiting factors in mammalian bioprocessing. Glutamine in particular needs to be
present at optimal levels and is an example for a limiting factor in bioprocessing
that has extensively been subject to study and attempted improvement. Amino
acid metabolism plays an important role in mammalian cell metabolism (Sheikh
et al., 2005; Selvarasu, Karimi, Ghim and Lee, 2010). However, many aspects
of amino acid metabolism are still unknown (Kontoravdi, Wong, Lam, Lee, Yap,
Pistikopoulos and Mantalaris, 2007). The amino acid glutamine is involved in
several physiological processes within the cell as an energy source and precursor
for nucleotides, lipids, all non-essential amino acids and hence proteins (Newland
et al., 1990; Jeong and Wang, 1995; Europa et al., 2000). In the blood and many
tissues glutamine occurs at the highest concentration of all amino acids (Newland
et al., 1990). It has long been recognised that glutamine has many functions. Hans
Krebs noted that although “most amino acids have multiple functions, glutamine
appears to be the most versatile” (Krebs, 1980; Wilmore and Rombeau, 2001), and
glutamine catabolism can occur through eight different metabolic routes (Newland
et al., 1990; Ha¨ggstro¨m, 1991; Vriezen and van Dijken, 1998). For these reasons,
mammalian cell cultures require glutamine to be supplied in the culture medium
(Eagle, 1956).
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The high proliferation rates as occur in bioprocessing result in rapid glutamine
depletion (Jenkins et al., 1992). Cell cultures that lack sufficient glutamine will
undergo cell death (Jeong and Wang, 1995). Glutamine has been identified as one
of the most important limiting factors for cell growth and proliferation and hence
mAb production (Jeong and Wang, 1995). Provision of increased glutamine in the
culture medium cannot solve this problem, not only as the cells produce ammonia as
a byproduct of glutamine metabolism, but also as glutamine has a short half life and
decomposes extracellularly to produce toxic ammonia (Newland et al., 1990). Most
of the ammonia secreted by CHO cells comes from glutamine metabolism from the
reaction catalysed by glutaminase (Street et al., 1993). Different cell types display
different tolerances to ammonia, e.g. myeloma cells (one of the constituents of
hybridoma cells) are very sensitive to ammonia (Newland et al., 1990), while other
cell types, HDF and Vero, show no sensitivity to ammonia (Butler and Christie,
1994). Ammonia production from cellular metabolism is more significant than from
decomposition in the medium, especially in the later stages of a culture (at high
cell density), but decomposition still has an effect worth noting (Newland et al.,
1990). Both the ammonium ion (NH+4 ) and ammonia (NH3) tend to be present in
the culture medium, although the former predominates at a culture pH of about
7 (Newland et al., 1990). Ammonia and ammonium can also have different effects
(Schneider et al., 1996). Glutamine consumption also varies with presence of other
metabolites, e.g. at low glucose concentrations, glutamine consumption is regulated
by glucose and vice versa (Newland et al., 1990). As glutamine requirements are
cell population-dependent (O’Callaghan and James, 2008), there is no “one-size-
fits-all” solution for providing glutamine to mammalian cell cultures. Specific mAb
productivity (i.e. productivity per cell) is less sensitive than cell growth to the
effects of ammonia (Newland et al., 1990). However, volumetric mAb productivity
(productivity per volume) can be strongly affected, not only due a lower number of
viable cells, but also as ammonia may change mAb glycosylation patterns (Andersen
and Goochee, 1995; Wong et al., 2005).
It has long been known that cells release specific amino acids into the culture medium
during cell growth, specifically aspartate (Burleigh et al., 2011) asparagine and
alanine (Butler, 1987; Miller et al., 1988; Newland et al., 1990; Bonarius et al.,
1996; Vriezen et al., 1997; Paredes et al., 1999; Europa et al., 2000; Sheikh et al.,
2005; Selvarasu et al., 2009; Selvarasu, Kim, Karimi and Lee, 2010; Selvarasu,
Karimi, Ghim and Lee, 2010; Burleigh et al., 2011; Young, 2013). It is thought
that secretion is preceded by an intracellular build-up of ammonia (Newland et al.,
1990), and hence acts as a way to deal with the excess toxic waste product, with
alanine being a major endproduct of glutamine metabolism (Street et al., 1993). It
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was shown that alanine replaced ammonia as the major byproduct of glutamine-
metabolism at ammonia concentrations above 5 mM, although the exact pathways
involved are not yet fully elucidated (Butler, 1987; Miller et al., 1988; Newland
et al., 1990; Sheikh et al., 2005). This is one way in which ammonia reduces the
metabolic efficiency of cells, by forcing excretion of valuable metabolites (Schneider
et al., 1996). Alternatively, it has been suggested that ammonia accumulation simply
causes inefficient “overflow” metabolism (Burleigh et al., 2011). A study using NMR
with labelled nitrogen showed evidence that in cell culture metabolism glutamine
forms ammonia and that ammonia subsequently forms metabolites such as alanine
(Street et al., 1993).
The glutamine challenge in mammalian cell culture and proposed solutions have been
discussed several times, e.g. by Newland et al. (1990); Schneider et al. (1996) and
Genzel et al. (2005). It consists of two main aspects: (1) strong need for glutamine
source in the culture medium for cell growth and hence mAb production and (2)
toxicity of the glutamine byproduct ammonia, both from cellular metabolism and
glutamine decomposition in the medium. It has been argued that if the accumulation
of metabolites, such as ammonia, could be reduced, then a higher cell density could
be attained (Europa et al., 2000; Hu and Himes, 1989). So far there has not been a
complete solution to the glutamine-problem, which may partially be because the
metabolic pathways of glutamine and ammonia are still not fully elucidated in
mammalian cell culture (Newland et al., 1990; Young, 2013). Mammalian cells have
complex and variable behaviour and their metabolism and its regulation is often not
completely understood (Newland et al., 1990; Europa et al., 2000; Sheikh et al., 2005;
Selvarasu et al., 2009). There is also the problem that a lot of what is known about
hybridoma cell metabolism is from studying mouse and human cell and genome
data rather than human cell metabolism directly (Sheikh et al., 2005; Selvarasu,
Karimi, Ghim and Lee, 2010). This type of data may not give an accurate picture,
as hybridoma cells cannot simply be equated with either human or mouse cells.
These unique kinds of cells act differently to the cells from which they are derived.
There are a number of focussed studies of mammalian cell metabolism (Fernandez
et al., 1988), but a complete, experimentally validated, overall picture of hybridoma
cells is missing. Some studies have been conducted to obtain experimental ‘omics’
data on these cells (Yee et al., 2008; Meleady, 2007). Approaches include genetic
engineering (Selvarasu, Kim, Karimi and Lee, 2010) and systems biology approaches
(O’Callaghan and James, 2008; Kondragunta et al., 2012; Young, 2013). Studies
are further complicated by the fact that consumption and fate of metabolites are all
interdependent, e.g. glutamine metabolism is interdependent on glucose metabolism
and possibly serum concentration (Figure 1.6) (Newland et al., 1990; Vriezen et al.,
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1997). There is therefore a need to study the cells that are used industrially in more
detail to understand their behaviour and optimise their utilisation.
There are a variety of ways in which scientists have tackled the glutamine and
ammonia problem, which are summarised below. There are several main principles
that have been used: decreasing glutamine need of the cells or preventing ammonia
accumulation (either by preventing ammonia being formed in the first place or
removing it).
(1) Use of alternative expression systems. Cell types other than mammalian cells can
have simpler nutrient requirements, but would have to be genetically engineered to
be able to produce mAbs. For example, bacteria can usually live on simple nitrogen
sources, such as ammonia and produce glutamine. Attempts have been made to
use the Bacculovirus system (Deparis et al., 2003), bacteria (Carter et al., 1992;
Spiess et al., 2013) or plants (Mullard, 2011). Alternatively, there are certain kinds
of mammalian cells that do not show ammonia sensitivity, such as HDF and Vero
cells (Butler and Christie, 1994) or mammalian cells that have an intrinsic ability
to produce glutamine. CHO cells (Tjio and Puck, 1958) are the most commonly
used cells in the production of recombinant biopharmaceuticals and are ever more
commonly used to produce mAbs (Schlatter et al., 2005; Jayapal et al., 2007). They
naturally contain a glutamine synthetase enzyme, and can thus produce glutamine.
However, they still commonly need growth medium supplemented with glutamine
or nitrogen sources like glutamate, as they cannot produce enough to cover their
needs (Altamirano et al., 2000).
(2) Genetic engineering of mammalian cells. One way to overcome this problem
has been the genetic engineering of the mammalian cell line NS0 to insert a
gene for a glutamine synthetase enzyme. The presence of the enzyme acts as a
selectable marker in glutamine-free medium. This is commonly used as an expression
system called GS SystemTM ([www.lonza.com], glutamine synthetase gene expression
system). Hybridoma cells have also been engineered to lower accumulation of
ammonia and lactate (Paredes et al., 1999). Some hybridoma cells have been have
been successfully engineered to contain a glutamine synthetase enzyme, which made
them glutamine-independent but also reduced growth rate (Bell et al., 1995). There
have been recent attempts to combine metabolic engineering of mammalian cells
with fed-batch feeding strategies (see below) to prevent waste product accumulation
(Young, 2013).
(3) Decreasing or eliminating glutamine in the medium. It is possible to some extent
to change mammalian cell metabolism by adaptation. The exact growth conditions
(medium and bioreactor) influence mammalian cell metabolism and can be modified
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to overcome the glutamine problem (Vriezen and van Dijken, 1998). Adapting cells
to very low glutamine concentrations works for some, but not all, mammalian cells
(Bell et al., 1995). Glutamine can also be provided to mammalian cell cultures in a
different, non-ammoniagenic form. Provision of glutamine can be through dipeptides
such as Ala-Gln or Gly-Gln, which are much more stable than molecular glutamine,
and hence decrease ammonia accumulation by non-enzymatic decomposition [www.
sigmaaldrich.com] (Butler and Christie, 1994; Christie and Butler, 1994b). Certain
media components can be changed or replaced to change glutamine requirements. In
some cases, glutamine can be replaced by high concentrations of pyruvate (Genzel
et al., 2005). This approach allowed MDCK, BHK21 and CHO-K1 cells to grow
in glutamine-free medium with no need for an adaptation step. However, all these
cell lines contain some endogenous glutamine synthetase activity, so it is unlikely
that this approach will work with hybridoma cells. Low glucose lowers glutamine
uptake (Vriezen and van Dijken, 1998), which shows interdependence of different
metabolic pathways (Figure 1.6c). Glutamine and glucose have been replaced
with galactose and glutamate in CHO cell medium (Altamirano et al., 2000, 2001,
2004). Replacement of glutamine with glutamate was attempted as early as 1956 by
Eagle (Eagle, 1956; Newland et al., 1990; Hassell and Butler, 1990; McDermott and
Butler, 1993; Butler and Christie, 1994; Christie and Butler, 1994a). Decreasing
glutamine concentration or increasing glucose concentration may reduce glutamine-
consumption and hence ammonia production (Jeong and Wang, 1995). But the
glutamine-replacement tends to only work with cell types that contain glutamine
synthetase (Newland et al., 1990). When oxygen uptake rate is unconstrained then
cells take up less glutamine (to a similar level as other amino acids) (Vriezen and
van Dijken, 1998; Sheikh et al., 2005). This strategy is also used to adapt cells
to various other conditions, e.g. serum-free media (Europa et al., 2000) and lower
glucose (Newland et al., 1990) or pyruvate, but not all cell lines can be adapted to
everything (Genzel et al., 2005).
(4) Removal of ammonia from culture medium. Removal of ammonia is not
straightforward because of its high solubility and ion exchange characteristics
(Newland et al., 1990). While there have been promising approaches, none of them
fully solve the problem. Approaches have included addition of ammonia degrading
enzyme to culture media (Newland et al., 1990), dialysis bags (Iio et al., 1985),
in situ removal of ammonium and lactate through electrical means for hybridoma
cultures (Chang et al., 1995) and in situ removal of ammonia and fed-batch addition
of glutamine and glucose (Park et al., 2000). Perfusion culture to remova ammonia
improved cell growth and mAb production and keeps ammonia concentration under
an inhibitory level (Matsumura and Nayve, 1995).
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A very interesting approach involved co-culture with rat liver cells (hepatocytes) to
remove ammonia from the culture medium of CHO cells (Choi et al., 2000). Some of
these approaches have also been used in the attempt to make artificial livers. In some
microbial industrial processes, e.g. amino acid production, microbial contaminants
that grow on by-products can actually increase the yield and purity of the product
(Hermann, 2003)
(5) Fed-batch culturing mode. A common and well known strategy to reduce
ammonia toxicity is the semi-continuous fed-batch culturing mode (Glacken et al.,
1986; Ljunggren and Ha¨ggstro¨m, 1990; Xie and Wang, 1994; Ljunggren and
Ha¨ggstro¨m, 1994; Linz et al., 1997; Nadeau et al., 2000; Hermann, 2003). This
method reduces glutamine and glucose concentration in culture medium (Europa
et al., 2000), reducing accumulation of toxic byproducts. Fed batch is also useful
as a research tool, as it allows the conditions in the culture medium to be changed
during the course of a run, for instance to elicit a metabolic change in the mammalian
cells (Europa et al., 2000). Addition of nutrients can be according to the results of
on-line medium analysis (Lee et al., 2003) or a pre-determined algorithm. Most
industrial bioreactors now use the fed-batch mode instead of the previously used
batch-mode in which the cell culture is provided with all the nutrients needed for
the entire run at the beginning. There is great demand for automatisation in the
bioprocessing industry, already quite successful in microbial production (Hermann,
2003). Generally, fed-batch is a very successful approach, however it requires
extensive on-line monitoring of cultures or alternatively knowledge about culture
dynamics that can feed into a model.
Automatic sensing and monitoring and adding (interface with computer) has
been discussed in bacterial bioprocessing (Hermann, 2003). For mammalian cell
bioprocessing this is not quite possible yet, as the monitoring alone is challenging
enough.
Overall, in order to maximise product yield from mammalian cell cultures, it is
important to provide an ideal growth environment for the cells at all times. Since
the environment is constantly changing during the course of a cell culture, ways
to monitor various culture parameters on-line are needed. By monitoring culture
parameters in detail and in real time, we can gather information needed to optimise
culture conditions and upscale processes. In short, bioprocess control demands
bioprocess monitoring.
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1.3.3.2 Glucose and lactate
Glucose is the main source of carbon in mammalian cell cultures. Lactate (also
known as lactic acid) is a byproduct of cellular glucose metabolism. High levels of
lactate can decrease medium pH below the optimal range (Newland et al., 1990).
This is generally not a great problem in short term pH-controlled cultures, however it
does become problematic in longer cultures, which are what the field of bioprocessing
is working towards (Newland et al., 1990).
At later culture stages, some cells can use lactate as a carbon source when
glucose has been depleted (Newland et al., 1990). Such processes can introduce
unwanted variability into processes. Attempted solutions to this overlap to some
extend with the attempted solutions to the glutamine problem (see above). For
example, replacement of medium components has also been used to address lactate
accumulation, as glucose has been replaced with fructose, galactose, or mannose
(Glacken et al., 1986; Barngrover et al., 1985; Newland et al., 1990). Similarly for
metabolic rewiring of mammalian cells (Young, 2013). By keeping glucose at a
low level, mammalian cell metabolism was altered to a state with decreased lactate
production (Europa et al., 2000). siRNA has been used to knock down genes in
lactate metabolism to reduce lactate production by mammalian cells and increase
productivity (Zhou et al., 2011).
1.3.4 Synthetic biology in mammalian bioprocessing
While synthetic biology has already been applied to microbial bioprocessing, there
have so far only been limited applications in mammalian bioprocessing (Rollie´ et al.,
2012). One aspect of synthetic biology as relevant to mammalian cell bioprocessing
is the genetic engineering of mammalian cells. In recent years there have been
rapid advances in designing and implementing synthetic circuits and more complex
systems in mammalian cells, largely led by the Fussenegger group at the ETH
(Weber et al., 2007; Weber, 2009; Weber et al., 2009; Weber and Fussenegger,
2011; Ausla¨nder and Fussenegger, 2013; Bacchus and Fussenegger, 2013), including
artificial cell-to-cell communication (Wang et al., 2008), gene switches (Ausla¨nder
and Fussenegger, 2013) and many other systems. More work needs to be done to
advance synthetic biology in mammalian cells and overcome current limitations. One
of the limitations is random integration into the genome of transgene elements in
mammalian cells. Systems to overcome this include the Cre/Lox recombinase and
FRT/FLP recombinase (Weber and Fussenegger, 2002). Weber (2009) suggested
that the synthetic biology “BioBrick” registry be extended to include “CytoBricks”,
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well-characterised mammalian cell lines containing transgenes. Some examples
of mammalian cell engineering were mentioned above in tackling limitations in
bioprocessing. One example of mammalian synthetic biology used in bioprocessing
is the dvelopment of intracellular FRET biosensors for glutamine and glucose for
mammalian cells (Behjousiar et al., 2012). These are intended to be used during
early stage process optimisation.
1.4 Monitoring of metabolites in bioprocessing
As discussed previously, bioprocess monitoring is of major importance in biopro-
cessing. In mAb production by hybridoma cells, control of key nutrients is essential
to cell viability and production and control is only possible with some level of
monitoring (Mulchandani and Bassi, 1995). Whilst optimising a process, the aim is
often to monitor a large number of parameters to learn as much as possible about the
cells, which are useful for scale-up (Harms et al., 2002). As there are many potential
parameters of interest, there are a number of methods for (mammalian) bioprocess
monitoring. Parameters of interest include oxygen and carbon dioxide levels, pH, cell
mass, cell viability and the concentrations of ions and metabolites, including those
already discussed (Figure 1.7a). The various methods for bioprocess monitoring
have been previously discussed (Mulchandani and Bassi, 1995; Harms et al., 2002;
French and Gwenin, 2012). There are stringent requirements for sensors that are to
be used in bioprocessing, including sterility, temperature and pH tolerance, life-time
and detection range, which limits the number of sensor methods that reach a useful
level of applicability (Harms et al., 2002).
Sensors are usually based on electronic, chemical or enzymatic mechanisms. Purified
proteins attached to electrodes or incorporated into membranes are often used as
biosensors in bioreactors (Inaba et al., 2003; Kwan et al., 2004). Numerous examples
of such biosensors have been created e.g. for glutamine (Cattaneo, Male and
Luong, 1992; Cattaneo, Luong and Mercille, 1992; White et al., 1994; Mulchandani
and Bassi, 1996), glutamate (White et al., 1994; Mulchandani and Bassi, 1996)
or lactate (White et al., 1994; Rohm et al., 1996; Male et al., 1997). Certain
commercially available systems combine a number of such sensors for monitoring
multiple parameters in parallel and some of these allow on-line measurements:
Yellow Springs Instruments [www.ysi.com], Nova Bioprofile-Analyzers [http://www.
novabiomedical.com/], e.g. (Derfus et al., 2010), or Finesse [http://finesse.com/]
analysers. For instance, equipment from the Nova bioprofile range use ion-
selective electrode potentiometry, amperometry, and enzymatic reaction-dependent
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Figure 1.7: Bioprocess monitoring. a) Parameters of interest that are
commonly monitored.Cellular waste products (red) and compounds that are
needed by the cells (blue). b) Possible monitoring method using flow injection
analysis. Small amounts of culture medium are diverted from the main reactor
and channelled towards sensors for monitoring and analysis. See more detail
in the main text. Diagram adapted from Mulchandani and Bassi (1995).
biosensors to monitor electrolytes and metabolites in samples (Derfus et al., 2010).
Some analysers use the acquired data to control the feed of a fed-batch culture
(Wong et al., 2005; Genzel et al., 2005). Amino acids can be measured using HPLC
methods. However, even though the technology is constantly improving, many of
these methods have a number of disadvantages in their use, as they tend to be
expensive, oﬄine, work-intensive, have limited detection sensitivity (Table 1.2) and
require large sample volumes and sample processing. Automatic monitoring and feed
control (using an interface with a computer) is already being studied in bacterial
bioprocessing (Hermann, 2003). For mammalian cell bioprocessing this is not quite
possible yet, as the monitoring alone presents a great challenge.
The use of whole-cell microbial biosensors in bioprocessing has been discussed
(Mulchandani and Bassi, 1995; Bracewell and Polizzi, 2014). Generally, the
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Table 1.2: Detection ranges of existing monitoring processes for cell culture
metabolites.
Metabolite Detection range Reference
Glucose 0.2 - 15.0 g/L Nova Biomedical
Lactate 0.2 - 5.0 g/L Nova Biomedical
Glutamine 0.2 - 6.0 mmol/L Nova Biomedical
Glutamate 0.2 - 6.0 mmol/L Nova Biomedical
Ammonium 0.2 - 25.0 mmol/L Nova Biomedical
advantages and limitations of whole-cell biosensors that were discussed above, apply
especially in a complex environment such as this. There are potential problems
with contamination of mammalian cultures with microbial cells and the sensors
may show decreased specificity in the complex culture medium. However, the
microbial cells can also be maintained for a long time using cheap growth medium
(Mulchandani and Bassi, 1995). Smart reactor set-up can be used to vastly lower
the chances of contamination. Biosensor cells could be immobilised using gel
entrapment (Mulchandani and Bassi, 1995). Hybridoma and biosensor cells can
also be kept apart by making use of flow injection analysis (FIA) or similar concepts
(Mulchandani and Bassi, 1995; Male et al., 1997; Mayer et al., 1999; Harms et al.,
2002) (Figure 1.7b). In this system, a small sample is taken from the main reactor
medium and injected into a carrier stream of buffer solution that continuously flows
past a detector (Mulchandani and Bassi, 1995). Because the sensors do not come in
contact with the main culture in this scenario, the requirements for the sensors can
be less stringent and do not require sterility (Mulchandani and Bassi, 1995). The
environment of the sensors could be tailored to the requirements of the sensor cells.
FIA analysis systems using enzymatic assays have for example been developed for
on-line monitoring of glutamine and glutamate (Mayer et al., 1999).
There are certain metabolite parameters that are of particular interest in biopro-
cessing, specifically those discussed above. And while many different kinds of
sensors have been developed for many different kinds of metabolites, there are
still gaps in what we can monitor in bioprocessing, especially in terms of basic
metabolites. Biosensors for bioprocessing that can report on availability of carbon
sources such as glucose and glutamate would be useful (Yeomans et al., 1999). Real
time visualisation of metabolites would be useful (Fehr et al., 2004). As far as
the author knows, no whole-cell sensors have been made yet for many important
bioprocessing parameters, and there is a need for specific amino acid biosensors in
the field (Kwan et al., 2004). Whole-cell biosensors for metabolites would allow
monitoring of more complex processes, e.g. glutamine-need of mammalian cells by
measuring fundamental metabolites and cellular biosensors would allow integration
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of several monitored signals. Cells behave differently in large bioreactors than flasks.
It is the up-scaling step of bioprocess development that is in particular need for novel
sensors.
The suggestion here is that a synthetic biology approach could be used to engineer
whole-cell microbial biosensors for mammalian cell culture to be used in process
monitoring and optimisation.
1.5 Natural bacterial sensing systems relevant
to bioprocessing
A literature search to find natural bacterial sensing mechanisms for metabolites
relevant to bioprocessing was carried out. The results are shown in Table 1.3. The
aim was to find suitable natural systems that could be used to engineer biosensors
used in bioprocessing. There already exist various biosensors for many amino acid
and metabolites, but many of them have an output that can be measured, but
which does not easily translate into a biological transcription output, e.g. FRET
sensors (Marvin and Hellinga, 1998; Dattelbaum and Lakowicz, 2001; De Lorimier
et al., 2002; Tolosa et al., 2003; Fehr et al., 2004), largely summarised by Dwyer and
Hellinga (2004).
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Table 1.3: Natural sensing mechanisms (or pre-existing biosensors) for
interesting bioprocessing variables.
Target Transcriptional Translational Post-translational
Glutamine GlnK/GlnL (Bacillus) (Satomura
et al., 2005; Ye et al., 2009)
GlnL/GlnG (C. glutamicum)
(Rehm, 2010; Ye et al., 2009)
PII/NRI ntrC (E. coli (Ninfa
and Atkinson, 2000))
GS/TnrA (Bacillus) (Satomura
et al., 2005)
glnA RNA motif
(Ames and Breaker,
2011)
Downstream-peptide
motif (Ames and
Breaker, 2011)
glutamine permease
operon glnHPQ (E. coli)
glutamine FRET sensor
(Behjousiar et al., 2012)
glutaminase/glutamate
dehydrogenase
colourimetric assay
Glucose Arabidopsis (Li et al., 2006) - glucose oxidase
rcsF (phosphorelay glucose and
zinc sensor)
Crr (glucose-specific enzyme IIA
component of PTS)
Ammonia soybean GS15 (cytosolic glutamine
synthetase gene promoter) (Terce´-
laforgue et al., 1999)
- -
GlnK
σ54 transcription factor (Charbit,
1996)
Lactate lldPRD operon (Aguilera et al.,
2008)
- lactate oxidase
lactate dehydrogenase
lldR FRET sensor
(San Mart´ın et al., 2013)
Alanine Lrp (leucine-responsive regu-
latory protein)
- -
Arginine artPIQMJ; argT -
Asparagine ans operon (Bacillus; Rhizobium
etli) (Ortun˜o-Olea and Dura´n-
Vargas, 2000)
- -
Aspartate Taz chemoreceptor (Jin and In-
ouye, 1993)
- gltI (Periplasmic
glutamate-aspartate
binding protein)
Cysteine cysH operon - -
Continued on next page
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Table 1.3 – continued from previous page
Target Transcriptional Translational Post-translational
Glutamate Check (Ye et al., 2009) - gltI (Periplasmic
glutamate-aspartate
binding protein)
Glutamate FRET sensor
(Palmer et al., 2011)
Glycine - glycine riboswitch
(Mandal et al., 2004)
ProX (Glycine betaine/L-
proline transport system
binding protein)
Histidine histidine attenuator (Vitreschak
et al., 2004)
HisPMQJ (histidine
transporter)
-
Isoleucine Threonine-isoleucine-dependent
attenuator (Vitreschak et al.,
2004)
- -
Leucine Lrp (Leucine-responsive regulatory
protein) (Wang et al., 1994)
- -
Leucine attenuator (Vitreschak
et al., 2004)
Lysine - Lysine riboswitch (Vit-
reschak et al., 2004)
-
Methionine Met repressor, MetJ, recognises
SAM
- -
Lrp (C. glutamicum) (Mustafi
et al., 2011)
Phenyl
-alanine
TyrR operon (Pittard et al., 2005) - -
Proline - - ProX (Glycine betaine/L-
proline transport system
binding protein)
Serine - - -
Threonine Threonine-isoleucine-dependent
attenuator (Vitreschak et al.,
2004)
- -
Tryptophan Trp operon - Trp FRET sensor (Kaper
et al., 2007)
TyrR regulator (Pittard et al.,
2005)
Tyrosine TyrR regulator (Pittard et al.,
2005)
- -
Valine - - -
40
1.6 Aim of this project and thesis overview
The aim of this work was to tackle some of the challenges in bioprocessing using a
new synthetic biology approach. Bacterial whole-cell biosensors for metabolites have
been engineered using the principles of synthetic biology. The model context chosen
for these sensors were target metabolites relevant in bioprocessing (Figure 1.8a).
This should lead to a “platform” involving biosensing, and interactions between
bacterial and mammalian cells that could be used in other contexts with minimal
modifications. Many of the principles that have previously been used in trying to
tackle the limitations of bioprocessing fed into the approach. Useful characteristics
of bacterial cells, such as fast production, robustness, flexibility, ability to be stably
transformed with genes, were used. Sensors for amino acids and other metabolites
will find applications in many fields (Mustafi et al., 2011). There have been studies
placing metabolite sensors directly inside mammalian cells (Behjousiar et al., 2012).
This can provide useful intracellular information, but also pose a metabolic burden
to the cells (Harms et al., 2002). The sensors proposed here would give extracellular
information and could be transferred to other systems and cell types more easily.
There already exist various biosensors for many amino acid and metabolites, but
many of them have an output that can be measured, but which does not easily
translate into a biological transcription output, e.g. FRET sensors (Marvin and
Hellinga, 1998; Dattelbaum and Lakowicz, 2001; De Lorimier et al., 2002; Tolosa
et al., 2003; Fehr et al., 2004), largely summarised in (Dwyer and Hellinga, 2004).
Here the aim is to design transcriptional or translational sensors that can be linked
up to a biological output. This would allow the sensors to possible be linked up to
various possible reactions from the cells.
The principles of systematic design were followed in this project. Initially,
specifications for the biosensors were drawn up (Figure 1.8b(1)). This involved
mammalian cell culture experiments that defined the environment in which these
sensors were to be used. These can be found in chapter 3 (Hybridoma cell culture
characteristics).
Natural sensor mechanisms were researched and biosensors designed (Figure 1.8b(2)).
Biosensor design fed into assembly (Figure 1.8b(3)). Biobrick format was used to
make use of existing parts and so that the devices would be compatible with other
constructs in the synthetic biology community. Several biosensors were designed in
this study. Details can be found in chapters 5 (E. coli lldPRD lactate-responsive
operon), 6 (E. coli Lrp operon) and 7 (E. coli Ntr regulon) and 8 (Bacillus subtilis
GlnK-GlnL system). The next step was biosensor characterisation (Figure 1.8b(4)).
The sensors were tested with an easily detectable output (e.g. presence of green
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Figure 1.8: a) Bacterial whole cell biosensors for bioprocessing. b) Approach
for engineering bacterial whole cell biosensors for bioprocessing. Design cycle
specific to thus project. 1) Specifications. 2) Design. 3) Assembly. 4) Testing.
5) Implementation.
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fluorescent protein (GFP)) and real time sensing with limited time delay (but
allowing for e.g. transcription) (Belkin, 2003) under standard conditions. Details
on characterisation protocol development can be found in chapter 4 (Development
of a biosensor characterisation protocol). Details can be found in chapters 5 (E.
coli lldPRD lactate-responsive operon), 6 (E. coli Lrp operon) and 7 (E. coli Ntr
regulon) and 8 (Bacillus subtilis GlnK-GlnL system).
To be implemented in a mammalian cell culture context, the biosensor cells needed
to function in complex medium (mammalian cell growth medium) in bioreactor
conditions (Figure 1.8b(5)). These experiments can be seen in chapter 9 (Biosensors
in Bioprocessing).
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2 Materials and methods
2.1 Hybridoma cell culture
Cell line
The murine hybridoma cell line ATCC-CRL1606, producing a mAb (HFN7.1)
against human fibronectin (Schoen et al., 1982), was obtained from the American
Type Culture Collection and was subcultured as recommended.
Cell culture at different glutamine concentrations
Cells were cultured in 500 ml Erlenmeyer flasks (Corning, UK) at 37◦C in an
atmosphere containing 5% CO2 on an orbital shaking platform rotating at 125
rpm. The basal growth medium was 100 ml glutamine-free DMEM (Sigma, D6546)
supplemented with 10% (v/v) calf bovine serum (ATCC, 30-2030) and either 0
mM Gln, 2 mM Gln, 4 mM Gln, 6 mM Gln, 8 mM Gln or 10 mM Gln (Sigma,
G3126). Cells had previously been grown in DMEM (Gibco, Invitrogen, 52100-039)
containing 4 mM Gln. Glutamine was sterilised by filtration.
Cell culture for sample collection
Cells were cultured in 1L Erlenmeyer flasks at 37◦C in an atmosphere containing 5%
CO2 on an orbital shaking platform rotating at 125 rpm. The basal growth medium
was 200 ml dulbecco’s modified eagle’s medium (DMEM) (Gibco, Invitrogen, 52100-
039), supplemented with 10% (v/v) calf bovine serum (ATCC, 30-2030).
Cell enumeration
Viable cell concentrations were determined using the Trypan blue exclusion method
(Patterson Jr, 1979). Small volumes of cell culture were samples and diluted with
water as appropriate. Samples were then mixed with an equal volume of trypan
blue. Using a light microscope, cells were determined to be alive (transparent) or
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dead (blue) and counted. Integral viable cell concentration (IVC) was calculated as
the integral of the viable cell concentration over time.
ELISA for antibody detection
Antibody analysis of culture supernatant samples was performed using an optimised
protocol based on that described in (Kontoravdi, 2007). Optimisation of this
assay used a number of different 96-well plates: medisorb (Nunc, 467320)*,
multisorb (Nunc, 467340) and microtitre (sterilin, 611F96). Two brands of human
fibronectin were tested: (BD, 354008)* and (Sigma-Aldrich, F0895). Two anti-
human fibronectin mAbs were tested for use as the standard: mouse monoclonal
anti-human fibronectin (HFN7.1, abcam, ab80923)* and mouse monoclonal anti-
human fibronectin (Sigma-Aldrich, F0791). Two HPR-conjugated anti-mouse Fc
immunoglobins were tested for use as the secondary antibody: (Sigma-Aldrich,
A0168) and (Dako, P0447)*. Reagents marked with a star were used in the ELISA
analysis of culture supernatant samples.
Figure 2.1: ELISA to specifically detect anti-human fibronectin antibody
produced by HFN7.1 hybridoma cells.
Metabolite analysis
Samples of culture supernatant were analysed using a Bioprofile 400 Analyzer (Nova
Biomedical) according to the manufacturer’s guidelines. Cells were removed by
centrifugation to optain supernatant samples. No further sample processing was
done. The Bioprofile Analyzer was used to measure ammonia, glucose, glutamine
and lactate concentrations.
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2.2 CHO cell culture
Cell line
A CHO-S cell line containing a fluorescent fusion protein integrated into the genome
was obtained from Antony Constantinou (CSynBI, Imperial College London).
Cell culture conditions
Cells were cultured in a 250 ml Erlenmeyer flask (Corning, UK) at 37◦C in an
atmosphere containing 5% CO2 on an orbital shaking platform rotating at 125
rpm. The basal growth medium was 100 ml CD CHO medium (Invitrogen, UK),
supplemented with 8 mM glutamine (Invitrogen, UK) and HT supplement (11067-
030, Gibco).
2.3 Assembly of bacterial biosensor constructs
Bacterial strains
Bacterial strains used in this study are summarised in Table 2.1.
Table 2.1: Bacterial strains used in this study
Bacterial strain Source Genotype
Escherichia coli DH5α (α-Select) Bioline
F- deoR endA1 recA1 relA1
gyrA96 hsdR17(rk-, mk+)
supE44 thi-1
phoA∆(lacZYA argF)
U169Φ80lacZ∆M15λ-
Bacillus subtilis subtilis 168 Bacillus Genetic Stock
Center (BGSC)
trpC2
Assembly of DNA constructs
The BioBrick assembly method was used in the assembly of all DNA constructs.
Lactate sensor constructs were assembled by undergraduate students Sharmilah
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Vetaryan and Katarzyna Roguska. Glutamine transporter constructs were assem-
bled by undergraduate student Kai Jiang. Nitrogen metabolism constructs were
assembled by undergraduate student Jonathan Chan. Plasmid pSB1A2 as used for
all constructs.
Promoter sequences
The promoter sequences used in the biosensors in this study are summarised in
Table 2.2.
Table 2.2: Promoters used in this study.
Primer Sequence
E. coli NtrC-responsive promoters
argTp TTTTGC AACCGCGATC AAATCCTCGA CATTTTGTTT CTGCCATTCA
ATCGAAACGC TGCGATTCAA CCGCTATACC TGCTATCTTC AACTTCAGGA
CAATAATGCA ACGTCTTATT AACATATTTA ACGTTGAATG TTACTGTTGT
CGTCAAGATG GCATAAGACC TGCATGAAAG AGCCT
astCp2 TTGTTAATGA TGTCAACGAT GGCGCAAAAA ATGCCCGCTT TTGGTGCGCG
CTGCGTCAGA ATGGCGCAGT AATTTCCAGT AAATTTCGTC AATGATCACA
ATTCCAGAAT TATATTTTAC TTCTGCATAA CATTGCGTTT TTTATTCTTT
TTATTCACCC ACATCGCAAA CGTATTCACT TTATATGCAC TTTAAATGCA
TATGGTTTGG TTATAACTCC TTGATTTCCA GTTAGCCTCC GCCGTTTATG
CACTTTTATC ACTGGCTGGC ACGAACCCTG CAATCTACAT TTA
glnAp1 GTCCCTTTGT GATCGCTTTC ACGGAGCATA AAAAGGGTTA TCCAAAGGTC
ATTGCACCAA CATGGTGCTT AATGTTTCCA TTGAAGCACT ATATTGGTGC
AACATTCACA TCGTGGTGCA GCCCTTTTGC ACGATGGTGC GCATGATAAC
GCCTTTTAGG GGCAATT
glnAp2 ATTGCACCAA CATGGTGCTT AATGTTTCCA TTGAAGCACT ATATTGGTGC
AACATTCACA TCGTGGTGCA GCCCTTTTGC ACGATGGTGC GCATGATAAC
GCCTTTTAGG GGCAATTTAA AAGTTGGCAC AGATTTCGCT TTATCTTTTT
TA
glnHp2 ATCCATCGCT GATGGTGCAG AACTTTAGTA CCCGATAAAA GCGGCTTCCT
GACAGGAGGC CGTTTTGTTT TGCAGCCCAC CTCAACGCAC TTATTTAGTG
CATCCATCTG CTATCTCCAG CTGATTAAGT AAATTTTTTG TATCCACATC
ATCACACAAT CGTTACATAA AGATTGTTTT TTCATCAGGT TTTACGCTAA
ATAATCACTG TGTTGAGTGC ACAATTTTAG CGCACCAGAT TGGTGCCCCA
GAATGGTGCA TCTTCAGGGT ATTGCCCTAT AAATCGTGCA TCACGTTTTT
GCCGCATCTC GAAAAATCAA GGAGTTGCAA AACTGGCACG ATTTTTTCAT
ATATGTGAAT G
glnKp AGCGCA ATATTTCATC GTTGGTGCAA AAATGTAACG CACTGTGCAC
TGTCATAGTG CGTTTTCATT TTCAAACTTC TTAACTTCCT GCTCTCTTTC
TCGTTTTTCA TTTCTGGCAC ACCGCTTGCA ATACCTTCTT C
glnLp TTGTCAGCTA TCTGTAGCCC ATCTCTGCAT GGGCTTTTTT CTCCGTCAAT
TCTCTGATGC TTCGCGCTTT TTATCCGTAA AAAGCTATAA TGCACTAAAA
TGGTGCAACC
Continued on next page
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Table 2.2 – continued from previous page
Primer Sequence
nac CGG GGCGCATATT AATGGCAGTG CATGGTGATG TCAAAGGGTG
AAATGCATTT TTTTGTTTGT TTGCTGTCAA TTTCAACAAA GTGGTGAGCT
TTCAATCTTA TTGGGTAATG AACCATCGTG GTGCATACCC TCCTTTTATA
GGGCAGGGGA ACGCGACAGC TGATTAAAGG AGCAAATGAC GAATCTATCA
TAATCTCTTA TTTGACAGTT GGTTAGCTTG TACATCAACA CCAAAATAAA
ACTGGCAAGC ATCTTGCAAT CTGGTTGTA
E. coli LRP-responsive promoters
fimBp1 GAAGGTTTAA GTCGTAGTGA CCAAAGCTAT ATTTACCAAC GAATGTAGAT
GAAAAAATCA TCTCCTGCGT TCCCCCATAT CTCTAGGATA AAAAGGAATG
TAACAATCTC ATGGCGTAAG CTGACGAATC AGCAGGAATA ATCGCTAGGG
ACCTAAGAAT TAGCATGATA ATAGCCACTA AGAAATTACT GCGCTCCATG
AAATAGCCAT TTTGTGGCAA ATGGAGTTGA CTAATAATGT CATATGTGAG
ACGGCTAGTT GAACGAATAT TAAATTTTGC TGAATTTTTT ATGTTGATTT
TACTTGTTAC AGAACATATC ACATGATATA TAGATAAGAT TAGTTGCATT
AATGATGAGG GTTATTATTA GATTCGTATC CGATTGATAA ATATATAAAG
GTACATAGCA TGCAAGAGCA TGGCGTTTGT ATGGCAACGT TATTATAATT
AACAGTTGCT AC
fimBp2 GCACCTTTATACCTGTT ATACCAGATC AAAAATCACG CAATCCATAC AA-
CAAAACCA GATTTGCAAT TCGTGTCACA AAATATGTCG ATCTTTTTCT
AAGAGGAAGA TGCCATGTGA AGCCAGACGA ACACTTGCGG TGGTCTTCAA
AAACTAAAGA TCTTAGTTTA ACTATTTGTT TTATAAATAA TTTATTAAGA
GTCTAAACAA GGGGAGCTTT GCAAGCTAAC TCAGTGAGCT TGGTGAAAAT
CAGTGTTTAC CCGCCATCAG GCTGAGCATA ATTCTCATCA TGAAATATGT
TTCCTGGTTT GTGGCTTGTA ACTGGTCACT TCTGAAGTCG ATCTGGAGAG
GCTTGTTGAT GTTGGTGTTT TCAGGATGAT GTTTCACTTA GTTTGTTTGC
CGTATCGCCC GGCGAATGGC TGTGATTGAG GAAGGTTTAA GTCGTAGTGA
CCAAAGCTAT ATTTACCAAC GAATGTAGAT GAAAAAATCA TCTCCTGCGT
TCCCCCATAT CTCTAGGATA AAAAGGAATG TAACAATCTC ATGGCGTAAG
CTGACGAATC AGCAGGAATA ATCGCTAGGG ACCTAAGAAT TAGCATGATA
ATAGCCACTA AGAAATTACT GCGCTCCATG AAATAGCCAT TTTGTGGCAA
ATGGAGTTGA CTAATAATGT CATATGTGAG ACGGCTAGTT GAACGAATAT
TAAATTTTGC TGAATTTTTT ATGTTGATTT TACTTGTTAC AGAACATATC
gltBp TTAAGGCAGT ATAAAATGCT GGTTTTGTCG TCAGTTCAAG GCAGGATAAG
GGTTAACACA CCTTTATGAC AGTCAGGAAT TGACTGTTTC TCTAACGACT
TCCCTTTTAG CCTTAAAGAT AAAATCCATT TTAATTTCAG TCATTTAATA
AAGAATTTTG CGCTAAAGCA CATTTCTGTA CCAATAAGCT TGCCATTTGA
CCTGTATCAG CTTTCCCGAT AAGTTGGAAA
ilvIHp1 GAATG TCTGGTTTAT TCTGCATTTT TTATTGAATG TAGAATTTTA
TTCTGAATGT GTGGGCTCTC TATTTTAGGA TTAATTAAAA AAATAGAGAA
ATTGCTGTAA GTTGTGGGAT TCAGCCGATT TATTATCAAT TTAATCCTCT
GTAATGGAGG ATTTTATCGT TTCTTTTCAC CTTTCCTCCT GTTTATTCTT
ATTACCCCGT GTTTATGTCT CTGGCTGCCA ATTGCTTAAG CAAGATCGGA
CGGTTAATGT GTTTTA
leuLp AACCACCGCA GCACAATTAG CTAATTTTAC GGATGCAGAA CTCACGCTGG
CGGGACGTTT TTATTGCGTC AGGGTTGACA TCCGTTTTTG TATCCAGTAA
CTCTAAAAGC ATATCGCATT CATCTGGAGC TGATTTAATG ACTCACATCG
TTCGCTTTAT CGGTCTACTA CTACTAAACG CATCTTCTTT GCGCGGTAGA
CGAGTGAGCG GCATCCAGCA TTAAGCCAGC ACGCAGTCAA ACAAAAAACC
CGCGCCATTG CGCGGGTTTT TTTATGCCCG AAGCGAGGCG CTCTAAAAGA
GACAAGGACC CAAACCa
Continued on next page
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Table 2.2 – continued from previous page
Primer Sequence
livJp TGAGAGTCCGGGGTTTTTGTTTT TTGGGCCTCT GTAATAATCA
ATTTCCCCTC CGGCAAAACG CCAATCCCCA CGCAGATTGT TAATAAACTG
TCAAAATAGC TATTCCAATA TCATAAAAAT CGGGTATGTT TTAGCA
E. coli lldR-responsive promoter
lldp CTTTACCAG ACATCTCCCC CCACAAGAAT TGGCCCTACC AATTCTTCGC
TTATCTGACC TCTGGTTCAC AATTTCCCAA TTAAAACTCA CATCAATGTT
GCCAATACAT AACATTTAGT TAACCATTCA TTGTCATTAT CCCTACACAA
CACAATTGGC AGTGCCACTT TTACACAACG TGTGACAAGG AGATGAGCAA
CAGACTCATT ACACGATGTG CGTGGACTCC
B. subtilis GlnK/GlnL-responsive promoter
PM8J2-706 TGCTTATTTT CAAAATGTTT TTGTCGTATT TTGTATGATT CTGTAGTCTC
CATTATACAG TAATTAT
Polymerase chain reaction
Polymerase chain reaction (PCR) to obtain biosensor promoters was carried out
using a variety of conditions, using the Pfu Turbo kit (Promega, UK) and Phusion
High-Fidelity DNA Polymerase (Thermo Scientific, UK). Detail of PCR reaction
conditions is given in Table 2.3. PCR primers (Invitrogen) used are summarised
in Table 2.4. For E. coli Ntr-responsive promoters, PCR with blunt primers was
followed by secondary PCR with primers containing the Biobrick prefix and suffix.
For the E. coli promoters, E. coli genomic DNA from JM109 or DH5α was used as a
template. E. coli DH5α genomic DNA was obtained by boiling cells in water at 98◦C
for 10 min. 1-2 µl of genomic DNA template were used in PCR reactions. Either Pfu
polymerase (Stratagene) or Phusion high-fidelity polymerase (FisherScientific) were
used. Promoter sequences were mostly taken from [ecocyc.org]. For the B. subtilis
PM8J2-706 promoter, two overlapping oligonucleotides, together representing the
whole promoter sequence were used in primary PCR, followed by secondary PCR
with primers containing the Biobrick prefix and suffix.
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Table 2.3: PCR conditions used in this study
Amplified fragment Polymerase Annealing tem-
perature (◦C)
Product
length (bp)
E. coli NtrC-responsive promoters
argTp Pfu 45 181
astCp2 Phusion 62 293
glnAp1 Phusion 70 167
glnAp2 Phusion 64 152
glnHp2 Pfu 45 361
glnKp Phusion 63 136
glnLp Phusion 60 90
nac Phusion 70 272
argTp-Biobrick Pfu 50 240
astCp2-Biobrick Pfu 50 352
glnAp1-Biobrick Pfu 50 226
glnAp2-Biobrick Pfu 59 211
glnHp2-Biobrick Pfu 50 420
glnKp-Biobrick Pfu 50 195
glnLp-Biobrick Pfu 50 149
nac-Biobrick Pfu 50 331
Bacillus GlnK/GlnL-responsive promoter
PM8J2-706 Pfu 61 67
PM8J2-706-Biobrick Pfu 50 126
E. coli Lrp-responsive promoters
Clp / / 345
fimBp1 Phusion 52 462
fimBp2 Phusion 58 747
gltBp Phusion 54 230
ilvIH Phusion 56 261
leuLp Phusion 63 317
livJp Phusion 53 139
oppAp Phusion 50 642
fimBp1-Biobrick Phusion 52 521
fimBp2-Biobrick Phusion 58 806
gltBp-Biobrick Phusion 54 289
ilvIH-Biobrick Phusion 56 320
leuLp-Biobrick Phusion 63 376
livJp-Biobrick Phusion 53 198
oppAp-Biobrick Phusion 50 701
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Table 2.4: Primers used in this study. (Briobrick extensions are underlined,
overlapping sequenced are bold.)
Primer Sequence (5’-3’)
E. coli NtrC-responsive promoters
argTp-F TTTTGCAACCGCGATCAAATCC
argTp-R AGGCTCTTTCATGCACATCTTG
astCp2-F TTGTTAATGATGTCAACGATG
astCp2-R TAAATGTAGATTGCAGGGTTC
glnAp1-F GTCCCTTTGTGATCGCTTTCAC
glnAp1-R AATTGCCCCTAAAAGGCGTTATC
glnAp2-F ATTGCACCAACATGGTGC
glnAp2-R TAAAAAAGATAAAGCGAAATCTGTGCC
glnHp2-F ATCCATCGCTAACTTTAGTAC
glnHp2-R CATTCACATATATGAAAAAATCGTG
glnKp-F AGCGCAATATTTCATCGTTG
glnKp-R GAAGAAGGTATTGCAAGCGG
glnLp-F TTGTCAGCTATCTGTAGCCC
glnLp-R GGTTGCACCATTTTAGTGC
nac-F CGGGGCGCATATTAATGGCAG
nac-R TACAACCAGATTGCAAGATGCTTG
E. coli NtrC-responsive promoters - Biobrick
argTp-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTTTTGCAACCGCGATCAAATC
argTp-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTAAGGCTCTTTCATGCACATCTTG
astCp2-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTTGTTAATGATGTCAACGATG
astCp2-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTATAAATGTAGATTGCAGGGTTC
glnAp1-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGGTCCCTTTGTGATCGCTTTC
glnAp1-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTAAATTGCCCCTAAAAGGCGTTATC
glnAp2-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGATTGCACCAACATGGTGC
glnAp2-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTATAAAAAAGATAAAGCGAAATCTGTGCC
glnHp2-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGATCCATCGCTAACTTTAGTAC
glnHp2-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTACATTCACATATATGAAAAAATCG
glnKp-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGAGCGCAATATTTCATCGTTG
glnKp-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTAGAAGAAGGTATTGCAAGCGG
glnLp-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTTGTCAGCTATCTGTAGCCC
glnLp-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTAGGTTGCACCATTTTAGTGC
nac-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCGGGGCGCATATTAATGGCAG
nac-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTATACAACCAGATTGCAAGATGC
Bacillus GlnK/GlnL-responsive promoter
PM8J2-706-F TGCTTATTTTCAAAATGTTTTTGTCGTATTTTGTATGATTCTGTAGTCTC
PM8J2-706-R ATAATTACTGTATAATGGAGACTACAGAATCATACAAAATACGACAAAAAC
Bacillus GlnK/GlnL-responsive promoter - Biobrick
PM8J2-706-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTGCTTATTTTCAAAATGTTTTTG
PM8J2-706-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTAATAATTACTGTATAATGGAGAC
Continued on next page
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Table 2.4 – continued from previous page
Primer Sequence (5’-3’)
E. coli Lrp-responsive promoters
Clp-blunt-F TTTTTAACTTTAAATTCAT
Clp-blunt-R AGAAATATAACCAGACC
fimBp1-blunt-F GAAGGTTTAAGTCGTAGTG
fimBp1-blunt-R GTAGCAACTGTTAATTATAAAC
fimBp2-blunt-F GCACCTTTATACCTGTTATACC
fimBp2-blunt-R GATATGTTCTGTAACAAGTAAAATC
gltBp-blunt-F TTAAGGCAGTATAAAATGCTG
gltBp-blunt-R TTTCCAACTTATCGGG
ilvIHp1-blunt-F GAATGTCTGGTTTATTCTGC
ilvIHp1-blunt-R TAAAACACATTAACCGTCCG
leuLp-blunt-F AACCACCGCAGCACAATTAG
leuLp-blunt-R TGGTTTGGGTCCTTGTCTC
livJp-blunt-F TGAGAGTCCGGGG
livJp-blunt-R TGCTAAAACATACCCG
oppAp-blunt-F ATTCCTTTCAAATGAAAC
oppAp-blunt-F GGTTACTTTATCGTTACG
E. coli Lrp-responsive promoters - Biobrick
fimBp1-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGGAAGGTTTAAGTCGTAGTG
fimBp1-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTAGCAACTGTTAATTATAAAC
fimBp2-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGGCACCTTTATACCTGTTATACC
fimBp2-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTAGATATGTTCTGTAACAAGTAAAATC
gltBp-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTTAAGGCAGTATAAAATGCTG
gltBp-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTATTTCCAACTTATCGGG
ilvIHp1-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGGAATGTCTGGTTTATTCTGC
ilvIHp1-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTATAAAACACATTAACCGTCCG
leuLp-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGAACCACCGCAGCACAATTAG
leuLp-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTATGGTTTGGGTCCTTGTCTC
livJp-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTGAGAGTCCGGGG
livJp-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTATGCTAAAACATACCCG
oppAp-BB-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGATTCCTTTCAAATGAAAC
oppAp-BB-R GTTTCTTCCTGCAGCGGCCGCTACTAGTAGGTTACTTTATCGTTACG
B. subtilis colony PCR primers
AmyE-short-F1 ATGTTTGCAAAACGATTCAAAAC
AmyE-short-R2 TCAATGGGGAAGAGAACCG
AmyE-near-F GAGTATTCCAAACTGGACACATGG
AmyE-near-R CTGGAAAAGAAAAGAGGCGTACTG
Bac-colPCR-Cmr-F GCAGTTTCTACACATATATTCGCAAG
Bac-colPCR-GFP-R ATTCCAATTTGTGTCCAAGAATG
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Gel electrophoresis
PCR products were analysed by gel electrophoresis using agarose gels of appropriate
concentration (1-2.5% w/v in TAE) with addition of GelRed (Cambridge Bioscience)
or SYBR safe (Invitrogen) according to the manufacturer’s protocol. The DNA
HyperLadder V (Bioline) or HyperLadder I (Bioline) was used a a standard.
Resolved DNA fragments were visualised using a UV transilluminator (Biorad).
Gel purification
Resolved DNA fragments were extracted from agarose gels by isolation of gel slice
and purified using the Wizard SV Gel and PCR Clean-Up System (Promega)
according to the manufacturer’s protocol.
PCR purification
PCR products were purified using the Wizard SV Gel and PCR Clean-Up System
(Promega) according to the manufacturer’s protocol.
Restriction enzyme digests
Restriction enzyme digests were typically performed in 50 µl total volume using the
appropriate combination of BioBrick enzymes, EcoRI, SpeI, XbaI and PstI (Promega
or NEB), according to the manufacturer’s guidelines.
Ligation
Ligation reactions were performed using T4 DNA ligase (Promega, UK) in 10 µl
according to the manufacturer’s guidelines.
Chemically-competent cells and transformation
Chemically-competent E. coli DH5α cells were either purchased (C2987H, NEB 5-
alpha Competent E. coli (High Efficiency); NEB) and transformed according to
the manufacturer’s protocol or made from non-competent E. coli DH5α cells and
transformed according to a protocol by the Blaser group (http://www.med.nyu.edu/
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medicine/labs/blaserlab/v1-protocols.html; NYU, NY, USA). Typically, 100 µl
of transformation mixture were plated on LB agar plates with suitable antibiotics.
Agar plates and antibiotic concentrations
For E. coli ampicillin was used where appropriate at the recommended concen-
trations (usually 100 µg/mL). For B. subtilis used CAM (5 µg/ml) according to
(Harwood and Cutting, 1990).
E. coli colony PCR
E. coli colonies were picked and boiled at 98◦C for 5 min in 100 µl of water of
which 17.25 µl as template in 25 µl colony PCR reactions using GoTaq polymerase
(Promega). The BioBrick Vf2 and Vr primers were mostly used for colony PCR.
Plasmid purification
Miniprep isolation of plasmids from E. coli cells was done using peqGOLD Plasmid
Miniprep Kit I (peqlab, Erlangen, Germany) according to the manufacturer’s
protocols. Midiprep isolation of plasmids E. coli cells was done using QIAGEN
Plasmid Midi Kit according to the manufacturer’s protocols.
B. subtilis transformation
B. subtilis transformation was done according to the protocol used by the 2008 Impe-
rial College iGEM team [http://2008.igem.org/Team:Imperial_College/Transformation]
with some modifications. Approximately 2 µg of midiprep plasmid DNA were used
in the transformation. Cells were then incubated with the DNA for 2 h at 37◦C. No
Tbase and glucose solution were added to cells. 100 µl of the cell mix were plated
onto LB agar plates. Plates were incubated for two days at 37◦C and colonies were
then selected for testing.
Amylase test
Correct integration of constructs into the AmyE site was checked using an amylase
test based on the protocol used by the 2008 Cambridge iGEM team [http://2008.
igem.org/Team:Cambridge/Bacillus_subtilis_transformation]. Starch for LB agar
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starch plates was purchased from Sigma-Aldrich (S9765-100G). Negative control was
untransformed B. subtilis cells and positive control was B. subtilis cells with an
insert in the AmyE locus kindly provided by Gary Dixon. 10 ml of Gram’s iodine
stain (Sigma-Aldrich, HT902-8FOZ) were added to plates and the plates were then
incubated for 5 min, after which the stain solution is decanted.
B. subtilis colony PCR
Large B. subtilis colonies were picked and boiled at 98◦C for 5 min in 100 µl of
water. Samples were centrifuged at high speed for 2 min and 2 µl used as template
in 25 µl colony PCR reactions. PCR conditions are summarised in Table 2.5.
Table 2.5: B. subtilis colony PCR conditions used in this study
Primers Polymerase Annealing
temperature
(◦C)
Product
length with
insert (bp)
Product length
without insert
(bp)
AmyE-short-F1;
AmyE-short-R2
Phusion 67 3451 1527
AmyE-near-F;
AmyE-near-R
Phusion 69 2158 234
Bac-colPCR-Cmr-F;
Bac-colPCR-GFP-R
Phusion 65 1014 0
DNA sequencing
DNA constructs were checked for correctness using various commercial services,
including Eurofins MWG operon, GATC and Biosource DNA sequencing service.
Glycerol stocks of bacterial cells
For both E. coli and B. subtilis glycerol stocks were made by mixing equal volumes
of bacterial overnight cultures and 50% (v/v) glycerol solution. Stocks were stored
in cryotubes at -80◦C.
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2.4 Characterisation of bacterial biosensor
constructs
Over the course of this study, a range of characterisation experiments were carried
out that informed changed to the protocol. Details on protocol development can be
found in results chapter 4.
M9 minimal medium and plates
The recipe used for M9 minimal medium was taken from http://openwetware.org/
wiki/Endy:M9_medium/minimal. NH4Cl has used as a nitrogen source. Depending
on the experiment, glycerol or glucose was used as a carbon source. For M9 agar
plates, 14 g/L agar were added. Single colonies of E. coli cells containing promoter
characterisation or the control construct were streaked onto the plate in a grid-
formation, incubated over night at 37◦C and analysed qualitatively the next day
using a blue light transilluminator.
MM minimal medium
The B. subtilis glutamine sensor was tested in MM medium made as by Yoshida
et al. (2000).
BMG plate reader
Fluorescence and O.D. measurements for biosensor characterisation and growth
curves were performed using a BMG Omega Polarstar fluorometer in a 96-well
plate format (Costar, 3370) at a temperature of 37◦C. The sampling time and gain
were varied according to the experiment. Fluorescence excitation filter 485 nm and
emission filter 510 nm was used. Data was analysed and visualised using Matlab
and Microsoft Excel.
For the detailed characterisation of individual NtrC promoters, colonies of cells
containing a characterisation construct and control cells were used to inoculate LB
cultures (with appropriate antibiotic) in 14 ml culture tubes, which were incubated
for several hours at 37◦C. ∼40 µl of these cultures were used to inoculate 5 ml
overnight cultures of DMEM and M9, both supplemented with 18.7 mM NH4Cl
and appropriate antibiotic. The following morning, cultures were diluted with fresh
56
media and grown up further during the day. In the evening the OD600 of each
culture was measured and cultures were diluted with fresh media to an appropriate
starting OD. After ∼1 h, cultures were induced by adding appropriate volumes of
a 200 mM glutamine stock to achieve concentrations of 0, 2.5, 5, 7.5 and 10 mM
glutamine. Three replicates of 100 µl of each culture were then transferred to a
96-well plate and measured for several hours.
Robotic characterisation
This experimental protocol and subsequent data analysis was adapted from one
developed and used by Chris Hirst (Hirst, 2014) (Figure 2.2). Experiments were
carried out using a Aviso-GmBH Theonyx robotic platform linked to a plate reader
(Synergy HT, Biotek) and a shaking incubator (Ventura 2000, Mikura). 1-5 ml
LB cultures of the E. coli biosensors and control cells were grown during the day
and used to inoculate 5 ml overnight cultures in M9, DMEM or LB medium (or
other appropriate media). On the next morning, cultures were transferred to 96-
well plate format. Using the Theonyx platform the cells then undergo dilution,
outgrowth, in some cases a second dilution and assaying with OD and fluorescence
measurements every 10 min. Cells were induced by addition of 25 µl of appropriate
inducer concentration in appropriate solvent to the 100 µl of cell culture in the
well, forming 125 µl of liquid in each well-post-induction. Shaking of cell cultures
during these experiments was usually at 700 rpm. Fluorescence excitation filter
485 nm and emission filter 528 nm was used with a bandpass of 20. Appropriate
fluorescence sensitivities were chosen in the plate reader settings for characterisation
of different biosensors. During data analysis, OD outliers were excluded and medium
blank controls and control cell fluorescence subtracted from sample data. Data
analysis was done using Microsoft Excel. Plotting was done using Microsoft Excel
and Mathematica. Raw fluorescence data was processed with an R-based spline-
fitting algorithm written by Catherine Ainsworth (unpublished). Growth curves
show sample absorbance values at OD600 with the average absorbance for media
subtracted. A trendline with the following equation was fitted to a graph showing
fluorescence vs corrected OD600 of the control cells:
FLcontrol = ODcontrol ×m+ c (2.1)
The equation of this trendline was used to subtract cell autofluorescence from
biosensor cell fluorescence as follows:
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FLi,corrected = FLi − ((ODi ×m) + c) (2.2)
Fluorescence production (GFP synthesis rate) was calculated as follows:
GFP synthesis rate =
FLi − FLi−1
(ODi −ODi−1)/2 (2.3)
In order to calculate lactate concentrations in cell culture samples, GFP synthesis
rate values from he standard lactate concentrations from an appropriate time point
of the time course were chosen to make a standard curve. GFP synthesis rate values
from the cell culture samples were used to interpolate the lactate concentrations
using the GraphPad Prism software.
Figure 2.2: Workflow for promoter characterisation using Theonix robotic
platform.
Flow cytometry
Cells were grown up overnight. Cells were measured using a FACscan flow cytometer
(Becton Dickinson) with a 96-Well Automated Micro-Sampler (Cytek). Data was
acquired using CellQuest software (Becton Dickinson) with wells being sampled on
high flow rate for 20 seconds. Data was analysed using CyFlogic or FlowJo software.
2.5 E. coli and B. subtilis growth curves
Using DMEM in flasks
Single colonies of E. coli DH5α and B. subtilis 1012 were used to inoculate 10 ml of
LB broth (Miller, 1.10285.0500) and grown overnight (37◦C, 225 rpm). Overnight
cultures were diluted 200-fold in 200 ml of DMEM (Gibco, Invitrogen) supplemented
58
with 10% (v/v) calf bovine serum (ATCC, 30-2030) and grown at 37◦C with shaking
at 225 rpm. Duplicate O.D. measurements were obtained using a Biomate 5
spectrophotometer (ThermoSpectronic).
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3 Hybridoma cell culture characteristics
3.1 Introduction
In order to design bacterial biosensors for mammalian cell bioprocessing, experi-
ments first needed to be carried out to study hybridoma cell culture more closely
and derive performance specifications for potential biosensors.
3.1.1 Hybridoma cell line
The mammalian cells used here were of the murine hybridoma cell line ATCC-
CRL1606 producing an industrially-relevant mAb (HFN7.1) against human fi-
bronectin. These cells were chosen for a number of reasons that make them very
suitable for this project: they are an established model cell line in bioprocessing
(Kontoravdi, Asprey, Pistikopoulos and Mantalaris, 2007; Selvarasu, Kim, Karimi
and Lee, 2010), they require glutamine in the culture medium and an assay has been
developed to detect the mAb produced by these cells (Kontoravdi, 2007). These
cells do not contain sufficient glutamine synthetase activity to sustain growth in
glutamine-free medium. It has been suggested that glutamine synthetase activity
is over time irreversibly repressed in many hybridoma cell lines that are grown at
high glutamine concentrations, as glutamine has been shown to suppress glutamine
synthetase (Juurlink, 1987; Newland et al., 1990). These cells grow in suspension
as opposed to being adherent cells. They therefore require mixing, which should
prevent heterogeneity in cultures and simplify conditions during experiments.
3.1.2 Metabolite concentrations in bioprocessing
Specifications for the biosensors concern the target compound, detection threshold,
accuracy, signal output and host chassis. An appropriate detection range is
required. Typical concentration ranges of metabolites in mammalian cell cultures
were researched (Table 3.1).
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Table 3.1: Concentrations of metabolites in mammalian cell culture
(over the course of ∼100-150h). Values were taken from the literature from
experiments using the same or a similar cell type and similar conditions. Common
growth medium concentrations were also taken into account as for a lot of compounds,
the greatest concentration will be at time zero, and hence equal to the concentration
of the growth medium. Concentration ranges depend on how long the cells are being
cultured and growth conditions as well as culturing mode (Male et al., 1997).
Metabolite Concentration range Reference
Glucose 0− 25 mM Kontoravdi, Asprey, Pistikopoulos and
Mantalaris (2007); Selvarasu et al.
(2009); Invitrogen
Ammonia 0− 6 mM (variable) Kontoravdi, Asprey, Pistikopoulos and
Mantalaris (2007); Selvarasu et al.
(2009)
Lactate 0− 80 mM Male et al. (1997); Selvarasu et al. (2009)
Serum (components) N/A
mAb 0− 2.5 g L−1 Kontoravdi, Asprey, Pistikopoulos and
Mantalaris (2007); Selvarasu et al.
(2009)
Cell 0− 5x106 cells ml−1 Selvarasu et al. (2009)
Amino Acids
Alanine 0− 0.6 mM (up to ∼6 mM if using
ala-gln dipeptide)
Christie and Butler (1994a); Selvarasu
et al. (2009)
Arginine 0− 1.0 mM Selvarasu et al. (2009); Invitrogen
Asparagine 0− 0.3 mM Selvarasu et al. (2009)
Aspartate 0− 0.4 mM Selvarasu et al. (2009)
Cysteine 0− 0.2 mM Invitrogen
Glutamate 0− 0.7 mM Selvarasu et al. (2009)
Glutamine 0− 5 mM Kontoravdi, Asprey, Pistikopoulos and
Mantalaris (2007); Selvarasu et al.
(2009); this work
Glycine 0− 0.5 mM (up to ∼6 mM if using
gly-gln dipeptide)
Christie and Butler (1994a); Selvarasu
et al. (2009); Invitrogen
Histidine 0− 0.5 mM Selvarasu et al. (2009); Invitrogen
Isoleucine 0− 1.2 mM Selvarasu et al. (2009); Invitrogen
Leucine 0− 1.2 mM Selvarasu et al. (2009); Invitrogen
Lysine 0− 1.2 mM Selvarasu et al. (2009); Invitrogen
Methionine 0− 0.5 mM Selvarasu et al. (2009); Invitrogen
Phenylalanine 0− 0.4 mM Invitrogen
Proline /
Serine 0− 0.4 mM Selvarasu et al. (2009); Invitrogen
Threonine 0− 1.2 mM Selvarasu et al. (2009); Invitrogen
Tryptophan 0− 0.08 mM Invitrogen
Tyrosine 0− 0.7 mM Selvarasu et al. (2009); Invitrogen
Valine 0− 0.5 mM Invitrogen
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3.2 Experimental Results
3.2.1 Characteristics of hybridoma cell growth
To explore the growth characteristics of CRL1606 hybridoma cells a batch over-
growth experiment was carried out (Figure 3.1). Figure 3.1(A) shows the viable cell
density. The cells show typical growth characteristics with an initial lag phase
(∼0.0-20.0 h), followed by exponential growth phase (∼20.0-55.0 h), stationary
phase (∼55.0-75.0 h) and death phase (∼75.0-100.0 h). There is great variance
in cell counts during late exponential and stationary phase. Fig. 3.1(B) shows the
percentage viability of the cells. Viability is near 100% at the beginning of the batch
culture. The beginning of the stationary phase marks the point at which cell division
rate and viability decrease due to depletion of nutrients and accumulation of waste
products. Figure 3.1(C) shows the integral viable cell concentration (IVC). This
represents the number of viable cells contributing to the expression of cell activity
during the accumulated time of cell growth. In short, the IVC is representative
of the antibody-producing power of the cells. As expected the IVC increases with
time and cell density, but increases more slowly towards the end of the culture run.
Sample taking from cultures affects culture volume but this was kept to a minimum
(Figure 3.1(D)).
Extracellular culture samples were analysed for metabolite concentrations (Fig-
ure 3.1(E)). This shows that the onset of stationary phase correlates with the
depletion of glutamine rather than glucose. Comparing culture flasks with a cell-
free culture shows that, as expected, glutamine concentration decreases to some
extent even in the absence of cells and some ammonia accumulates. Glucose
however stays at a constant level in the absence of cells and no lactate is detected.
Over the course of the experiment, glutamine concentration in the cell-free flask
approximately halved, giving glutamine a half life of approximately 100 hours under
these conditions. Table 3.2 shows the concentration ranges of metabolites found in
this experiment. All metabolites and cell concentrations shown in Table 3.2 fall into
the ranges from Table 3.1. Only glucose shows a slightly higher concentration at
the beginning of the culture, which could be due to glucose from the added serum.
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Figure 3.1: Batch overgrowth of CRL1606 hybridoma cells in DMEM. (A)
Viable cell density (cells/ml). (B) Percentage viability. (C) Integral viable
cell concentration (cells h/L). (D) Volume changes of cultures due to sample
taking. (E) Culture supernatant metabolites analysis using a Nova BioProfile
Analyzer. Arrows indicate lower concentration detection limits. Data are
based on two replicate culture flasks. Error bars are standard deviation of
samples from these two flasks.
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Table 3.2: Metabolite concentration ranges in mammalian cell culture
experiment shown in Figure 3.1.
Metabolite Concentration range
Cell 2.00× 105 - 1.92× 106 cells/ml
Glutamine <0.2 - 3.49 mM
Lactate 5.6 - 29.7 mM
Glucose 11.75 - 28.7 mM
Ammonia 0.73 - 2.095 mM
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3.2.2 CRL1606 hybridoma glutamine requirement
An experiment was carried out to study cell culture characteristics when changing
the concentration of essential metabolites. The aim was to help identify interesting
targets for biosensing, important limiting factors for culturing these cells. Cells
were cultured with different starting concentrations of glutamine. Glutamine
concentrations used ranged from 0 mM to 10 mM. Typical concentrations in
commonly used mammalian growth media range from 2 mM to 8 mM. Cell growth
was monitored (Figure 3.2(A)). Cells supplemented with 0 mM glutamine were
unable to divide and underwent cell death, reaching a cell density of essentially
zero after ∼90.0 h. As all the other cultures that were supplemented with varying
concentrations of glutamine were able to grow and divide, this shows the strong need
for glutamine for these hybridoma cells. The highest cell density of all cultures was
reached by the 6 mM glutamine culture after ∼80.0 h with a cell density of ∼3.00 x
106 cells/ml. The cultures with lower glutamine concentrations, 2 mM and 4 mM,
reached lower maximum cell densities and entered stationary phase and death phase
earlier, after ∼55.0 h and ∼70.0 h, respectively. None of the cultures apart from
possibly 8 mM Gln and 10 mM glutamine showed a pronounced stationary phase,
but seemed to go from exponential phase straight to death phase.
During the early lag phase (∼0.0-10.0 h) cells at 8 mM glutamine showed the highest
viability (Figure 3.2(B)). During the exponential phase (∼20.0 - 65.0 h) cells at 4
mM glutamine showed the highest viability. Only the cells at 0 mM glutamine
never showed any increase in viability. The 6 mM glutamine culture displayed the
highest IVC of all the cultures at all times, i.e. higher than both higher and lower
glutamine concentrations (Figure 3.2(C)). These results confirmed that these cells
require glutamine, but that at high glutamine concentrations (>6 mM) growth was
inhibited.
Culture supernatant samples were also analysed for the mAb product using an
ELISA method. Figure 3.2(D)) shows samples taken after 100 h of cell culture (i.e.
the second to last time point on Figure 3.2(A)-(C)). Relative mAb concentration
reaches an optimum at 8 mM glutamine, which was a higher glutamine concentration
than the 6 mM glutamine optimum for integral viable cell concentration. The
data showed that the CRL1606 hybridoma cells need glutamine to be provided
at optimum concentration for growth and mAb production. mAb production is
often greatest during stationary phase, which does seem most pronounced at 8 mM
glutamine.
Extracellular culture supernatant samples were collected at each time point for
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metabolite analysis. Results are shown in Figure 3.2(E)-(H). The nutrients
glutamine and glutamate, as well as the metabolic waste products ammonia
and lactate were measured. As expected, the nutrient concentrations decrease
as they are being used up by the cells. Metabolic waste products increase in
concentration, as cells secrete them. The differences in cell growth at different
glutamine concentrations are reflected in the rate at which metabolites are produced
or used up. To clarify how changes in metabolite concentrations and cell growth
relate to each other, time courses for each flask are shown in Figure 3.3. These results
again that cell growth is largely correlated with glutamine depletion and ammonia
accumulation. Glutamine is thus confirmed as a relevant cell culture parameter for
these cells.
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Figure 3.2: CRL1606 hybridoma cells batch overgrowth in DMEM growth
medium supplemented with different concentrations of glutamine. (A)
Viable cell concentration. (B) Percentage viability. (C) Integral viable cell
concentration. (D) Optimum glutamine starting concentration in terms of
cell growth and mAb production after ∼100h of cell culture. Error bars of
mMb concentration show standard deviation of three replicate measurements
in the same experiment. Relative mAb concentration was measured using an
ELISA. (E)-(H) Extracellular metabolite concentrations. (E) Glutamine.
(F) Ammonia. (G) Glucose. (H) Lactate. A single culture flask per
glutamine concentration was used.
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Figure 3.3: Metabolites and cell growth during CRL1606 hybridoma cells
batch overgrowth in DMEM growth medium supplemented with different
concentrations of glutamine shown by glutamine concentrations. (A) 0 mM
glutamine. (B) 2 mM glutamine. (C) 4 mM glutamine. (D) 6 mM glutamine.
(E) 8 mM glutamine. (F) 10 mM glutamine. Missing data points were caused
by values being larger or smaller than the detection limit. A single culture
flask per glutamine concentration was used.
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3.3 Summary of results
Hybridoma cell cultures were carried out to learn more about cell growth and
metabolite dynamics in this potential biosensor context. Initially, a hybridoma
batch culture was carried out. Cell growth and metabolite concentrations were found
to fall within ranges expected from the literature. Hybridoma cultures at different
glutamine concentrations were then carried out to further investigate limiting factors
in cell culture. It was found that glutamine is an important limiting metabolite for
cell growth and mAb production in the conditions used here.
While antibody production by hybridoma cells was tested, the glycosylation patterns
of the mAb product where not analysed here. It is possible that changing the
glutamine concentration changes these patterns as glycosylation is very sensitive to
culture conditions (van Berkel et al., 2009; Wong et al., 2010).
These cultures refine specifications for potential metabolite biosensors used in
bioprocessing. Table 3.1 and the results in this section indicate required detection
ranges for metabolites. Although it not be necessary for sensors to cover the whole
range in each case, as long as they can detect certain critical threshold levels.
Based on the results herein, the literature overview in the introduction and the
availability of natural sensing systems (see Introduction) it was decided that a
small number of sensing systems should be selected to be tested for their suitability
as biosensors in bioprocessing. The selected systems were the lactate-responsive
E. coli LlPRD system, leucine/alanine-responsive E. coli Lrp system, glutamine-
responsive E. coli Ntr system, and the glutamine-responsive B. subtilis GlnK/GlnL
system. Glutamine is an extremely important cell culture nutrient. The results
in this chapter show that the depletion of glutamine correlates with the onset of
stationary and death phase for the hybridoma cells. Lactate is a common waste
product in cell cultures, as was discussed in the introduction. It accumulated to
high concentrations in the hybridoma cultures shown in this chapter. Alanine is a
common cellular metabolism byproduct in cell cultures that is indicative of ammonia
stress in cells.
Experiments towards engineering biosensors from these systems can be seen in
subsequent chapters.
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4 Development of a biosensor
characterisation protocol
4.1 Introduction
After exploring the parameters of mammalian cell culture and choosing bacterial
sensing systems to test as biosensors, the next step was to develop a suitable protocol
for characterising these systems. The crucial promoter elements from the selected
bacterial sensing systems were incorporated into testing constructs and tested.
General parts characterisation and biosensor engineering was previously discussed in
the introduction. Several landmark synthetic biology parts characterisation papers
discuss standardisation of genetic constructs and characterisation protocols (Canton
et al., 2008; Kelly et al., 2009). A lot of successful biosensors in the field respond to
compounds that are largely orthogonal to intracellular metabolism, i.e. they are not
produced within the cells and come from the external environment. However, some
of the target compounds in this work are metabolites that can be produced within
bacterial cells and are found in many common growth media. Such factors needed
to be considered in the characterisation protocol used here. There are some existing
examples of biosensors with amino acid targets, such as an intracellular sensor for
methionine and other branched amino acids (Mustafi et al., 2011).
This chapter outlines the characterisation protocol development using example
data from several of the promoters studied in this work. The systems used here
include promoters of the lactate-responsive E. coli LlPRD system (Chapter 5),
leucine/alanine-responsive E. coli Lrp system (Chapter 6), and the glutamine-
responsive E. coli Ntr system (Chapter 7). More details on the background,
assembly and characterisation results on these promoters can be found in these
subsequent chapters. Data shown in this chapter relates to experiments that
informed the characterisation set-up.
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4.2 Choice of experimental growth conditions
and equipment
When working in liquid medium, the important parameters to measure for biosensors
were cell growth and fluorescence, to estimate promoter activity. It was therefore
decided to carry out these experiments using a plate reader and 96-well plates to
allow high-throughput characterisation.
4.2.1 Growth media
The Ntr promoters were used to set up a protocol for quantitative characterisation
experiments of the promoter constructs. An important question was what kind
of growth medium should be used during characterisation experiments. There
are many different growth media to choose from, the most common distinction
being rich or complete media on one hand and minimal media on the other.
The glutamine-responsive promoters would need to be studied in a glutamine-free
medium which could be supplemented with known concentrations of glutamine. The
mammalian growth medium DMEM represents the context in which the biosensors
would eventually be used. However, DMEM is a complex medium which normally
contains glutamine, leucine and alanine. Fortunately, glutamine-free varieties are
available. LB is the most commonly used rich growth medium for supporting growth
of bacterial species such as E. coli and B. subtilis in molecular biology. LB can
display batch-to-batch variation, although due to the rich availability of nutrients
this rarely affects bacterial growth. However, as it contains a source of amino acids in
the form of mixed peptides, it is not a suitable medium to use for testing of dynamics
of the glutamine- or leucine/alanine-responsive systems. It could, however, be used
for the lactate-responsive system. LB is commonly used in synthetic biology, e.g.
Gardner et al. (2000); Stricker et al. (2008). A common defined minimal growth
medium for characterising bioparts is M9 medium, which is free of amino acids.
Carbon and nitrogen sources used can be chosen as needed. M9 has been used in
synthetic biology, e.g. Basu et al. (2005), as well as promoter characterisation in E.
coli (Zaslaver et al., 2009). It was therefore decided that promoter characterisation
would be carried out in DMEM and M9 where possible.
For mammalian cell culture, including the CRL 1606 hybridoma cells growth
experiments reported in the previous chapter, DMEM is often supplemented with
phenol red as a pH indicator. To test if phenol red would interfere with fluorescence
measurements, experiments were carried out in DMEM with phenol red, DMEM
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without phenol red and M9. Results showed that phenol red interferes with green
fluorescence detection (Figure 4.1(A)). It was therefore decided that DMEM without
phenol red supplement, and M9 medium would be used for subsequent promoter
characterisation.
4.2.2 Effect of target metabolites on measurements
In a characterisation experiment of a glutamine-responsive promoter, cells express-
ing the characterisation construct would be grown in media containing varying
concentrations of glutamine and cell growth (600 nm wavelength) and green
fluorescence (485 nm wavelength) would be measured. The effect of glutamine
concentration in cell-free media on absorbance measurements at 600 nm and
fluorescence measurements at 485 nm was tested (Figure 4.1(B) and (C)). It
was found that glutamine concentration has no effect on these measurements,
and therefore there would be no need for a medium blank for each glutamine
concentration in subsequent characterisation experiments.
A similar test was carried out for lactate (Figure 4.2). It was found that both
OD600 and fluorescence at 510 nm decreased a small amount with increasing lactate
concentration. Lactate has been suggested to form higher-order structures at higher
concentrations in the presence of divalent ions (Cariati et al., 1977), which could
cause this trend. This effect could lead to slight underestimates of the effects of
lactate on the lldPp promoter.
4.2.3 Cell growth dynamics
Growth behaviour in the available liquid media was studied. For this, biosensor cells
containing lactate-sensing constructs were used.
The growth of the lactate sensor cells was studied in relevant growth media for
biosensor characterisation, LB, M9 and DMEM (Figure 4.3). The cells grew well in
LB medium (Figure 4.3(A)). lldPp+lldR+lldP grew at a lower rate than the others,
suggesting that overexpression of the permease inhibits the cells. In M9 minimal
medium, cells grew at a lower rate than in LB and lldPp+lldR+lldP did not grow
at all (Figure 4.3(B)). The added metabolic burden of permease overexpression or
the effects from the presence of additional transporters seem to prohibit these cells
from growing in this minimal medium. This is also seen in DMEM medium. It
was therefore decided to not pursue work with the lldPp+lldR+lldP construct (see
Chapter: E. coli lldPRD lactate-responsive operon). The DMEM used here did
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Figure 4.1: (A) Suitability of different glutamine-free growth media
for quantitative characterisation of glutamine-responsive promoters.
The media tested were DMEM with or without a supplement of phenol red
and M9 medium. The three culture tubes for each medium hold a medium
blank or E. coli cells with control or test plasmids. (B) Absorbance at 600
nm of different concentrations of glutamine in cell-free growth media. (C)
Fluorescence at 485 nm of different concentrations of glutamine in cell-free
growth media.
not contain added serum or glutamine, instead using NH4Cl as a nitrogen source.
The Blank trace showed noise in the OD signal (Figure 4.3(C)). The peak at time
150 min in the traces for lldPp, lldPp+lldR and Control is thought to result from
precipitation of medium components. DMEM is known to contain components that
can precipitate out of solution, e.g. sulphur and calcium. The medium is also
optimised to be used under high CO2 (i.e. acidic) conditions, which were not used
here. Basic conditions can promote precipitation of certain ions. Notably this
precipitation does not occur in the Blank, nor does it occur in lldPp+lldR+lldP,
where cells are not growing. The precipitation thus seems to be promoted by the
bacterial cells during the exponential growth phase. Following this peak, the trace
seems to rejoin the bacterial growth curve, suggesting that precipitated material
returned into solution as bacterial cells consumed ions or changed the pH. When E.
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Figure 4.2: OD600 and fluorescence (510 nm) of lactate in cell-free M9
medium.
coli or B. subtilis cells were grown in DMEM with added serum, the OD followed a
smooth curve (Chapter 9). However, that experiment used larger culture volumes in
flasks and measurements used cuvettes. Larger volumes and longer times between
time points may have masked the trends seen here. The growth rates in M9 and
DMEM in particular are relatively low. This in itself is not a problem. Ideally the
growth rates should not be too slow as that is an indication that the cells are not
growing healthily and so will not react as expected. But the growth rate should
also not be too fast for two reasons: if cell division is faster than maturation of the
relevant protein (here GFP) then the fluorescence increase may not be visible due
to too much dilution and if cells grow too fast then the exponential growth phase is
over too quickly to obtain sufficient data for characterisation.
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Figure 4.3: Growth of E. coli cells expressing lactate sensor
constructs in LB, M9 and DMEM growth media. OD600 was measured
using BMG omega polarstar fluorometer in a 96-well plate. (A) LB. (B)
M9. (C) DMEM. Error bars represent standard deviations of three biological
replicate wells.
75
4.2.3.1 Growth medium precipitation
An experiment was carried out to test if any of the culture additives could be
causing the precipitation and what additives might prevent it (data not shown).
It was shown that in the absence of cells, NH4Cl does not cause precipitation.
Addition of acid to some extent prevents precipitation and base causes precipitation.
The manufacturer recommends addition of HEPES if using DMEM in a non-
CO2-enriched atmosphere to prevent precipitation. However, addition of HEPES
increased the levels of precipitation. While precipitation is a problem for OD
measurements during promoter characterisation, it may not necessarily interfere
with biosensor function. As GFP synthesis rate is calculated using fluorescence and
OD600 measurements, interference in either of these measurements disrupts the data
analysis. DMEM was therefore found to be largely unsuited to be used as the main
growth medium in biosensor characterisation.
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4.2.4 Preliminary characterisation
An end-point characterisation experiment of the Ntr promoters over a glutamine
concentration range of 0 - 100 mM was carried out (see Figure 4.4). All promoters
show different responses to glutamine. Large changes in output can be seen in the
glutamine concentration range 0 - 10 mM (the range relevant for mammalian cell
cultures), and smaller changes can be seen in the range 10 - 100 mM. A second
experiment was therefore carried out, which explores the glutamine concentration
range of 0 - 10 mM more closely (Figure 4.5). This shows that target concentration
ranges may need to be optimised. Note that such end-point experiments can
be prone to error due to differences in growth rates and growth phases between
cells in the different wells that are not being accounted for. The corrected
fluorescence for glnKp shows negative values in both Figure 4.4 and (Figure 4.5.
While absolute fluorescence cannot give negative values, the fluorescence values
here have been corrected by substraction of fluorescence from the control cells.
These control cells contain the same construct as the biosensor cells, except lacking
the relevant responsive promoter. It is therefore possible for control cells to give
higher fluorescence than the sensor cells if sensor cell fluorescence is low, leading to
negative values. The next step was to develop a protocol for dynamic time-resolved
experiments.
4.2.4.1 Equipment choice
More detailed time-resolved characterisation experiments in M9 were then carried
out for the Ntr promoters. However, these experiments did not produce usable
characterisation data (data not shown). It was observed that the experimental set-
up, which involved many time-sensitive manual pipetting steps lead to time delays
in induction, settling of cells at the bottom of wells (i.e. insufficient mixing) and
volume errors and hence inconsistent and noisy data. Replicate cultures on the
same plate often showed differences for example in growth rates, which made them
difficult to combine during data analysis.
Therefore, it was decided to use a plate reader integrated into a robotic liquid-
handling platform and a protocol as developed by Christopher Hirst (Hirst, 2014).
This would increase consistency across samples and experimental through-put.
Hirst developed an automated characterisation methodology specifically focused
on promoters and suitable for both inducible and constitutive promoters. The
standardised workflow has been optimised to enable parts characterisation under
highly reproducible growth conditions, which should thus produce high quality data.
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Figure 4.4: Preliminary characterisation of Ntr promoters in M9 medium at
glutamine concentrations 1-100 mM. E. coli DHα cells containing the various
Ntr promoter characterisation constructs were grown in M9 medium on a
96-well plate for 5.5 h at different glutamine concentrations. a) individual
promoters. b) all promoters in comparison. Data are based on single cultures.
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Figure 4.5: Preliminary characterisation of Ntr promoters in M9 medium at
glutamine concentrations 1-10 mM. E. coli DHα cells containing the various
NtrC promoter characterisation constructs were grown in M9 medium on a
96-well plate for 5.0 h at different glutamine concentrations. a) individual
promoters. b) all promoters in comparison. Data are based on single cultures.
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The method is based around the aforementioned robotoc liquid-handling platform
with an integrated incubator and plate reader. This allows for reproducible and
high-throughput dilution, outgrowth, induction and assaying of biosensor cells. For
full detail, see the Materials and Methods section. In short, cells are grown up in
cultures overnight. On the day of the characterisation assay, cultures are transferred
onto a 96-well plate and diluted with fresh medium. This is followed by an outgrowth
phase, induction and regular OD600 and fluorescence measurements. The details,
such as durations, can be changed as appropriate. The protocol by Christopher Hirst
was adapted for the present biosensors and further developed over time with specific
adaptations for each of the biosensors described in this work. Data shown in the
later chapters was obtained using different variants of the basic set-up. For instance,
the protocol used in this work initially included a dilution of cell cultures, followed
by an outgrowth phase and a second dilution before induction, thus following the
work flow of Hirst (2014). However, with the very minimal M9 growth medium
used here, it was found that only the first dilution of cultures was necessary and
leaving out the second dilution vastly improved the biosensor characterisation data
that could be collected. This is due to the fact that a lot of the sensors shown in
this work produce low levels of fluorescence and so higher cell densities are needed
during characterisation in order to distinguish biosensor output from background
signal.
4.3 Summary of results
The experiments in this chapter showed the development of a general protocol for
characterisation of the metabolite-responsive promoters discussed in this work.
Different growth media were considered as the base medium for bacterial growth
during biosensor characterisation. It was found that the mammalian growth
medium DMEM (as used in Chapter 3) is not a suitable base medium for
biosensor characterisation, due to precipitation events, which interfered with OD
measurements. A version of the minimal bacterial growth medium M9, containing
no amino acids, was found to be a suitable base medium. This is due its defined
contents, predictable growth dynamics and lack of interference with fluorescence
measurements. However, DMEM would be the base medium of many cell culture
samples that could be analysed with the sensors shown in this work. This challenge
is addressed in chapter 9 (Biosensors in Bioprocessing).
Preliminary characterisation experiments involved manual loading, dilution and
induction in 96-well format. However, the data obtained during these experiments
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was found to be unusable due to noise from pipetting errors, time delays and other
factors. It was therefore decided to use a robotic characterisation platform.
The protocol that is used in subsequent chapters is based on a robotic platform
using 96-well plate format and measurements of absorbance and fluorescence. The
protocol is based on one developed by Hirst (2014). Throughout this work, there
have been small alterations to the protocol, meaning that datasets shown in the
subsequent chapters may use slightly different versions of the basic protocol.
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5 E. coli lldPRD lactate-responsive operon
5.1 Introduction
5.1.1 Lactate-responsiveness of the lldPRD operon
The lldPRD operon (previously called lct) in E. coli is expressed in response to
the presence of L-lactate (Nu´n˜ez et al., 2001; Hua et al., 2007; Aguilera et al.,
2008). The operon comprises three genes transcribed from a single promoter (lldPp):
Lactate permease lldP (Nu´n˜ez et al., 2002), regulatory protein lldR and lactate
dehydrogenase (Figure 5.1(A)) lldD (Dong et al., 1993; Aguilera et al., 2008). D-
lactate has also been shown to induce expression from lldPp, though to a lesser extent
than L-lactate (Nu´n˜ez et al., 2001). Growth and evolution on medium containing
lactate as the carbon source lead to increased transcriptional expression of LldP and
LldD, though not LldR (Hua et al., 2007).
LldR was shown to have an N-terminal helix-turn-helix motif that is homologous
to that of a number of bacterial transcription factors, including FadR (Dong et al.,
1993). It was suggested that LldR functions as a repressor in the absence of lactate
(Lynch and Lin, 1996). A comparative study placed LldR in the FadR subfamily of
the helix-turn-helix GntR family of bacterial regulators (Rigali et al., 2002; Aguilera
et al., 2008). Similar lactate operons exist in other bacterial species. The LldR
protein from Corynebacterium glutamicum and the operon that it regulates have
been extensively characterised (Stansen et al., 2005; Georgi et al., 2008; Gao et al.,
2008; Toyoda et al., 2009). Systems have also been found in Pseudomonas aeruginosa
(Gao et al., 2012) and Shewanella oneidensis (Pinchuk et al., 2009).
The structure of the lldPp promoter was analysed for transcription factor binding
sites and transcription start sites (Lynch and Lin, 1996) and a model for lldPp
regulation through lactate was proposed. A subsequent extensive study updated
this model (Aguilera et al., 2008) (Figure 5.1(B)). In absence of lactate, the LldR
transcription factor acts as a repressor of gene expression from this operon. In
presence of lactate, LldR activates transcription by aiding the assembly of the
transcription machinery.
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Figure 5.1: Lactate response of the lldPRD operon in E. coli. (A)
Genetic structure of lldPRD operon. It consists of three structural genes and
an inducible promoter. Figure taken from Aguilera et al. (2008). (B). Gene
expression in lldPRD operon in absence and presence of lactate. Expression
from the lldPRDp promoter is thought to be repressed in the absence of lactate
and activated in the presence of lactate. Figure is based on information from
Dong et al. (1993); Lynch and Lin (1996) and Aguilera et al. (2008).
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5.1.2 Biosensor assembly and preliminary characterisation
It is proposed here that the lldPp promoter could be used as part of a whole-cell
lactate biosensor. The LldR protein has previously been used as a FRET lactate
sensor called Laconic in mammalian cells (San Mart´ın et al., 2013). In that context,
the sensor was shown to be quantitatively responsive to lactate in the concentration
range from 1 µM to 10 mM and was not significantly affected by a large number of
other metabolites at the concentrations found in mammalian cells. pH was shown
to affect the response of Laconic quantitatively but not qualitatively (San Mart´ın
et al., 2013). The effect of pH, however, may be due to the pH sensitivity of the
fluorophores rather than the LldR itself.
A number of constructs were made to study the potential of this promoter as a
biosensor (Figure 5.2). These constructs were made by undergraduate students
Sharmilah Veterayan (Veterayan, 2011) and Katarzyna Roguska (Roguska, 2012).
Veterayan (2011) constructed lldPp (containing the responsive promoter linked to
a GFP gene) and lldPp+lldR (additionally overexpressing the transcription factor)
and confirmed that they respond to lactate with a linear detection range between
2.5 mM and 0.05 mM. Roguska (2012) constructed variants of lldPp and lldPp+lldR
plasmids containing the lldP permease gene (to potentially aid import of lactate
and change response time), as well as variants with different plasmid copy numbers
(to potentially change the sensitivity range of the sensor). Lactate-response of lldPp
and lldPp+lldR in presence of other carbon sources were also investigated (Roguska,
2012). Confirming previous results (San Mart´ın et al., 2013), it was shown that
the sensors were lactate-responsive in the presence of a number of different carbon
sources, but that the quantitative fluorescence output differs for these different
conditions. This could be due to different carbon sources leading to different levels
of intracellular lactate accummulation or due to different carbon sources causing
different levels of repression of the lldPp promoter. In this work it was found that the
lldPp+lldR+lldP cells did not show significant growth in M9 or DMEM media and
this construct was therefore not characterised further (see Chapter: Development of
a biosensor characterisation protocol).
To act as a lactate sensor, the lldPp promoter should ideally only change activity
in response to lactate concentration and not respond to any other compounds or
conditions. In addition to LldR, the lldPp promoter is also regulated by the two-
component system ArcB-ArcA. ArcB-ArcA reacts to cellular redox state, which is
representative of cellular oxygen availability. Expression of the lldPRD operon is
activated under aerobic conditions and repressed under anaerobic conditions (Iuchi
et al., 1994). ArcB is a sensor kinase thought to detect an electron transport
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Figure 5.2: Lactate biosensor constructs used in this study, made
by undergraduate students Sharmilah Veterayan (Veterayan, 2011) and
Katarzyna Roguska (Roguska, 2012).
component in reduced form, and is ArcA a response regulator phosphorylated by
ArcB during anaerobic growth (Lynch and Lin, 1996). Changes in expression of
lldPRD can be as much as 30-fold or 90-100-fold in response to respiratory growth
conditions, which represents the widest range of responses to ArcA of all operons
regulated through this system (Dong et al., 1993; Lynch and Lin, 1996). This
may be explained by the fact that the ArcA binding sites in lldPp are very similar
to the ArcA consensus binding site (Liu and De Wulf, 2004). During transition
from anaerobic to aerobic growth conditions, expression from lldPRD is rapidly
increased ∼3-5-fold within 5 minutes (Partridge et al., 2006). The regulation by
ArcA could interfere with the use of lldPp as a lactate sensor. Using the lldPp
and lldPp+lldR constructs, it was shown that ArcA regulation of lldPp could
become insignificant in biosensor 2, probably because the endogenous ArcB-ArcA
expression is too low (Roguska, 2012). Alternatively, presence of nitrate in the
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growth medium can partially relieve the anaerobic repression of ArcB-ArcA due to
its high redox potential (Iuchi et al., 1994). A possible indirect but small regulatory
effect on lldPRD by Fnr, a global regulator involved in aerobic metabolism, has
also been suggested (Iuchi et al., 1994). Another transcription factor, PdhR, was
also suggested to regulate expression of lldPRD (Lynch and Lin, 1996), but this was
later shown not to be the case (Aguilera et al., 2008).
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5.2 Results
5.2.1 Biosensor characterisation on solid medium
A qualitative biosensor characterisation was carried out. E. coli cells expressing
the various biosensor constructs were plated on LB agar plates containing varying
concentrations of lactate (Figure 5.3). As previously shown (Veterayan, 2011;
Roguska, 2012), overexpressing lldR leads to lower expression levels of GFP from the
lldPp promoter. However, fluorescence changes with respect to lactate concentration
were not discernible by eye.
5.2.2 Biosensor characterisation in liquid medium
Results shown in this section were always representative of multiple replicate
experiments with a minimum two technical replicates of three biological replicates.
The biosensor cells were characterised in M9 medium (containing glycerol as a carbon
source) using a robotic plate reader platform. Both lldPp sensor cells (Figure 5.4)
and lldPp+lldR sensor cells (Figure 5.5) were characterised. As mentioned above,
lldPp+lldR+lldP was also characterised, but these cells showed reduced growth,
probably due to additional metabolic burden or toxicity due to the overexpression
of the permease.
The lldPp sensor showed a limited response to lactate and a high baseline
fluorescence in absence of lactate (Figure 5.4). The lldPp+lldR sensor shows a
strong and very defined response to lactate (Figure 5.5). In absence of lactate,
sensor cell fluorescence is equal to control cell autofluorescence. Presence of lactate
leads to an increase in fluorescence and over time cells arrive at a higher stable
fluorescence level, the level of which depends on the lactate concentration.
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Figure 5.3: Lactate sensor characterisation on solid medium. E.
coli DHα cells were plated out on plates with LB agar containing different
concentrations of lactate and grown for approximately 20 hours. (A) Photo
of colonies on plates. (B) Colonies re-ordered for comparison. Plates are
shown placed on a UV-illuminator.
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Figure 5.4: lldPp lactate sensor characterisation. a) Corrected fluorescence.
b) GFP synthesis rate. c) Cell growth. Biosensor cells were grown in
M9 minimal medium. Error bars represent the standard deviation of three
biological replicates.
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Figure 5.5: lldPp+lldR lactate sensor characterisation. a) Corrected
fluorescence. b) GFP synthesis rate. c) Cell growth. d) Dose-response graph.
Biosensor cells were grown in M9 minimal medium. Error bars represent the
standard deviation of three biological replicates.
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5.2.3 Effect of carbon and nitrogen sources on lactate
biosensing
5.2.3.1 Lactate sensing in presence of glucose
Results from the literature suggest that the lldPp promoter is repressed by the
presence of glucose. Cells would use glucose as a carbon source in preference to
lactate and hence keep expression from the lldPp promoter low. This is also similar
to other carbon source operons, such as the lac operon. It was suggested that the
presence of glucose would lower the baseline expression from the lldPp promoter
in such a way that the lldPp sensor cells would show a greater response to lactate.
Furthermore, most mammalian cell growth media contain glucose as a carbon source
and so it was important to test the sensors in presence of this compound. Both
lldPp sensor cells and lldPp+lldR sensor cells were characterised for their response
to lactate in M9 medium containing glucose as a carbon source instead of glycerol
(Figure 5.6).
Overall, the results show that the biosensors behave very similarly in the presence
of glucose as in the previous experiments in absence of glucose, except that the
fluorescence output is lower. lldPp still only shows a limited lactate response with a
high background baseline and lldPp+lldR still shows a very strong lactate response
with a low background baseline. Corrected fluorescence values in the negative range
are due to calculations of removing background fluorescence from the control cells.
This suggests that there is some leaky expression of GFP by the control cells.
5.2.3.2 LB medium
Characteriation of the biosensors in LB was attempted but these experiments did
not give usable data (data not shown). Cell growth in LB medium is very fast. This
means that cells quickly reach stationary phase where biosensor characterisation is
difficult as the assumptions of exponential phase no longer hold true. Also, very fast
cell division can mask potential GFP accumulation in cells from being detectable.
Modifications would have to made to the protocol to characterise the sensors in this
medium.
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Figure 5.6: Lactate sensor response to lactate in presence of glucose. a) - c)
show lldPp and d) - f) show lldPp+lldR. a) Corrected fluorescence. b) GFP
synthesis rate. c) Cell growth. d) Corrected fluorescence. e) GFP synthesis
rate. f) Cell growth. Biosensor cells were grown in M9 minimal medium.
Error bars represent the standard deviation of three biological replicates.
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5.2.4 Other inducers - D-lactate and pyruvate
It is possible for biological molecules to interact with more than one target molecule.
For a biosensor, this can have both advantages and disadvantages. Responsiveness
to several inducers can increase or decrease the possible application range. It reduces
specificity, but opens up new sensing targets. It was decided to test the response of
the lldPp+lldR lactate sensor to D-lactate and pyruvate. Both these molecules are
similar to L-lactate in size and structure. Pyruvate is present in many cell culture
media and there is potential interest in our Centre for creating a D-lactate sensor.
5.2.4.1 D-lactate
D-lactate has previously been shown to induce expression from lldPp, though to a
lesser extent than L-lactate (Nu´n˜ez et al., 2001). Results from characterisation of
the response of lldPp+lldR to D-lactate confirm these results from the literature
(Figure 5.7). As before, corrected fluorescence values in the negative range are due
to calculations of removing background fluorescence from the control cells.
5.2.4.2 Pyruvate
The lldPp+lldR lactate sensor cells were exposed to different concentrations of
pyruvate (Figure 5.8). While pyruvate concentrations in the range 0 - 1.0 mM cause
a small activation effect, fluorescence at 14 mM pyruvate was always the lowest of
all concentrations. As before, corrected fluorescence values in the negative range are
due to calculations of removing background fluorescence from the control cells.
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Figure 5.7: lldPp+lldR lactate sensor response to D-lactate. a) Corrected
fluorescence. b) GFP synthesis rate. c) Cell growth. Biosensor cells were
grown in M9 minimal medium. Error bars represent the standard deviation
of three biological replicates.
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Figure 5.8: lldPp+lldR lactate sensor response to pyruvate. a) Corrected
fluorescence. b) GFP synthesis rate. c) Cell growth. Biosensor cells were
grown in M9 minimal medium. Error bars represent the standard deviation
of three biological replicates.
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5.3 Summary of results
Lactate sensors based on the lldPRDp promoter were characterised for their response
to lactate. It was found that a construct containing the promoter linked to a
GFP gene, as well as overexpressing the lldR regulator (lldPp+lldR) showed strong
activation by lactate in the range 0-14 mM in liquid M9 medium. A construct
containing the responsive promoter, but not overexpressing the lldR regulator
(lldPp) showed a much more limited response to lactate in liquid M9 medium.
Characterisation in M9 medium containing glucose or glycerol as a carbon source
gave similar results qualitatively, though quantitatively, fluorescence output from
the sensor was lower in presence of glucose. Characterisation on solid medium did
not show a response that was visible to the eye. Cells with constructs overexpressing
the lldP permease gene did not grow well enough for characterisation. It therefore
seems that overexpression of this gene is damaging to the cells.
The lldPp+lldR construct was also characterised for its response to D-lactate and
pyruvate. There was a response to D-lactate that was similar to, though less
pronounced than, that to L-lactate. This means that protein engineering could
potentially be used to create a D-lactate biosensor from this system. While pyruvate
concentrations in the range 0 - 1.0 mM cause a small activation effect, fluorescence
at 14 mM pyruvate was always the lowest of all concentrations. This could be due
to the cells utilising pyruvate as a nutrient source.
Overall, E. coli cells containing the lldPp+lldR construct appear very suitable for
use as a lactate biosensor under the conditions used here. Further experiments
showing this sensor in conditions more similar to mammalian cell culture are shown
in Chapter 9 (Biosensors for bioprocessing).
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6 E. coli Lrp operon
6.1 Introduction
6.1.1 Leucine- and alanine-responsiveness of promoters in
the Lrp operon
Promoters of the Lrp regulon are controlled by the leucine-responsive protein (Lrp).
Lrp acts as a global regulator in E. coli and regulates the expression of many genes
in response to leucine and in some cases alanine (Ernsting et al., 1992; Calvo and
Matthews, 1994; Newman, 1995). It directly regulates over 200 genes in E. coli
and is present across bacteria (Newman, 1995; Hart and Blumenthal, 2011). The
details of the Lrp regulon have been extensively discussed elsewhere (Calvo and
Matthews, 1994; Newman, 1995). Lrp can act on cellular promoters in a number
of different ways and this regulation in turn can be differently affected by leucine
(Figure 6.1(A)). The Lrp operon is interlinked with other metabolic control operons
such as Ntr and argR (Ernsting et al., 1992).
In order to make a library of known promoters, six E. coli promoter elements,
which are regulated in response to leucine (fimBp1, gimBp2, gltBp, ilvIHp1, leuLp
and livJp) were chosen to be characterised. From the literature, it is possible to
make predictions about the behaviour of these promoter under relevant experimental
conditions (Table 6.1).
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Figure 6.1: Lrp system in cells. Lrp regulation affects different operons in
different ways (see Table 6.1). This diagram was made using information from
[ecocyc.org].
Table 6.1: Expected promoter response to changing Lrp, leucine and alanine
concentrations based on the literature. Alanine can have a similar effect to
leucine, but less so and in some cases it has no effect.
Promoter Natural con-
text
Predicted promoter behaviour Reference
+Lrp +Leu +Ala
fimBp1 type I pili Activation Activation Activation (Calvo and Matthews,
1994; Newman, 1995);
check: (Kiryu et al., 2005;
Berezhnoy et al., 2006)
fimBp2 type I pili Activation Activation Activation (Calvo and Matthews,
1994; Newman, 1995)
gltBp glutamate
synthase
Activation Repression No known
effect
(Newman, 1995), check:
(Martinez-Vaz et al.,
2010)
ilvIHp1 isoleucine
and valine
biosynthesis
Activation De-
activation
De-
activation
(Calvo and Matthews,
1994; Newman, 1995;
Chen et al., 2005); check:
(Kaltenbach et al., 1998)
leuLp leucine
biosynthesis
Activation Repression No known
effect
(Newman, 1995); check:
(Selvamani et al., 2013)
livJp leucine
transport
Repression Repression Repression (Ernsting et al., 1992;
Calvo and Matthews,
1994; Newman, 1995);
check (also for other
promoters) (Barker et al.,
2001)
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6.2 Results
6.2.1 Biosensor construct assembly
Alanine is an interesting target in hybridoma bioprocessing, as it is secreted by
mammalian cells in response to ammonium stress (see Introduction). In order to
make a whole-cell leucine- or alanine-biosensor six E. coli promoter elements, which
are regulated by the leucine/alanine-responsive Lrp regulator, fimBp1, gimBp2,
gltBp, ilvIHp1, leuLp, livJp (Figure 6.2(B)) were chosen to be tested for their
function using the gene circuit shown in Figure 6.2(A). Unlike the lactate sensor
construct shown in chapter 5, the sensor constructs here do not overexpress the
transcription factor that controls the promoter, i.e. Lrp. Undergraduate student
Harold Taylor attempted to overexpress the Lrp protein in E. coli, but found that
cell colonies did not grow after transformation, indicating that Lrp overexpression
may be toxic to these cells.
The promoters were successfully amplified from the E. coli genome, transformed
into BioBricks and transformed into E. coli DHα cells. After transformation of
the constructs into cells, the cells showed different levels of fluorescence on LB
agar plates with the fimBp-containing cells showing the highest level of fluorescence
(Figure 6.2(C)). All the constructs were verified by DNA sequencing.
99
Figure 6.2: Lrp operon promoter assembly. (A) Characterisation and
control gene circuit. (B) List of lrp operon promoters tested here. (C) LB agar
plates with E. coli DHα transformed with the constructs from (A) containing
six different Lrp promoters.
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6.2.2 Biosensor characterisation on agar plates
As it is known that growth conditions can affect the behaviour of the Lrp
regulon (Cho et al., 2008), it was important to characterise the promoters in
a number of different conditions and to clearly define each particular condition.
Initially, biosensors were tested qualitatively on M9 minimal medium plates,
supplemented with varying concentrations of leucine. Leucine concentrations
ranged from 0-2.0 mM, which approximately covered leucine solubility range in this
medium. (Figure 6.3). To test the effect of different level of nitrogen availability,
different concentrations of NH4Cl were also tested. Plates contained either 19
mM (Figure 6.3(B)-(C)) or 37 mM NH4Cl (Figure 6.3(D)-(E)). ∼19 mM is the
commonly used concentration of NH4Cl in M9 medium and ∼37 mM is double that
concentration.
Generally, increasing leucine concentrations correlated with decreasing cell fluo-
rescence. However, non-control cells grown on higher leucine concentrations also
showed decreased growth. Thus the decreased fluorescence is likely to be a side-
effect of decreased growth. Control cells did not show growth inhibition. Leucine
has been shown to be toxic to E. coli cells at high concentrations (Quay et al., 1977;
Tavori et al., 1981; Ernsting et al., 1992). Addition of 10 mM leucine has been
shown to slow E. coli growth (Ernsting et al., 1992). The concentrations used here,
however, were lower than 10 mM. The results suggest that leucine toxicity is only
displayed here when cells are forced to overproduce GFP from the characterisation
construct. It is possible that the additional metabolic burden of overexpression
causes the toxicity in sensor cells, but not control cells. However, the effect of
leucine toxicity was more pronounced under high NH4Cl conditions.
Response to alanine was also tested. From the literature it is predicted that
alanine has a similar (though smaller) effect to leucine on many of these promoters
(Table 6.1). The promoters gltBp, ilvIHp1 and livJp showed repression, leuLp
showed activation and fimBp1 showed very little to no effect (Figure 6.3(F)-(I)).
Results were similar in high and low NH4Cl conditions, although the centre of cell
streaks were less fluorescent in high NH4Cl conditions.
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Figure 6.3: Promoter characterisation on solid medium. (A) Plate layout.
(B)-(E) Response to leucine with plates containing (B)-(C) 19 mM NH4Cl or
(D)-(E) 37 mM NH4Cl. (F)-(I) Response to alanine with plates containing
(F)-(G) 19 mM NH4Cl or (H)-(I) 37 mM NH4Cl. Plates are shown placed on
a UV-illuminator. Image was taken after ∼1.5 days at 37◦C.
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6.2.3 Biosensor characterisation in liquid media
These potential leucine/alanine-responsive biosensors were then tested in liquid
medium and 96-well plate format using a robotic platform with an integrated plate
reader. Promoters were characterised for their response to alanine (Figure 6.4) and
leucine (Figure 6.5). Cell growth during these experiments is also shown.
fimBp2, gltBp, ilvIHp1 and livJp showed repression by alanine and leucine; fimBp1
and leuLp showed activation by alanine and leucine. In each case, magnitude and
dynamics of responses differ between the different promoters and also between the
two inducers.
Figure 6.4: (a) GFP synthesis rate of Lrp promoters at different alanine
concentrations in M9 medium. Error bars represent the standard deviation of
three biological replicates. (b) Growth of cells during the assay. Error bars
represent the standard deviation of three biological replicates.
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Figure 6.5: (a) GFP synthesis rate of Lrp promoters at different leucine
concentrations in M9 medium. Error bars represent the standard deviation of
three biological replicates. (b) Growth of cells during the assay. Error bars
represent the standard deviation of three biological replicates.
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Table 6.2: Observed promoter responses compared to expectations from the
literature.
Promoter Observed promoter behaviour Commentary
+Leu
solid
medium
+Leu
liquid
medium
+Ala
solid
medium
+Ala
liquid
medium
fimBp1 growth
inhibition
small
activation
repression/
no effect
small
activation
predicted to be ac-
tivated
fimBp2 growth
inhibition
repression no effect repression predicted to be ac-
tivated
gltBp growth
inhibition
repression repression repression not previously
known to be
responsive to
alanine
ilvIHp1 growth
inhibition
repression repression repression as expected
leuLp growth
inhibition
activation activation activation predicted to be re-
pressed
livJp growth
inhibition
repression repression repression as expected
Legend could not
determine
prediction
fulfilled
prediction
partially
fulfilled
prediction
not
fulfilled
These results show different levels of biosensing, but also different agreements with
the existing literature. Table 7.2 summarises how the results shown here compare
with what was expected from the literature (Table 6.1). The results are mixed.
ilvHp1 and livJp behave as expected. gltBp shows repression by alanine, though
previous studies could not find a response. fimBp1, fimBp2 and leuLp do not
behave as expected from the literature. fimBp2 have been shown to be activated by
leucine, whereas here there is a small repressive effect. This may be as this promoter
becomes less active in E. coli laboratory strains (Iida et al., 2001). leuLp should
be activated by Lrp, but repressed by leucine. In this work, increasing leucine
concentration activated leuLp. In some cases there are differences between solid
and liquid medium results. Liquid and solid media present quite different growth
conditions to cells (Dubey and Ben-Yehuda, 2011; Dalchau et al., 2012), which
explains why the promoters behave differently in the two conditions. The cells are
thought to be in stationary phase on agar plates. There are also edge effects to
consider on plates, as cells at the edge of a growth zone are exposed to different
conditions that those near the centre. It can be difficult to relate observations on
solid medium to cell concentration.
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6.3 Summary of results
Promoters of the E. coli Lrp operon were assembled into constructs to be
characterised for their response to alanine and leucine. The promoters showed
a range of responses and different dynamics, which in some cases changed with
growth conditions. In some cases the responses differed from those predicted from
the existing literature.
Biosensor cells were characterised for their alanine and leucine response on agar
plates. Leucine caused growth inhibition of the cells. In response to alanine, cells
exhibited a range of responses, including both activation and repression (Table 7.2).
Biosensor cells were then characterised for their response to alanine and leucine
in liquid M9 medium. Under these conditions, several of the promoters showed
responses to leucine and alanine (Table 7.2).
Undergraduate Harold Taylor attempted to overexpress Lrp in these cells, but did
not succeed, possibly because the overexpression construct was toxic to the cells.
Lrp overexpression has many effects on general cell metabolism (Newman, 1995).
Elevated protein concentrations could also lead to non-physiological cross-talk even
where it normally does not exist (Ninfa et al., 2007). This is one of the challenges in
synthetic biology when working with systems that are based on transcription factors
that are integral to cellular metabolism instead of only controlling one promoter.
Therefore, in the sensors shown here, Lrp was not overexpressed in these constructs.
Instead, the constructs used the endogenous Lrp. The effect of overexpressing the
promoters on plasmids is predicted to be equivalent to lowering the concentration of
Lrp (Table 6.1). It is possible that the dynamics of these parts could be improved in
terms of signal amplitude and repeatability if Lrp were successfully overexpressed.
These promoters are now characterised bioparts under these conditions that could
be used by the synthetic biology community. gltBp, ilvHp1, leuLp and livJ show
responses to alanine and leucine, and could in theory be used as biosensors for these
compounds. However, since the promoters respond to both these amino acids, they
could not currently be used to e.g. determine the alanine concentration in a sample
that also contains leucine (as would be the case with most cell culture samples). It
is possible that protein engineering of Lrp could be used to increase specificity to
either alanine to leucine.
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7 E. coli Ntr regulon
7.1 Introduction
7.1.1 Glutamine-responsiveness of the Ntr system
Promoters in the Ntr (nitrogen-responsive) regulon in E. coli are regulated in
response to nitrogen availability (Reitzer, 2003; Mutalik and Venkatesh, 2007). The
two-component system NtrB/NtrC (NRI/NRII) controls gene expression from many
promoters in response to cellular nitrogen status (Maheswaran and Forchhammer,
2003). Glutamine feeds into this system as an indicator of nitrogen status
(Figure 7.1). NRI-P activates gene expression from several promoters when cells
enter nitrogen starvation. High concentrations of glutamine cause a decrease of
NRI-P and increase of NRI.
Figure 7.1: Ntr system in E. coli. Figure taken from [http://commons.
wikimedia.org/wiki/File:Ntr_system.jpg].
Promoters from the Ntr regulon were researched in the literature. Based on previous
knowledge of this system from the literature, it is possible to make predictions for
how these promoters should behave when exposed to different concentrations of
glutamine (Table 7.1).
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Table 7.1: Promoters of the Ntr regulon and their predicted response to
glutamine.
Promoter Gene context Predicted promoter behaviour Reference
+NRI-P +Gln
argTp lysine/arginine/ ornithine
ABC transporter
periplasmic binding protein
Activation Repression? Ecocyc
astCp2 enzymes of arginine suc-
cinyltransferase (AST) path-
way
Repression Activation Ecocyc
glnAp1 glutamine synthetase Repression Activation Ecocyc
glnAp2 glutamine synthetase Activation Repression Ecocyc
glnHp2 glutamine ABC transporter Activation or re-
pression depend-
ing on other fac-
tors
Activation or re-
pression depend-
ing on other fac-
tors
Ecocyc
glnKp nitrogen regulatory protein
PII-2
Activation Repression Ecocyc
glnLp NtrB (NRII) Repression Activation Ecocyc
nac Nac DNA-binding transcrip-
tional dual regulator
Activation Repression Ecocyc
The Ntr operon has been previously used in synthetic biology. Components
of the system have been used to create oscillatory behaviour (Atkinson et al.,
2003), attempts have been made to rewire signalling through this network by
adding different receivers (Wang, Barahona, Buck and Schumacher, 2013) and the
downstream region of the glnAp2 promoter has been used as part of a bioreporter
by fusing it with a xylene-responsive promoter (Carmona et al., 2005; van der Meer
and Belkin, 2010).
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7.2 Results
7.2.1 Biosensor construct assembly
In order to make a whole-cell glutamine biosensor, eight E. coli promoter elements,
which are regulated by the glutamine-responsive NtrC regulator, argTp, astCp2,
glnAp1, glnAp2, glnHp2, glnKp, glnLp and nac (Figure 7.2(A)), were chosen to
be tested for their function using a characterisation gene circuit (Figure 7.2(B)).
The promoters were successfully amplified from the E. coli genome and converted
into BioBricks via two PCR reactions (Figure 7.2(C)) and assembled into the
characterisation circuit. After initial transformation of the constructs into E.
coli DHα cells, cells showed different levels of fluorescence on LB agar plates
(Figure 7.2(D)). This indicates different expression levels from the various Ntr
promoters under the conditions on LB agar plates. All eight constructs were shown
to be correctly assembled and verified by DNA sequencing.
Colonies transformed with the astCp2 promoter in the characterisation construct
showed fluorescence heterogeneity (Figure 7.2(E)). This was found to be caused by
an insertion in the construct present in some of the colonies. The more fluorescent
cells contained a TAGCGGCCGCTACTAG insertion in the TACTAG ∨AG BioBrick
scar site between the promoter and the ribosome binding site. Both versions of the
astCp2 construct were included in subsequent characterisation experiments.
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Figure 7.2: Biosensor construct assembly. a) Genetic circuit used to
characterise promoters of interest. The BioBrick name of each part is shown
in brackets. b) List of Ntr promoters tested here. c) Agarose gel showing
successful amplification of E. coli glutamine-responsive promoters as indicated
in the legend. PCR products were run on two separate gels, and one lane on
the left-hand gel was omitted from the figure for clarity. d) LB agar plates
with E. coli DHα transformed with the characterisation construct containing
different promoters. e) - f) Fluorescence heterogeneity in colonies transformed
with the astCp2 promoter in the characterisation construct in e) colonies and
f) cultures.
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7.2.2 Biosensor characterisation on agar plates
Once the promoter constructs were correctly assembled, the next step was to
characterise them in terms of their dose response and dynamic response. A
qualitative end-point characterisation test was carried out in which E. coli DHα
cells containing the verified promoter constructs were streaked out onto M9 minimal
medium plates supplemented with varying concentrations of glutamine. Cells were
left to grow overnight and photographed the next day (Figure 7.3). While it is
difficult to draw firm conclusions from these results, general trends can be seen. By
comparing the behaviour of the promoters in different glutamine concentrations in
M9, biosensor responses can be discerned. Comparing the fluorescence of the cells
on M9 minimal medium with that in rich LB medium, shows how these promoters
change behaviour between minimal and rich conditions. However, this is difficult to
interpret on Petri dishes with solid medium, as the cells may also show increased
growth in rich medium. Also, fluorescence levels or changes may not be great enough
to see by eye. The promoters glnAp2, glnKp and nac show repression with increasing
glutamine concentration. glnLp shows some activation. argTp, astCp2, glnAp1 and
glnHp2 do not show a visible effect. glnAp2, glnKp, glnLp and nac do therefore
behave as predicted from the literature (Table 7.1).
Growth conditions can have large effects on BioPart function (Dalchau et al., 2012)
and so it is important to test these under a number of different conditions to see
where they fail and work and any differences in function.
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Figure 7.3: Ntr promoter characterisation on solid medium. E. coli DHα
cells containing the various NtrC promoter characterisation constructs were
plated out on plates containing different concentrations of glutamine. Plates
are shown placed on a UV-illuminator. (A) Arrangement of cells on the plates.
(B) Cells in re-arranged order for better comparison.
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7.2.3 Biosensor characterisation in liquid medium
Subsequent time-resolved characterisation experiments were carried out on a robotic
platform using a plate reader to aid high-thoughput processing and repeatability.
Figure 7.4 shows fluorescence and GFP synthesis rate from these characterisation
experiments. Several of the promoters show synthesis rate trends that mark them as
possibly suitable biosensors. Specifically arpTp, glnAp1, glnKp and nac. However,
the responses to glutamine are all minor. Upon initial inspection of the data in
Figure 7.4, ArgTp seemed to be the most promising biosensor. However, data
analysis and close inspection of the OD data for these experiments (Figure 7.5), it
was found that the response was largely caused by the OD values, as the cells grew
differently in different glutamine concentrations.
In Figure 7.4 many of the sensors seem to react to glutamine concentration during
the first few time points and then level off. This might suggest that the reaction
to glutamine in terms of different protein expression rates happens very quickly
and only for a short time. Alternatively, it could be that the cells very quickly use
up any available glutamine and so the reaction to any glutamine “sensed” would
decrease over time. This possibility was further investigated by testing some of
the promoters at higher glutamine concentrations in Figure 7.6. No response to
glutamine was seen in the fluorescence output, however, synthesis rate data again
showed some initial response to glutamine. This could indicate a brief response
in gene expression changes to changing glutamine concentration, followed by quick
adaptation or re-equilibration.
The results of the promoter characterisation in this chapter are summarised in
Table 7.2.
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Figure 7.4: Ntr promoter characterisation in liquid medium. (A)
Fluorescence of Ntr promoters at different glutamine concentrations in M9
medium measured by robot. Error bars represent the standard deviation
of three biological replicates. (B) GFP synthesis rate of Ntr promoters
at different glutamine concentrations in M9 medium measured using an
integrated robotic platform. Error bars represent the standard deviation of
three biological replicates.
114
Figure 7.5: Cell growth from experiments shown in Figure 7.4.
Figure 7.6: GFP fluorescence and synthesis rate of argTp, astCp2 (insertion)
and astCp2 Ntr promoters at higher glutamine concentrations in M9 medium.
Error bars represent the standard deviation of three biological replicates.
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Table 7.2: Observed Ntr promoter responses to glutamine.
Promoter Observed promoter behaviour
+Glutamine
solid medium
+Glutamine
liquid medium
argTp No response No response
astCp2 No response No response
glnAp1 No response No response
glnAp2 Repression No response
glnHp2 No response No response
glnKp Repression No response
glnLp Activation No response
nac Repression No response
Legend Promoter behaves as
expected
Promoter does not be-
have as expected
7.3 Discussion
There are a number of factors that may make the Ntr system unsuitable as a basis
for bacterial whole-cell glutamine biosensors for bioprocessing contexts. The system
reacts to intracellular glutamine availability (Schumacher et al., 2013), which may
not be representative of extracellular glutamine. Internal concentration is related to
external through processes like transport, synthesis, degradation and consumption
of glutamine. Undergraduate student Kai Jiang investigated the possibility of over-
expressing the glnHPQ E. coli glutamine import complex. However, it was not
possible to overexpress these proteins, which may suggest that such overexpression
is toxic to the cells. Nohno et al. (1986) have previously cloned the proteins using
a low copy number plasmid. As NtrC-type proteins are very widely distributed in
bacteria it would be difficult to find a chassis where this system would be completely
orthogonal (Ninfa et al., 2007). A known intracellular glutamine biosensor could be
used in cells exposed to known extracellular glutamine concentrations to observe the
relationship between intracellular and extracellular glutamine concentrations and to
compare to the output of the Ntr biosensors. An example of such a sensor that could
be used is one presented by Behjousiar et al. (2012). The Bacillus subtilis glutamine
sensor (see Chapter 8) is thought to be extracellular, and therefore should be more
suitable.
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Another factor is that the Ntr system processes a number of inputs in addition
to intracellular glutamine availability such as carbon availability and nitrogen
availability in general (Schumacher et al., 2013). Therefore, promoter output may
not be specific to glutamine concentration and changes in other metabolites can
change promoter output (Willis, 1975). Even more so, as the promoters tested
here control expression of glutamine uptake and level of glutamine synthetase. The
relation between intracellular and extracellular glutamine is therefore influenced
by availability of not just glutamine, but also other nitrogen sources and even
carbon source. These promoters therefore influence their own expression in very
complex ways. Higher glutamine concentrations as used in the experiment shown in
Figure 7.6, may therefore not have the predicted effect, because there are complex
feedback systems in play. The output may also be influenced by concentration of
ammonia, which might be different for different experimental wells depending on
previous dilutions steps. In addition to this, E. coli has several glutamine uptake
systems which possibly underlie different kinds of regulation, making the level of
glutamine uptake is difficult to predict. α-ketoglutarate, an intracellular indicator
of carbon status can override glutamine signalling to NtrC under certain conditions
(Schumacher et al., 2013).
Finally, what might influence the results is that glutamine is used up by the cells as
well as sensed. The same is true for a number of sensor systems that have shown good
responses, e.g. the arabinose operon [http://partsregistry.org/Part:BBa_I0500]
and lactose operon. However, in those two cases, the operon encodes the genes
needed for the breakdown of the inducer, so there is expected to be a time lag
between sensing and breaking down, which may not be true for a glutamine sensor,
as glutamine is always used up and the enzymes for glutamine breakdown are always
present. Also, E. coli cells preferentially use glucose over lactose and arabinose.
Non-metabolisable glutamine analogues could be used to tackle this challenge and
make glutamine biosensors more versatile in general. While the promoters shown
here may not be suitable as glutamine sensors under the conditions used, they
may yet be useful as inducible promoters. For a bacterial cell to act as a whole
cell biosensor, it is useful if the inducer is 1) specifically detected by the biosensor
mechanism, 2) does not interfere with other cellular function in any way and 3) is not
metabolised by the cell so that its concentration remains unchanged. This standard
is difficult or impossible to achieve when working with inducers that are staple
cellular metabolites, products or nutrient sources, such as glutamine, leucine, alanine
or lactate. Non-metabolisable analogues for metabolite biosensor inducers provide
a partial solution, insofar as they can be used to characterise a biosensor and act
as inducers for inducible biosensors. These analogues could assist the development
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process and help separate interfering factors from the sensing mechanism.
A very commonly used metabolite analogue is the lactose analogue Isopropyl β-D-
1-thiogalactopyranoside (IPTG) (Figure 7.7(A)), which is used to induce expression
from the pLac promoter. This system works well because lactose is not an essential
metabolite in the presence of other carbon sources such as glucose and IPTG cannot
be metabolised by E. coli cells. IPTG is used in the concentration range 100 uM-
1mM. IPTG, however, does have toxic effects on cells at high concentrations (mM
range), but this is outside the range where it is used as an inducer. It has been
shown that IPTG imposes a metabolic burden cells, possibly caused by utilisation
of proton pumps during uptake (Malakar and Venkatesh, 2012). Presence of IPTG
might also impact the utilisation of other carbon sources by E. coli.
Figure 7.7: Chemical structures of lactose and IPTG. Chemical structures
of glutamine and DON. Figure modified from www.sigmaaldrich.com.
There exists a non-metabolisable glutamine analogue called 6-Diazo-5-oxo-L-norleucine
(DON). This has been used to study mechanisms of glutamine utilisation (see
Fig. 7.7(B)). This compound could be used when characterising glutamine biosensors
and avoid the effects of glutamine metabolism. DON was first isolated from
Streptomyces and has been used as a tumour inhibitor (Dion et al., 1956). Many
investigations show its potential use for tumour treatment (Shelton et al., 2010).
The compound DON can for example be used to distinguish between effects of
glutamine due to its role as a substrate of metabolism and effects of glutamine due
to its other roles (Wischmeyer et al., 1997). DON can inhibit amination reactions,
where an amide nitrogen is transferred from glutamine to an acceptor molecule, so
it is also called glutamine antagonist (Coggin and Martin, 1965; Hartman, 1971). It
can be used to determine presence of glutaminase activity in an enzyme and number
of active sites (Hartman, 1971). It forms covalent bonds with active sites. When
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used in E. coli, DON inhibits E. coli ATCC 9637 by inhibiting purine, hexosamine
and cell wall synthesis, as these involve such reactions (Coggin and Martin, 1965;
Khedouri et al., 1966). Adding glutamine could not revert the inhibition, but adding
inosine and glucosamine can bypass the inhibitory effects of DON and cells could
acquire resistance.
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7.4 Summary of results
Promoters from the E. coli Ntr regulon (argTp, astCp2, glnAp1, glnAp2, glnHp2,
glnK, glnL, nac) were cloned and assembled into characterisation constructs to test
them for their suitability as glutamine biosensors. Characterisation experiments
were carried out on agar plates and in M9 liquid medium. The biosensors showed
no clear response to glutamine in liquid medium. However, several of the promoters
showed responses on solid medium. Where promoters showed a response to
glutamine, it confirmed predictions from the literature.
Suggestions are made as to why these promoters may not reliably function as
glutamine biosensors under these conditions. These include the fact that this system
is an intracellular sensor and that expression is affected by several factors in addition
to glutamine, including carbon source. Work on an extracellular glutamine sensor
is shown in Chapter 8.
Improvements to the characterisation procedure that were made after the data in
this chapter were obtained could improve the quality of the characterisation data in
this chapter.
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8 Bacillus subtilis GlnK-GlnL system
8.1 Introduction
8.1.1 Glutamine-responsiveness of the GlnK-GlnL system
The promoter element PM8J2-706 (PglsA-glnT) from B. subtilis is naturally
under the control of the glutamine-responsive two-component system GlnK-GlnL
(Figure 8.1).
The adjacent genes glnK and glnL were identified during the sequencing of the B.
subtilis genome as parts of a two-component system of unknown function (Kunst
et al., 1997). These genes were initially named ycba and ycbB to emphasise that
their function had not yet been ascertained (Kunst et al., 1997). The B. subtilis
two-component system kinases were found to fall into five classes based on sequence
analysis of the regions around the phosphorylated histidine, of which YcbA fell
into group IV together with three other systems (Fabret et al., 1999). Structure
prediction from the sequence was used to predict that YcbA has four transmembrane
segments (Figure 8.1) (Fabret et al., 1999). The Ycba-YcbB system as well as several
other systems in group IV had unknown function and were known to be nonessential
(Fabret et al., 1999). Out of the four kinase-regulator pairs in group IV, three have
been reported to sense tricarboxylic acid cycle intermediates (Satomura et al., 2005).
DNA microarray analysis suggested that YcbA-YcbB regulates the expression of 19
genes, 5 of which were upregulated and 14 were downregulated Kobayashi et al.
(2001). However, in work by Satomura et al. (2005) only one of the positively
regulated candidate gene targets (ybgH ) was confirmed and the others were found
to be false positives. YbgH is located adjacently to the ycbAB genes and was found
to constitute an operon with ycbJ. YbgH was shown to encode a glutaminase and
renamed glsA. ycbJ was shown to encode a glutamine transporter and renamed glnT.
YcbA-YcbB was found to be responsive to extracellular glutamine and renamed
GlnK-GlnL. This nomenclature is somewhat unfortunate as it leads to confusion
with the PII-like GlnK protein (previously named NrgB) involved in regulation of B.
subtilis nitrogen metabolism (Forchhammer, 2007). GlnK has also been called GlnJ
(www.ecocyc.org). Some of these results were later confirmed using time-resolved
transcriptome analysis (Ye et al., 2009). The glsA-glnT operon was induced 25/50-
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fold 5 minutes after glutamine addition (Ye et al., 2009). Relatively little is known
about the system. The exact mechanism is unknown (see Fig. 8.1).
Figure 8.1: B. subtilis GlnK/GlnL two-component system. (A) General
schematic of two-component signal transduction systems. Figure taken from
Kremling et al. (2004). (B) Schematic showing a proposed model of the B.
subtilis GlnK/GlnL glutamine-responsive two-component system. Previous
gene and protein names: glnK/GlnK - ycbA/YcbA; glnL/GlnL - ycbB/YcbB;
glsA/GlsA - ybgJ/YbgJ; glnT/GlnT - ybgH /YbgH. Based on information
from Fabret et al. (1999); Kobayashi et al. (2001); Satomura et al. (2005);
Forchhammer (2007) and Ye et al. (2009).
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8.2 Results
8.2.1 Biosensor construct assembly
The PM8J2-706 promoter element was chosen to be tested for its suitability as
a glutamine biosensor. The promoter was integrated into a suitable character-
isation construct that would allow for integration into the B. subtilis genome
(Figure 8.2(A)). The promoter was amplified from the B. subtilis genome by PCR
and transformed into a BioBrick (Figure 8.2(B)). The constructs were assembled
in E. coli and verified by sequencing and subsequently transformed into B. subtilis
cells. Successful integration of the correct constructs into the AmyE locus was
verified using an amylase test (Figure 8.2(C)), colony PCR and DNA sequencing.
8.2.2 Biosensor characterisation
The next step was to confirm the glutamine-responsive behaviour of the PM8J2-706
promoter under conditions identical or similar to those used previously. Satomura
et al. (2005) carried out experiments in MM medium, which is the standard minimal
medium used by the “Functional analysis of the Bacillus subtilis genome in Japan
and Europe” consortium. Ye et al. (2009) used an adapted minimal medium.
Initial characterisation experiments were carried out in MM medium and using flow
cytometry as opposed to the plate reader format used in the previous chapters. This
was done because the protocol developed in Chapter 4 was optimised for E. coli and
modifications would have to be made to optimise the set-up for B. subtilis.
Cells were grown overnight in LB and then used to seed MM cultures with or
without glutamine. Samples for flow cytometry were taken after several hours
of growth (Figure 8.3(A-C)). There was some precipitation in the MM medium,
probably iron from the medium Fluorescence of the control cells did not change
much between absence and presence of glutamine (10.12 to 11.5), whereas the sensor
cell fluorescence changed greatly (2.68 to 22.46). Also, the coefficient of variance
for sensor cells is much lower than for control cells. Unexpectedly, the fluorescence
level of the control cells is higher than for the sensor cells in absence of glutamine.
The control cells do not contain a promoter in front of the GFP gene, however the
local gene sequence must be acting as a promoter, allowing leaky gene expression
of the GFP gene in the control cells. It was decided that, ideally, a further two cell
lines should be established, one containing a positive and one containing a negative
control circuit for future characterisation (Figure 8.3(D)).
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Figure 8.2: B. subtilis glutamine sensor assembly. (A) Genetic
constructs that will be used to characterise the B. subtilis PM8J2-706 (glsA-
glnT) promoter. The control construct is identical to the biosensor construct
but missing the PM8J2-706 (glsA-glnT) promoter. (B) Agarose gel showing
successful amplification of the B. subtilis PM8J2-706 (glsA-glnT) promoter.
(*) Blunt primers used for primary PCR, see Table 2.4) PM8J2-706-F and
PM8J2-706-R. (**) BioBrick extension primers used for secondary PCR,
see Table 2.4) PM8J2-706-BB-F and PM8J2-706-BB-R. (***) Primary PCR
product, 67 bp. (****) Secondary PCR product, 126 bp. (C) LB agar starch
plate showing results of amylase test for the sensor and control constructs.
Top row shows positive and negative control colonies. Subsequent rows show
test colonies.
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Figure 8.3: B. subtilis glutamine biosensor characterisation in MM
medium. (A) Fluorescence of cells in absence or presence of glutamine
measured through flow cytometry. (B) Fluorescence data from (A) shown as
bar chart. (C) Coefficient of variance. (C) Additional control constructs for
testing of the B. subtilis glutamine sensor. Error bars represent the standard
deviation of three biological replicates.
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8.3 Summary of results
The PM8J2-706 promoter controlled by the B. subtilis GlnK-GlnL system was used
to create a glutamine biosensor. Characterisation experiments in MM medium
and using flow cytometry measurements confirmed responsiveness to extracellular
glutamine. This confirms the results from the literature about this system under the
conditions used here. These results make the construct made in this work promising
as a potential glutamine biosensor that could be used in a bioprocessing context.
The B. subtilis glutamine sensor shown in this chapter is a more promising basis for
a glutamine biosensor than the E. coli constructs shown in Chapter 7.
However, further characterisation of this system would be necessary before it could
be used as a glutamine biosensor. This characterisation would involve adapting the
protocol from Chapter 4 for B. subtilis. This would involve doing characterisation
in M9 medium suitable for B. subtilis and adapting the work flow to the growth rate
of these cells under such conditions. Also, the constructs from Figure 8.3(D) would
need to be made to further investigate the behaviour of this sensor.
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9 Towards using bacterial biosensors in
bioprocessing
9.1 Introduction
Once a number of metabolite biosensors had been built and characterised (i.e.
in terms of response to the target metabolite, dynamic range, dose-response and
interfering factors), the next step was to test the biosensors in the mammalian
bioprocessing context. Chapters 4-7 discussed the assembly and testing of
metabolite biosensors for lactate, leucine/alanine and glutamine. The sensors were
characterised for their response to the target metabolites in defined bacterial growth
medium. To test the biosensors in a mammalian bioprocessing context requires an
understanding of the growth characteristics of bacteria in standard culture medium
as well as an assessment of how the biosensor performance is affected by the addition
of samples in complex growth medium. These experiments are shown in this chapter.
9.2 E. coli and B. subtilis growth on DMEM
If the biosensors in this work are to be used to monitor mammalian cell cultures, the
bacterial cells would be exposed to at least some amount of mammalian cell culture
medium. To test the possibility of co-culturing bacterial and hybridoma cells in
a shared growth medium, the bacterial growth characteristics in DMEM growth
medium were explored. The DMEM used in Chapter 4 (Biosensor characterisation
protocol) was free of glutamine, serum and phenol red and contained NH4Cl as
an additional nitrogen source. The DMEM used here does contain glutamine,
serum and phenol red but no NH4Cl and so is the exact same medium as used
in the hybridoma cell experiments. E. coli and B. subtilis were cultured in DMEM
and extracellular medium samples were collected at each time point for analysis
(Figure 9.1). The growth rate of E. coli in DMEM was higher than that of B.
subtilis (Figure 9.1(A) and (B)). While E. coli cells grow to a high density (∼2.0),
B. subtilis growth almost ceases after ∼6 h, reaching an eventual level of ∼0.400. As
expected, bacterial cell growth rate is much higher than hybridoma cell growth rate.
This presents a challenge for bacterial-mammalian cell co-culture, as the bacterial
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cells would form the dominant population and consume nutrients needed by the
mammalian cells. Some form of population control would be necessary in a co-
culture scenario, at least for E. coli cells. These growth curves were not done under
conditions of high CO2 and yet no precipitation in the medium was observed as had
been seen previously. This could be due to the added serum.
Photos taken of the culture flasks and culture samples at a late stage of the culture
showed a stronger colour change of phenol red in the E. coli culture than in the B.
subtilis culture (Figure 9.1(C)). Phenol red is a pH indicator that is red or pink at
pH > 7 and orange or yellow at pH < 7. Bacterial growth in DMEM causes the
medium to acidify, more so for E. coli than for B. subtilis . This may simply be
reflective of the different growth rates of these species. This would likely negatively
affect hybridoma cells in a co-culture. Separating the bacterial and mammalian cells
and their respective growth media to some extent will probably be necessary for a
viable co-culture, at least for E. coli cells.
The next question was whether the bacterial cells would affect the levels of specific
metabolites relevant for hybridoma cells. Extracellular medium samples were
analysed for metabolites (Figure 9.1(D)). E. coli cells rapidly deplete both glucose
and glutamine, while the levels of these metabolites are only slowly decreasing in
B. subtilis cultures, probably reflective of the B. subtilis growth rate. The most
important carbon source for hybridoma cells is glucose and the most important
nitrogen source is glutamine. Therefore, for co-cultures of any significant time-scale,
E. coli cells would need to be provided with a secondary nutrient feed to avoid
nutrient depletion for the hybridoma cells. Both E. coli and B. subtilis cultures
show slowly increasing levels of ammonia. Ammonia has a negative impact on
hybridoma growth. While the maximum level of ammonia reached in this experiment
was relatively low, the time-scale of the bacterial cultures is much shorter than
for mammalian cell experiments. At typical mammalian culture time-scales, the
ammonia could reach inhibitory levels. However, the depletion of glutamine and
glucose by E. coli is a much more significant factor than the ammonia production
for co-culture viability. This is because glutamine and glucose would be depleted
long before ammonia from the bacteria had reached a significant level. E. coli cells
do not seem to produce lactate at levels above the detection limit during the culture.
B. subtilis do produce lactate, reaching ∼3.5 mM at the end of the culture. It should
be noted that the sudden increase in lactate for the B. subtilis culture after 8 h is an
artefact of the lower detection limit for lactate of the Nova BioProfile Analyzer as
indicated (Figure 9.1(D)). The lactate sensor presented in this work, however, can
be used to monitor lactate in that concentration range.
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It was suggested that the lower growth rate of B. subtilis in DMEM was caused
by lack of tryptophan. DMEM contains 16 mg/L tryptophan, whereas B. subtilis
growth media are often supplemented with 50 mg/L tryptophan. Dependency of a
cell population on a particular compound can be used to control population growth
(Chuang et al., 2010), which would be very useful for a co-culture. Growth of B.
subtilis in DMEM supplemented with additional tryptophan compared to growth in
DMEM without additional tryptophan was monitored (Figure 9.1(E) and (F)). B.
subtilis cells cultured in higher levels of tryptophan did not show increased growth.
The growth rate was in fact lowered by added tryptophan, suggesting that B. subtilis
cells in DMEM are not limited by tryptophan levels.
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Figure 9.1: Bacterial growth in DMEM. Optical density of E. coli and B.
subtilis cultures grown in DMEM growth medium shown on a (A) linear and
a (B) logarithmic scale. (C) Photos showing culture medium colour in flasks
and culture samples. (D) Metabolite analysis of extracellular medium samples
using a Nova BioProfile Analyzer. Red arrow indicates lower concentration
detection limit of lactate (E) and (F) Optical density of B. subtilis cultures
grown in DMEM growth medium with and without added tryptophan shown
on a (E) linear and a (F) logarithmic scale. Error bars represent standard
deviation of O.D. measurement on two repeat samples.
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9.3 Testing of biosensors in cell culture relevant
conditions
The lactate lldp+lldR sensor is the most responsive, reliable and well-characterised
sensor in this work. This sensor was therefore chosen for further testing in conditions
approximating the testing of cell culture samples.
9.3.1 Lactate sensor characterisation in DMEM and CD
CHO growth media
lldp+lldR sensor cells were grown and characterised for their lactate response directly
in DMEM medium and also CD CHO medium (common growth medium used for
Chinese hamster ovary, CHO cells). However, the growth and fluorescence data
collected under these conditions were inconsistent and did not allow for reliable
characterisation data to be collected (data not shown). This may partially due to
similar reasons as for LB medium (see Chapter 5: E. coli lldPRD lactate-responsive
operon). These media contain many complex molecules and in the case of CD CHO
medium the composition is not publically available. It is possible that any of these
molecules may be interfering with the sensing mechanism of the biosensor.
Because of this, it was decided to grow cells in M9 medium (with glycerol as the
main carbon source) (100 µl) and add small amounts of cell culture samples (25 µl)
for testing. As there may still be interference and other issues from the components
and properties of the cell culture medium, a number of experiments were carried
out using increasingly complex conditions to verify the functioning of the biosensor
at each stage.
9.3.2 Simulating cell culture samples (DMEM)
9.3.2.1 Standard lactate concentrations in DMEM
lldp+lldR sensor cells were grown in 100 µl M9 medium and 25 µl of DMEM
containing known lactate concentrations were added (Figure 9.2). The results show
that the lactate sensor shows good lactate responsiveness under these conditions.
Although the exact shape of the fluorescence and synthesis rate graphs changes
slightly in each run based on small cell growth and fluorescence variations, the
overall dynamics are consistent. Even in the presence of all the potentially interfering
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compounds found in DMEM, there is clear differentiation of GFP synthesis rate by
lactate concentration.
Figure 9.2: Testing standard lactate concentrations in DMEM with sensor
cells grown in M9. a) Corrected fluorescence. b) GFP synthesis rate. c)
Cell growth. Error bars represent the standard deviation of three biological
replicates.
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9.3.2.2 Standard lactate concentrations in DMEM supplemented with
serum
With the exception of the bacterial growth experiment shown at the beginning of
this chapter, all biosensor characterisation experiments in this work used DMEM
that did not contain any supplements. Here, a characterisation experiment was
carried out using standard lactate concentrations in DMEM, where the DMEM
was supplemented with 10 % (v/v) fetal bovine serum, which is a commonly used
supplement for hybridoma cells. Serum is a complex mix of compounds that have
the potential to interfere with the mechanism of the lactate sensor. It was found
that the sensor showed a lactate-response under these conditions (Figure 9.3). The
data was more variable than in the conditions where serum was not present. This
could be due to the fact that the presence of serum presents a more variable and
complex environment for the sensor to function. These results mean that the sensor
will likely be able to function if used to test real mammalian cell culture samples
using this medium.
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Figure 9.3: Testing standard lactate concentrations in DMEM
(supplemented with serum) with cells grown in M9. a) Corrected fluorescence.
b) GFP synthesis rate. c) Cell growth. Error bars represent the standard
deviation of three biological replicates.
134
9.4 Mammalian cell culture samples
9.4.1 CHO cell culture
During the course of this work, the opportunity for collecting samples from a CHO
culture in CD CHO medium was presented. The specific cells were CHO cells
transformed with a construct made by Antony Constantinou (CSynBI, Imperial
College). CD CHO was supplemented with 8 mM glutamine and HT supplement.
The cells were grown for four days. Supernatant samples were collected at regular
intervals during the culture and spent medium was collected at the end of the culture
run. Supernatant samples were analysed for metabolite concentrations (Figure 9.4).
Figure 9.4: CHO culture supernatant metabolites analysis using a Nova
BioProfile Analyzer. Arrows indicate lower or upper concentration detection
limits. Data are based on a single culture.
9.4.2 Simulating cell culture samples (CD CHO medium)
Before analysing these CHO cell culture samples using the lactate biosensor, the
biosensor was tested under conditions resembling cell culture samples.
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9.4.2.1 Standard lactate concentrations in CD CHO
As previously done for DMEM growth medium, lactate sensor cells were grown in
M9 medium and known lactate concentrations in fresh CD CHO medium were added
to simulate CD CHO cell culture samples (Figure 9.5). CD CHO was supplemented
with 8 mM glutamine and HT supplement. This was done to test if lactate sensing
from CD CHO culture samples would work with this biosensor. The results show
that the lactate sensor shows lactate-responsiveness under these conditions. At the
highest lactate concentration (14 mM), the data shows high variability. This could
be due to the complex CD CHO medium affecting the function of the sensor at this
lactate concentration range. The GFP synthesis graphs also show a dip in synthesis
rate at around 150 min. This could be due to the bacterial sensor cells reacting
to components in the CD CHO medium or any other change in conditions during
this run. Overall, the results indicate that the sensor could be used under these
conditions, as there is differentiation in fluorescence and GFP synthesis rate for
different lactate concentrations.
9.4.2.2 Diluted spent CD CHO medium samples
During a cell culture, mammalian cell may secrete many molecules into the culture
medium. When cells die they may burst, emptying their contents into the
supernatant. All these substances have the potential to interfere with the lactate
biosensing that is being tested here. In order to create a more realistic test for
using the biosensor on cell culture samples, collected spent medium was diluted in
different ratios with fresh CD CHO medium and the resulting samples tested using
the biosensor (Figure 9.6-9.7). As in the experiment using the standard lactate
concentrations in CD CHO, the variability at 14 mM lactate is relatively high. The
sensor cells that were exposed to the spend medium dilutions show decreases in
fluorescence at various times after 100 min. Overall, the sensors shows lactate-
responsiveness under these conditions.
The lactate concentration in the spent medium dilution samples was determined
in parallel using the biosensor and the bioprofiler (Figure 9.7). The lactate
concentrations determined through the two different methods are comparable.
9.4.2.3 Samples from CHO culture
Finally, the samples from the CHO cell culture were analysed for lactate con-
centration using the lactate biosensor (Figure 9.8-9.9). The biosensor cells that
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Figure 9.5: Testing standard lactate concentrations in CD CHO with sensor
cells grown in M9. a) Corrected fluorescence. b) GFP synthesis rate. c)
Cell growth. Error bars represent the standard deviation of three biological
replicates.
were exposed to cell culture samples showed a dip in fluorescence that is especially
pronounced with the cell culture samples from later time points. A similar, though
smaller, dip is seen for the biosensor cells exposed to standard lactate concentrations
in CD CHO.
Only the last two cell culture samples contained lactate at concentrations that
were high enough to be detected by the bioprofiler (Figure 9.9). The lactate
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Figure 9.6: Using the lactate biosensor to determine the lactate
concentration in spent CD CHO medium dilutions. a) - c) Spent medium
dilutions. d) - f) Standard lactate concentrations in CD CHO. a) Corrected
fluorescence. b) GFP synthesis rate. c) Cell growth. d) Corrected
fluorescence. e) GFP synthesis rate. f) Cell growth. Error bars represent
the standard deviation of three biological replicates.
concentrations in the sample collected after 73.58 h of cell culture were similar
whether determined by biosensor (12.83 mM) or bioprofiler (14.4 mM). However,
for the sample collected after 100.33 h, the lactate concentrations determined by
the two methods differ strongly (biosensor: 140.46 mM; bioprofiler: 23.4 mM). This
could be due to a number of reasons, including the variability seen in the sensor
response for these samples.
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Figure 9.7: Using the lactate biosensor to determine the lactate
concentration in spent CD CHO medium dilutions. a) Dose-response curve
for spent medium dilutions. b) Dose-response curve for standard lactate
concentrations. c) Lactate concentrations in spent culture medium dilutions
according to biosensor and bioprofiler. Missing data points for the bioprofiler
graph are due to lactate concentration being lower than the detection limit of
the machine. Error bars for biosensors represent standard deviations of three
biological replicates. Error bars for bioprofiler data represent imprecision of
bioprofiler measurements.
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Figure 9.8: Using the lactate biosensor to determine the lactate
concentration in CHO cell culture samples. a) - c) CHO cell culture samples.
d) - f) Standard lactate concentrations in CD CHO. a) Corrected fluorescence.
b) GFP synthesis rate. c) Cell growth. d) Corrected fluorescence. e) GFP
synthesis rate. f) Cell growth. Error bars represent the standard deviation of
three biological replicates.
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Figure 9.9: Using the lactate biosensor to determine the lactate
concentration in CHO cell culture samples. a) Dose-response curve for spent
medium dilutions. b) Dose-response curve for standard lactate concentrations.
c) Lactate concentrations in spent culture medium dilutions according to
biosensor and bioprofiler. Missing data points for the bioprofiler graph are due
to lactate concentration being lower than the detection limit of the machine.
Error bars for biosensors represent standard deviations of three biological
replicates. Error bars for bioprofiler data represent imprecision of bioprofiler
measurements.
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9.5 Results summary
Experiments were carried to out towards using the metabolite biosensors created
in this work to determine metabolite concentrations in mammalian cell cultures.
Growth of E. coli and B. subtilis cells in DMEM growth medium was characterised.
E. coli cells had healthy growth characteristics, while B. subtilis cells could only be
grown to a low optical density.
Testing of the lldp+lldR lactate sensor in DMEM or CD CHO media did got give
usable characterisation data. It was therefore decided to keep M9 as the main
growth medium for the biosensor cells and add small amounts of cell culture samples
to these cultures. The biosensor showed good lactate-responsiveness for standard
lactate concentrations in DMEM, DMEM supplemented with serum, and CD CHO
medium.
The lactate biosensor was used to determine the lactate concentration in diluted
spent CD CHO medium samples and cell culture supernatant samples. These
samples were also analysed for lactate concentration using a bioprofiler. For the
diluted spent medium samples, the results from the two methods were comparable.
For the cell culture samples, the lactate concentrations matched closely for one of
the data points and differed strongly for another data point. This may be caused
by variability in the sensor response seen for these samples. Improvements to the
analysis method for determining lactate concentrations could address this issue. In
presence of CD CHO, the biosensor cells often show a dip in fluorescence over the
time course. When picking a time point to determine lactate concentrations, this
dip may affect the results.
Overall, the lactate sensor showed promising results for use in mammalian cell
cultures, although the exact process for determining lactate concentrations may
need to be optimised further.
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10 Discussion
The aim of this project was to engineer novel bacterial in vivo biosensors for
mammalian bioprocessing applications. Growth dynamics of a hybridoma cell line
were investigated to learn more about the context in which biosensors would be
used, and to suggest possible targets for biosensing. Based on these results and
literature searches of interesting mammalian cell culture parameters and bacterial
sensing systems, a number of systems were chosen for further investigation:
The E. coli lldPRD operon that is responsive to lactate. Lactate is produced by
mammalian cells during culture and can inhibit cell growth.
The E. coli Lrp operon that is responsive to leucine and alanine. Both these amino
acids are present in mammalian cell culture media. Alanine is secreted by certain
mammalian cells in response to ammonia stress.
The E. coli Ntr system as well as the B. subtilis GlnL/GlnK system which are
both responsive to glutamine. Glutamine is the major nitrogen source in many
mammalian cell cultures.
Promoters from these systems were cloned into DNA constructs using GFP as the
reporter and characterised for their response to the metabolite of interest and hence
their suitability as biosensors.
10.1 Engineering biosensors for common
metabolites
10.1.1 Lactate biosensors based on the E. coli lldPRD
system
Three biosensor constructs were investigated in this work. lldPp + lldR + lldP
was found to show reduced growth compared to the other sensors and could not be
characterised. This may be due to the additional metabolic burden or toxicity from
the overexpression of the permease. lldPp contains the lldPp promoter linked to
a GFP gene. lldPp + lldR contains all the parts of the lldPp construct as well as
an overexpression construct for the lldR transcription factor. lldPp + lldR showed
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lactate-responsiveness under all conditions tested. lldPp was also responsive to
lactate, though less usefully than lldPp + lldR.
The results shown here support the current model of how this operon is regulated.
When the lldR transcription factor is overexpressed, fluorescence in absence of
lactate is very low. When lldR is not overexpressed (with only the genomic copy
of the gene present), fluorescence baseline in absence of lactate is much higher.
Specifically, the high basal expression prevents the ability to measure the small
changes in expression that result from the addition of small amounts of lactate.
A much more differentiated response to lactate is seen for lldPp + lldR than for
lldPp. These results support the model stating that lldR acts as a repressor of gene
expression from the lldPp promoter in absence of lactate and as an activator in
the presence of lactate. In the presence of overexpressed lldR, the fluorescence in
absence of lactate is lower than when lldR is not overexpressed. Also, the relative
increase in fluorescence in response to increasing concentrations of lactate is greater
in presence of overexpressed lldR than in absence.
The difference between lldPp and lldPp + lldR agrees with a theory discussed in
Dehli et al. (2012). This theory states that the higher the unregulated activity the
less induction can be achieved with an activator. Thus in general activator-operated
promoters show low unregulated activity while repressor operated promoters show
high unregulated activity. This is referred to as an activation ceiling. lldPp shows
high unregulated activity, indicating a repressor operated promoter.
Presence of glucose in the growth medium lowers gene expression from the lldPp
promoter, but does not change qualitatively the overall dynamics of the lactate-
response. The results shown here confirm previous results from the literature
showing that this system is also responsive to D-lactate, though to a lesser extent
than L-lactate. Characterisation of the response of this sensor to pyruvate was
inconclusive, as increasing concentrations of pyruvate lead to increased fluorescence,
but the highest concentration used (14 mM) showed the lowest fluorescence. This
may be caused by the way that the cells utilise pyruvate in ways not connected
to the biosensor construct. The presence of large concentrations of pyruvate may
change the flux in E. coli metabolism.
Overall, lldPp + lldR was found to act as a reliable lactate biosensor in a
concentration range ∼0-14 mM, which was the concentration range tested here.
The exact dynamic range of the sensor changes with extracellular conditions.
Undergraduate student Katarzyna Roguska (Roguska, 2012), who tested the sensor
in LB medium using a different protocol to the one used here found responses up
to 100 mM under certain conditions, although this required measuring over a much
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longer time scale.
10.1.2 Leucine/alanine biosensors based on the E. coli Lrp
system
Six promoters controlled by the Lrp protein in response to leucine and alanine were
incorporated into DNA constructs using GFP as a reporter and characterised for
their response to, and their potential to be used as biosensors for, these metabolites.
Biosensors were characterised on solid and in liquid media. Biosensor responses are
summarised in Table 7.2. The biosensor cells showed some differences in behaviours
between the two media. High concentrations of leucine caused growth inhibition
on solid medium but not in liquid medium. Some biosensors showed responses
in liquid media but not on solid media. However, that could be due to the fact
that fluorescence on solid media were assessed by eye. Solid and liquid media are
very different growth conditions, especially in terms of diffusion, which can explain
differences in cell behaviour (Dalchau et al., 2012). Different behaviours between
plates and liquid medium have been shown for E. coli and B. subtilis (Dubey and
Ben-Yehuda, 2011).
Every promoter tested showed a response to either alanine or leucine in at least one
of the conditions tested. Some promoters showed activation in response to alanine
and leucine and some showed repression. Not all the responses seen agree with what
was predicted from the previous literature on these promoters. fimBp1 and fimBp2
were predicted to be activated by leucine/alanine, but showed little to no response
here.gltBp showed repression by leucine, which was expected from the literature.
It also showed repression by alanine, to which it was not previously known to be
responsive. ilvIHp1 and livJp both behaved as predicted. LeuLp showed activation
in response to leucine/alanine under the conditions used here, but it was predicted
to be repressed. These results are useful for commenting on the utility of these
promoters as biosensors. They also shows how these systems behave under the
conditions used here, which teaches us about the how this operon works.
The Lrp transcription factor was not overexpressed in these constructs. Overexpres-
sion of Lrp is known to have a range of effects on E. coli metabolism. Undergraduate
Harold Taylor attempted to overexpress the Lrp protein in E. coli cells. However,
while he was able to transform a plasmid containing the Lrp gene and a terminator,
this was not possible when a promoter and RBS was added to the front of the
gene. This may suggest that the Lrp gene cannot be overexpressed in E. coli cells
(at least not in a straightforward way). Because the promoters were overexpressed
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on high copy plasmids, whereas the Lrp protein is only present in one genomic
copy, the effect is equivalent to lowering the concentration of Lrp relative to the
promoters compared to wild type cells. If possible, overexpression of Lrp might
increase responsiveness of the biosensor in the same way that overexpression of the
transcription factor improves function of the lactate sensor. However, the “dilution”
of Lrp may not have that great an effect considering that Lrp is present at relatively
high copy number (3000 dimers) in E. coli cells. The exact concentration of Lrp
within cells changes with growth conditions.
When switching from rich to poor media, Lrp concentration can increase 10-
fold (Newman, 1995). This may again explain why an Lrp-dependent response
to leucine/alanine is seen here in minimal medium without the overexpression of
Lrp. However, the fact that Lrp concentration changes with growth conditions and
presence of certain amino acids (Newman, 1995), makes this system a complicated
basis for synthetic biology biosensors. If Lrp is not easily overexpressed in E.
coli cells then the system may be difficult to transfer between cells trains while
maintaining predictable behaviour.
For these reasons, systems such as the lldPRD operon that are more orthogonal to
cellular metabolism than the Lrp system are generally more suitable for synthetic
biology systems like biosensors. However, the Lrp promoters shown here do represent
usable bioparts and some of them act as leucine/alanine biosensors.
10.1.3 Glutamine biosensors based on the E. coli Ntr
system
Eight promoters that are controlled by the Ntr operon in response to glutamine were
incorporated into DNA constructs using GFP as the reporter and characterised for
their response to, and their potential to be used as biosensors for, glutamine.
The promoters were characterised on solid and liquid medium. Several of the
promoters showed responses to glutamine concentration on solid media, but none
of the promoters showed a significant response to glutamine when characterised in
liquid medium.
As discussed in detail in Chapter 7, there are a number of reasons that this system
may not be suitable for glutamine-sensing under the conditions used here. The
system reacts to intracellular glutamine concentration, which may not equilibrate
with extracellular glutamine concentration. Glutamine is not the only input for the
Ntr system. α-ketoglutarate is also detected as an indicator of cellular carbon status
(Schumacher et al., 2013). Glutamine is also used up by cells as it enters the cells.
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Overall, the Ntr promoters shown in this work did not act as glutamine biosensors
under the conditions used here.
10.1.4 Glutamine biosensor based on the B. subtilis GlnK-
GlnL system
The PM8J2-706 promoter that is controlled by the glutamine-responsive B. subtilis
GlnK-GlnL two-component system was cloned into a characterisation construct that
was integrated into the B. subtilis genome at the AmyE locus. The construct linked
the promoter to GFP as a reporter. These cells were characterised for their response
to glutamine and their utility as biosensors.
In an experiment using flow cytometry, biosensor cells grown in MM medium with
glutamine showed higher fluorescence than those grown in MM medium without
glutamine. Control cells did not show a fluorescence shift in response to glutamine.
However, control cell fluorescence was consistently at the same level as biosensor
cells in presence of glutamine. there are several possible explanations for this. The
control construct is identical to the sensor characterisation construct except that it
does not contain the relevant promoter. The region in front of the GFP gene in
the control construct may act as a cryptic promoter leading to leaky uncontrolled
GFP expression. The GFP expression may also be caused by read-through from
the antibiotic resistance cassette that is located upstream of the GFP gene. Finally,
the control of the PM8J2-706 promoter by the GlnK-GlnL two-component system
may work through repression of expression in absence of glutamine rather than
activation of expression in presence of glutamine as previously thought. Further
characterisation constructs could be constructed to investigate these dynamics more
closely (see Chapter 8).
Unlike the E. coli sensors shown in this work, which are based on high-copy plasmids,
the B. subtilis sensor is based on a single genomic copy of the characterisation
construct. Signal strength of the response could be amplified by having the sensor
based on a plasmid. The glnL and glnK genes could also be overexpressed in this
context. This, however, could prove challenging as glnK is a transmembrane protein.
The characterisation protocol used for the E. coli sensors in this work would have
to be adapted for use on this B. subtilis sensor. This would involve studying the
growth dynamics of the B. subtilis cells under the chosen conditions more closely
and adapt incubation and measurement times accordingly.
The results shown here confirm previous results from the literature showing that the
system is responsive to extracellular glutamine. This sensor is the only sensor shown
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in this work that directly responds to the extracellular concentration of the target
metabolite instead of the intracellular concentration. As the aim of this work is to
engineer biosensors that can be used to monitor metabolite concentrations in the
culture medium this represents a major advantage for a biosensor. No assumptions
have to made about whether the intracellular concentration equilibrates with the
extracellular concentration.
Overall, this system is promising as the base for a glutamine biosensor but further
characterisation is required before it can be put to use in a mammalian cell culture
context.
10.2 Metabolite biosensors and synthetic biology
The aim of this work was to engineer metabolite biosensors for mammalian cell
bioprocessing contexts. Several functioning biosensors were created as discussed
above. This work therefore presents an overall strategy for engineering such
biosensors. Many challenges were encountered during this work that ultimately
taught us about the biological process underlying these biosensors. Some of these
topics were already discussed above for the relevant biosensors.
Attempts were made in this project to follow the synthetic biology design cycle
process (see Introduction) (Freemont and Kitney, 2012). Initially, the context
in which the biosensors were to be used (i.e. mammalian cell culture) was
analysed to derive specifications for how the biosensors needed to function. Natural
bacterial sensing systems were researched and several suitable candidates chosen
for characterisation. Characterisation was mostly done in liquid M9 medium using
96-well format on a robot platform that integrated an incubator and a plate reader.
There exist different kinds of data used to represent the output of GFP-based
biosensors when using plate reader-based measurements of fluorescence and optical
density: GFP synthesis rate (Ronen et al., 2002; Canton et al., 2008), relative
promoter units (RPU) (Kelly et al., 2009) and normalised or corrected fluorescence
(Lee et al., 2011).
The measures used in this work were corrected fluorescence (fluorescence/OD)
and GFP synthesis rate. Both of these are calculated from measures of OD and
fluorescence over time (see details in Materials and Methods). Corrected fluorescence
is the fluorescence from a given time point divided by the cell OD from that time
point and therefore roughly represents fluorescence per cell. GFP synthesis rate
calculated the fluorescence change between two time points and therefore represents
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the amount of GFP produced or broken down in that time. Both of these measures
have been shown for various biosensors here and GFP synthesis rate data was used
to determine the lactate concentrations in cell culture samples. However, corrected
fluorescent data could also have been used. Synthesis rate is more sensitive and
an indicator of what is directly happening in the system. However, as it is more
sensitive, it is also much more affected by noise as well as cell state. This means that
when comparing systems with vasty different growth rates, corrected fluorescence
may be the more suitable measurement. An additional complication is that both
synthesis rate and fluorescence/OD can be calculated differently, with a number
of alternate ways of accounting for control measurements. Which method is most
suitable will depend on the individual experimental set-up and aims.
The control cell used in this work contained a construct that was identical to the
biosensor constructs, except lacking the potentially responsive promoter. In some
cases, subtraction of control cell fluorescence from biosensor cell fluorescence gave
negative corrected fluorescence values. This may be cased by run-through expression
from the control constructs. Different kinds of control circuits (see Introduction)
could be used instead to prevent this problem.
Overall, all these different methods are based on certain assumptions that may not
hold true under all conditions and they all come with advantages and disadvantages
which will depend on the situation. In many cases, biosensor output will be reported
in vague terms such as “reporter signal intensity” (van der Meer and Belkin, 2010).
Therefore, the real important factor is complete reporting of metadata to make data
from different labs comparable.
A lot of the systems used in this work are “non-orthogonal”. This means that the
sensor system is not entirely separated from cellular metabolism. The sensor may
respond to inducers that also interact with other cellular pathways or may respond
to more than one input. In all the systems used here, the biosensor was composed
of elements that were already present in the cells, i.e. the natural operon is there
and working, which could cause cross-talk.
The metabolites that act as biosensor targets in this work are metabolisable and in
some cases fulfill many cellular functions. This means that the metabolites sensed
could be produced or used up by the bacterial cells, which could interfere with the
sensing mechanism, e.g. by causing noise in the sensing or preventing the sensing
output. This is unlike the properties of commonly used inducers such as IPTG,
which are non-metabolisable by cells.
Overall, orthogonality of a system from the cellular machinery makes the system
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more suitable for use in synthetic biology. In this work, the more orthogonal systems
(lldPRD and GlnK-GlnL) are more promising as biosensors than the less orthogonal
systems (Ntr and Lrp). However, even highly non-orthogonal systems can be used
as biosensors or other bioparts as long as the limitations are known. This means
that during characterisation point of failure need to be identified. This work has
shown that natural promoters can be used as biosensors to sense non-orthogonal
extracellular metabolites.
While most of the characterisation was carried out in liquid M9 medium, some
characterisation experiments were carried out on solid media or in different
liquid media. Generally, the biosensors characterised here often showed context-
dependency, i.e. they function differently in different conditions. This could be
due to factors specific to the biosensor system. Some biosensors react to more than
one target. The presence or absence of these alternate targets in different media
could cause differences in biosensor response. Alternatively, the differences could be
caused by processes that alter larger parts of cellular metabolism instead of just the
biosensor system. For instance, cells grow differently on solid and liquid media.
With the exception of the B. subtilis glutamine sensor, all the sensors presented
here respond to intracellular metabolite concentrations. As the parameters we are
ultimately interested in are extracellular metabolite concentrations in mammalian
cell culture, an assumption in this work is that the intracellular and extracellular
concentrations will equilibrate. It is assumed that intracellular concentration is
sufficiently representative of extracellular concentration. However, this may not
always be the case and is dependent on available cellular transport systems.
Standardisation was attempted at several levels in this work. All parts and
constructs used the BioBrick standard DNA assembly method and can thus be
used by the wider synthetic biology community. As far as possible the same control
constructs and general characterisation conditions were used for characterisation of
all the biosensors. However, it is not always possible to keep all constructs and
experiments in the same format. This is due to differences between the biological
processes underlying the different systems. Overall, it is important to appreciate
that not every experimental technique or analysis method is suitable for every kind
of biosensor. While standards and standard methods are very useful, they need to
be flexible to some extent to be able to incorporate most contexts. However, this
fact makes extensive reporting of characterisation and analysis methods all the more
important. Datasheets, which are already used in many areas of synthetic biology
(Canton et al., 2008) are an example of this. However, better reporting standards
for publications should also be implemented.
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It has been stated hat synthetic biology is less like highly modular and standardised
electrical engineering and more like civil and mechanical engineering in that it
requires optimisation and appreciation of whole-system stresses (Church et al.,
2014).
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10.3 Using bacterial biosensors in mammalian
cell culture
After a number of biosensors were engineered and characterised under standard
conditions, the next step was to test these biosensors in a mammalian cell culture
context (see chapter 9).
Initially, the growth of E. coli and B. subtilis cells in DMEM medium was
investigated. During future applications, the bacterial biosensors would be exposed
to samples of mammalian cell culture medium or even be used in a co-culture set-up
with the mammalian cells. Therefore, it was important to know if these cells could
grow in presence of mammalian growth media. Growth of E. coli in DMEM in 96-
well plate format was already shown in chapter 4. In that format, precipitation of
medium components was seen, which interfered with optical density measurements
needed for biosensor characterisation. This was not seen when E. coli and B. subtilis
cells were grown in DMEM also containing serum and based in a flask (chapter 9).
There are many differences between the conditions in a 96-well plate and in a culture
flask, such as the surface to volume ratio and aeration through shaking. These
differences could explain why precipitation was seen in one case and not the other.
The presence of serum and the different measurement methods (direct measurement
of well using a plate reader and cuvette-based sample measurements) could also
have an effect. This experiment showed that E. coli and B. subtilis cells can grow
in DMEM and that E. coli cells have a higher growth rate than B. subtilis cells and
grow to a higher final optical density.
It was decided to carry out the tests of biosensors in a cell culture context using the
lldPp + lldR lactate sensor, as this was the sensor showing the most reliable response
of all the sensors shown in this work. The lactate biosensor was characterised for
lactate response in CD CHO medium. However, this did not give usable data. Due
to this, as well as the precipitation issues in DMEM in 96-well plate format, it was
decided to initially use the biosensor by growing cells in M9 medium and adding
small volumes of mammalian cell culture samples. The lactate sensor was found to
be responsive to lactate when testing standard lactate concentrations in DMEM,
DMEM+serum and CD CHO medium.
A CHO cell batch culture was carried out to collect samples that could be tested
using the lactate biosensor as well as using a bioprofiler machine (the current
industry standard for cell culture sample metabolite analysis). There was a good
match between lactate concentrations in spent culture medium dilutions determined
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through the two methods. When the same approach was applied to cell culture
samples, the results from the two methods were similar for one time point, but
differed significantly for a later time point.
There are a number of things that need to be tested for novel sensing or monitoring
methods (Derfus et al., 2010): Equivalence of measurement to previous methods,
reproducibility of measurements, length of sampling process, sensitivity, specificity,
required sample volume, interference, ability to give quantitative versus qualitative
information and measurement window over which quantification is possible (i.e.
dynamic range).
The Bioprofiler 400 Analyzer used in this work can monitor lactate in the
approximate concentration range 2-50 mM. The lactate biosensor presented in this
work can detect lactate in a lower concentration range of approximately 0.01 mM
to 14+ mM, though the exact dynamic range can change with cellular growth
conditions and presence of other compounds in the samples. It is therefore possible
to determine the lactate concentration in samples that would be below the detection
limit using the Bioprofiler. Furthermore, as samples get diluted 1:5 when added to
the bacterial biosensor culture, the protocol used here would allow samples with
higher lactate content to be tested as well. The level of dilution could be modified
to some extent for different cell cultures if needed. Overall, the dynamic range of
lactate sensor and testing protocol presented here can cover the lactate concentration
range found in mammalian cell culture samples.
As the dynamic range of the lactate biosensor is so much lower than for the
Bioprofiler, it was difficult to use the Bioprofiler for validation here. Only a small
number of samples showed lactate concentrations that could be accurately detected
by both methods. An alternative established method for lactate analysis could
be used to validate the results of the biosensor in the lower concentration range.
Examples of possible methods include enzymatic assays (e.g. the lactate oxidase
assay), HPLC or mass spectrometry-based methods.
The lactate sensor presented here can be used to quantitatively determine lactate
concentration in cell culture samples grown in DMEM and CD CHO growth media.
The biosensor cells are very low cost compared to the reagent packs that need
to be purchased for the Bioprofiler. As the sensor is based on the transcription
machinery of living cells, the output of the biosensor could in future be linked to a
more complex biological response by the bacterial cells. For instance, the bacterial
cells could produce nutrients for the mammalian cells as needed or deplete waste
compounds. Alternatively the bacteria could produce compounds to induce mAb
production by the mammalian cells.
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However, as can be seem from the large difference in the last cell culture samples,
there are ways in which the use of the biosensor needs to be improved and factors
that may affect the function of the sensor. The large difference shown for the late
time point could be due to a number of reasons.
Mammalian cell culture is a very complex biological context. Mammalian growth
media contain many complex molecules that have the potential to interfere with
biosensor function. Undergraduate student Harry Taylor showed that glutamate,
galactose and mannose can all disrupt the sensing function of the biosensor under
certain conditions (data not shown, unpublished data).
As mentioned above, in the current protocol cell culture samples are diluted 1:5
during addition to the biosensor culture. While this can be advantageous, it also
means that small errors in calculating the concentration will be amplified 5-fold
when calculating back to the original sample.
The lactate concentration in cell culture samples in this work was calculated using
the information from a lactate standard curve. The way this curve was constructed
was by picking a particular time point to compare the standard and sample results.
This introduces a source of error and bias. Variances in any given time-point will
affect the result. A better way of doing this analysis would be to use an average
over several time points. Alternatively, integration over the whole time course could
be used, thus greatly reducing bias of selecting a particular end-point and error due
to point-to-point variation. GFP synthesis rate rather than normalised fluorescence
was used. But other options could be investigated.
There are always small differences in bacterial cell growth between different runs of
a characterisation experiment. For this reason, use of the biosensors in this work for
analysis of cell culture samples currently always needs to include a set of standard
known lactate concentrations to create a dose-response curve for a given experiment.
However, this is also the case for most current methods used for metabolite analysis,
including the BioProfiler, enzyme assay kits and HPLC methods. Because of the
growth differences, it can be complicated to combine datasets collected in separate
experimental repeats. There is ongoing work by Catherine Ainsworth (CSynBI,
Imperial College London) to address this problem that occurs in many areas of
synthetic biology by using novel data analysis methods.
For these biosensors to be used in industrial contexts, changes to the process
technology would need to be considered as well as any regulations from governing
bodies concerning the use of bacterial cells in this context. The system would be an
example of contained use of genetically engineered organisms.
154
Many of the sensors shown here work well as biosensors and with some further
characterisation and optimisation could be used in many contexts including
mammalian cell culture. All the parts shown also represent bioparts that have
been characterised under specific sets of conditions and that could be used by the
synthetic biology community. The biosensors presented in this work (for lactate,
leucine, alanine and glutamine) contribute to the field of biosensors and bioprocess
monitoring.
Proteins and peptides are involved in many biological processes and represent many
important biopharmaceuticals. Amino acids are the monomers of these proteins.
This is why ways to calculate the concentration ranges of amino acids in cell culture
are of vital importance (Mustafi et al., 2011; Rollie´ et al., 2012; Kyriakopoulos,
2014). While the use of in vivo biosenors in complex contexts is still a nascent
technology, it offers exciting prospects for the future (Bracewell and Polizzi, 2014).
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10.4 Future work
There are many further lines of investigation that were opened up by the results
shown in this investigation. These are discussed below. The main themes are that
the biosensors that are shown this work could be progressed to a fully functional
stage for monitoring mammalian cell cultures and that the biosensors could be
developed towards more complex applications.
The biosensors presented here could be progressed to a stage of being fully usable
for monitoring mammalian cell cultures. While the lactate biosensor was the most
promising biosensor in this work in terms of the sensing characteristics, the B.
subtilis glutamine sensor and several of the Lrp promoters also showed promising
results. Further work on the characterisation could lead to these sensors also being
used on cell culture samples.
Many further cell culture samples could be analysed using the sensors shown here.
There are currently plans for a CHO cell culture in collaboration with Cher Goey
(Chemical Engineering, Imperial College London) during which supernatant samples
will be collected. These samples will be analysed using the Bioprofile Analyzer
as well as the lactate biosensor presented here. This will allow for further cross-
validation of the biosensor. This culture will use a bioreactor as opposed to the
cell cultures shown in this work, which were based in flasks. This will make the
culture conditions more relevant to industrial contexts. As the bioreactor represents
a very different cellular environment compared to flasks, the dynamics seen in these
samples may be very different to those shown in this study.
During the glutamine requirement experiment (see Chapter: Hybridoma cell culture
characteristics) culture supernatant samples were collected and stored. These
samples will be analysed using the biosensors in this work.
The biosensor systems could be modelled mathematically, which is an important part
of the synthetic biology design cycle. Understanding the underlying mechanisms
of the biosensors well enough to allow for prediction would greatly improve the
applicability of the sensors. Preliminary attempts have been made to write a
mathematical model describing the mechanism of the lactate sensor. The main
limitation here is knowledge of biochemical parameters for the different systems.
As discussed above, there are a number of ways the statistical data analysis for
determining the lactate concentration in cell culture samples could be improved.
For instance, by using integration over the GFP synthesis rate graphs to create the
dose-response curve instead of just picking an end-point value. Different possible
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analysis methods will need to be tested and compared to select the most accurate
option.
There is also ongoing work by Catherine Ainsworth (CSynBI, Imperial College
London) for how to properly combine datasets collected in separate experiental
repeats. Currently this can be complicated due to slight differences in cell growth in
different runs. Once this work is at a usable stage, it would be interesting to apply
it to the data shown herein.
Instead of collecting cell-culture samples for off-line analysis, it would be good to
be able to co-culture the mammalian cells with the bacterial biosensor cells for
on-line monitoring of cell cultures. In addition, only in a co-culture system could
the bacterial biosensor function be linked to a biological response that could feed
information back into the mammalian cell culture. There are many factors that
need to be considered to create such a system (Goers et al., 2014). According
to Mulchandani and Bassi (1995), any scheme for online monitoring needs: 1) a
biosensor; 2) a way of making contact between sensor and culture medium; and 3)
control system to implement a suitable control strategy.
As mentioned above, the biosensors may not work in certain complex media. Steps
would need to be taken to keep the biosensor cells in appropriate conditions. As an
example, bacterial and mammalian cells would need to be separated, e.g. using a
semi-permeable membrane and kept in optimised growth medium. In a system akin
to flow injection analysis, the bacterial biosensors could be exposed to small volumes
of mammalian cell culture volume. Therefore, while this project concentrated on the
biological aspects of the system, the results can inform the kind of bioreactor set-up
that will be required e.g. to prevent contamination of mammalian cells with bacterial
cells. The fact that B. subtilis cells show reduced growth in DMEM compared to
E. coli cells could be useful here for controlling bacterial growth.
Mammalian cell culture is only one of many possible contexts where the metabolite
biosensors presented here could be applied to answer important biological questions.
The possible examples are countless, including industrial processed and fundamental
biology. There are already plans to use the lactate biosensor and a number of the
leucine/alanine biosensors to monitor chemical reactions involving these compounds.
Similarly, there are currently plans and ongoing work to expand the use of the
biosensors used here. This includes work towards using the sensors in a cell-free in
vitro context or directly inside mammalian cells.
The strategy used in this work for engineering metabolic biosensors could be applied
to other natural sensing systems, for example those listed in Table 1.3 (see Chapter:
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Introduction). Over the course of this work, the procedure used for engineering
biosensors was optimised extensively. This means that if this procedure were applied
to a new potential biosensor system, results could likely be obtained much faster than
was the case in this study. However, there are some ways in which the procedure
used in this work to create biosensors could be further improved in order to get
results faster. For instance, instead of the BioBrick method, faster DNA assembly
methods could be used, such as the Gibson method.
The functions of several biosensors could be combined. Mammalian cell culture is a
complex environment. There may not be a single limiting factor to cell growth and
productivity, but several parameters may need to be considered. Using synthetic
biology logic gates based on DNA constructs (Miyamoto et al., 2012) it is possible
to detect several metabolites and integrate the information into a cellular response.
Statistical methods such as principal component analysis (PCA) could be used to
determine suitable combinations of targets.
Results may also suggest ways to design artificial metabolite-responsive promoters
of predictable strength by combining certain transcription factor binding sites in
the same promoter. This has previously been done for the glnAp2 promoter (Bulter
et al., 2004).
By combining the function of several biosensors, certain limitations could be
overcome. For example the fact that the Lrp biosensors shown here are responsive
to both leucine and alanine. If either a specific leucine or alanine biosensor could
be constructed then both metabolites could be monitored.
By monitoring several parameters, very complex biological processes can be studied
(Goers et al., 2013). Correlation analysis and other statistical methods could be
used to find a suitable combination of parameters for a given biological process to
be studied.
Finally, these whole-cell bacterial biosensors have great potential. By linking the
detection step to a transcriptional output, the bacterial cells could directly respond
to the information by changing culture conditions. This could lead to a low-cost
artificial symbiosis system.
If successful, the artificial symbiosis system could lead to a new kind of modular
bioreactor, in which different bacterial cell cultures can be used to provide nutrients
or remove waste products on demand for a mammalian cell culture (see Fig. 10.1).
158
Figure 10.1: Possible future bioreactor design using mammalian-bacterial
artificial symbioses. In this system, each of the different bacterial populations
produce nutrients for the mammalian cells in response to a target population-
specific signal
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